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Background: Neonatal infections remain a leading cause of newborn deaths globally. In 2015, 
the World Health Organization (WHO) issued guidelines for managing possible serious bacterial 
infection (PSBI) in young infants (0-59 days) using simplified antibiotic regimens when 
compliance with hospital referral is not feasible. Bangladesh was one of the first countries to 
adopt WHO’s guidelines for implementation. This implementation research study assessed 
fidelity and acceptability of the guidelines in three rural sub-districts of Bangladesh during 
August 2015-August 2016. 
Methods: This study was conducted in 19 primary health centers and their catchment areas. 
Facility readiness was assessed using checklists completed by study staff at three time points and 
case management data were extracted from registers weekly. Questionnaires were administered to 
caregivers of cases to assess treatment adherence. To measure fidelity, we assessed 1) trends in 
provider adherence to guidelines; and 2) conducted a multinomial logistic regression to assess 
patterns and determinants of caregiver adherence to the oral amoxicillin regimen. Caregiver 
acceptability was measured for key guideline components including acceptance of referral and 
simplified antibiotic treatment.  Focus group discussions and in-depth interviews with providers 
and caregivers were conducted to identify barriers and facilitators for implementation fidelity and 
acceptability.  
Results: Provider errors in classification and antibiotic treatment were highest at the beginning of 
the study period, but performance improved over time. Qualitative data suggest errors in early 
implementation may be due to providers learning new methods for assessment and treatment, and 
some providers’ concerns about the efficacy of simplified antibiotic regimens. Few caregivers 
accepted referral to the hospital, which was attributed to previous negative experiences at these 
facilities. Caregivers that received follow-up from the provider during the illness episode were 
less likely to provide fewer than the recommended doses of oral amoxicillin. Acceptability of 
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simplified antibiotic treatment was high, especially when caregivers had trust and good 
communication with the provider. 
Conclusions: Clinical supervision and mentoring are important drivers of implementation when 
introducing complex guidelines. Strategies to monitor early performance and targeted supports 
are important for enhancing implementation fidelity. Counseling on continued treatment and 
follow-up by the provider improved caregiver acceptability and adherence to the simplified 
antibiotic regimen.  
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Abbreviations & Key Definitions 
CHW: Community Health Worker 
CI: Critical illness (CI) in a young infant (0-59 days) is characterized by the presence of any of 
the following signs: unconscious, convulsions or history of convulsions, unable to feed at all, no 
movement on stimulation, unable to cry, persistent vomiting, bulging fontanelle, cyanosis. 
CSI: Clinical severe infection (CSI) in a young infant (0–59 days old) is characterized by the 
presence of at least one of the following signs: severe chest in-drawing, hypothermia (<35.5C), 
fever (>37.5C), movement only on stimulation, not feeding well (based on history and 
observation). 
DGFP: Directorate General of Family Planning  
DGHS: Directorate General of Health Services  
FGD: Focus Group Discussion 
FPI: Family Planning Inspector 
FWV: Family Welfare Visitor 
IFB (<7 D): Isolated Fast Breathing (IFB), characterized by a respiratory rate of greater than or 
equal to 60 breaths per minute as the only sign of infection, in an infant 0-6 days old. 
IMCI: Integrated Management of Childhood Illness  
MaMoni HSS: MaMoni Health System Strengthening project 
MOHFW: Ministry of Health and Family Welfare 
PSBI: Possible Serious Bacterial Infection (PSBI) is a clinical syndrome used in the Integrated 
Management of Childhood Illness package referring to a sick young infant (0-59 days old) who 
requires urgent referral to hospital. Per WHO guidelines, young infants with one or more clinical 
signs of possible infection:  
▪ Respiratory rate >=60 per minute if <7 days 
▪ Severe chest in-drawing 
▪ Hypothermia (<35.5 ºC)  
▪ Fever (>=38.0 ºC)  
▪ No movement or movement only upon stimulation 
▪ Convulsions 
▪ Feeding poorly or not feeding at all 
 
SACMO: Sub-Assistant Community Medical Officers 
SAT: Simplified Antibiotic Therapy 
UH&FWC: Union Health & Family Welfare Centers 
UHC: Upazila Health Complex 
WHO: World Health Organization 
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Chapter 1.  Introduction  
Bangladesh observed an impressive decline in under-five mortality and achieved the 
fourth Millennium Development Goal for child survival (1). Deaths in neonates, however, have 
been declining at a lower rate than mortality in older children. As a result, the proportion of 
under-five deaths occurring in the neonatal period increased from 44% in 1990 to 62% in 2015 
(1). With a neonatal mortality rate of 28 per 1,000 livebirths, the country experiences over 74,000 
neonatal deaths annually. Most of these deaths are due to three causes: prematurity, infections, 
and intrapartum-related complications (1-3). Progress towards reducing neonatal mortality due to 
these three causes is imperative for Bangladesh to achieve the Sustainable Development Goals 
target of 12 neonatal deaths per 1,000 livebirths by 2030 (1). 
Neonatal infections, including sepsis, meningitis and pneumonia, remain a leading cause 
of newborn death in Bangladesh. Severe infections have a rapid onset and definitive diagnosis is 
often not possible (4). A recent population-based cohort study in rural Bangladesh attributed 46% 
of all neonatal deaths to serious infections (5). The World Health Organization (WHO) 
recommends that young infants (0-59 days) with signs of possible serious bacterial infection 
(PSBI) be referred to hospitals and treated with a seven to 10-day course of a combination of two 
injectable antibiotics: gentamicin and either penicillin or ampicillin (6). However, in resource-
limited settings, many young infants with PSBI do not receive the recommended inpatient 
treatment because hospital care may not be accessible, acceptable or affordable (6). Based on trial 
data from South Asia and sub-Saharan Africa, WHO issued new guidelines in 2015 for managing 
PSBI in young infants, when referral is not feasible for families, with simpler antibiotic regimens 
that include fewer doses of injectable antibiotics coupled with oral antibiotics delivered by care 
providers closer to the community (6-9). Findings from these studies also contributed to a new 
evidence-base of implementation strategies for safely delivering outpatient treatment to newborns 
in resource-constrained settings (4, 9-13). 
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Recognizing the need to increase access to and coverage of newborn health services, 
particularly management of PSBI, the Government of Bangladesh developed and implemented 
the National Newborn Health Program as part of the 4th Health, Population and Nutrition Sector 
Program (14). Bangladesh was one of the first countries to adopt the WHO guidelines and adapt 
them into national guidelines as part of a Comprehensive Newborn Care Package of interventions 
targeting leading causes of neonatal death in the country (14-16). Effective implementation of the 
updated guidelines requires multi-stakeholder partnership and collaboration across the health 
system (17). Implementation research provides an opportunity to study how interventions work in 
real world conditions, aiming to bridge the gap between evidence and practice to accelerate 
development and equitable delivery of health services (4, 17, 18). 
Guided by principles of implementation research, Johns Hopkins University and other 
development partners collaborated with Bangladesh’s Ministry of Health and Family Welfare 
(MOHFW) to support the rollout of national guidelines for managing infections in young infants 
at outpatient primary health centers in selected districts (16). The aim of this implementation 
research study is to share early program learnings and provide recommendations for 
strengthening the program as it is scaled-up in Bangladesh. This dissertation will discuss support 
to the MOHFW-led implementation of the guidelines in 3 sub-districts of 2 districts in 
Bangladesh, focusing on implementation strategies—informed by WHO’s guidance and 
embedded in the local context (12, 13)— and assessment of the implementation research 
outcomes of fidelity and acceptability of the guidelines (Figure 1).  
The first chapter of this dissertation provides background on the development of WHO’s 
guidelines for managing PSBI in young infants when hospital referral is not feasible, the 
Government of Bangladesh’s adoption of WHO’s guidance and adaption into national guidelines, 
and rationale for studying implementation of the guidelines (Figure 1). Chapter two focuses on 
the study context and intervention and provides an overview of the parent study’s implementation 
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support and embedded mixed methods evaluation activities. Chapters 3-5 discuss the main 
findings of this dissertation by study objective: 
1) Provider performance and facility readiness for managing infections in young infants 
in primary care facilities (Chapter 3) 
2) Caregiver acceptability of the guidelines for managing young infants with possible 
serious bacterial infections (PSBI) in primary care facilities (Chapter 4) 
3) Patterns and determinants of caregiver non-adherence to oral amoxicillin for sick 
young infants receiving simplified antibiotic treatment (Chapter 5) 
Finally, Chapter 6 provides a summary of the study’s findings, including implications for 
programs and policies, study strengths and limitations, and opportunities for future research.  
1.1 Background 
Global guidance—Development of guidelines for management of PSBI in young infants 
when hospital referral is not feasible 
In 1999, findings from a field trial in Gadchiroli, India, demonstrated that home-based 
care of newborns, including management of sepsis, could cut neonatal mortality in half (19). 
Subsequent trials also achieved substantial reductions in neonatal mortality through 
implementation of a package of community-based health care interventions (19-21). In rural 
Bangladesh, a package of newborn health interventions delivered through antenatal and early 
postnatal home visits contributed to a 34% reduction in neonatal mortality (20, 22). A 
commonality across these studies was an intervention package, which included home visits 
during the neonatal period, identification and treatment of sick infants by community health 
workers and facilitation of referral to hospitals when accepted by the families (19, 21-23). 
In 2007, a research initiative organized through the collaborative efforts of WHO, 
USAID, and Save the Children/Saving Newborn Live (SC/SNL) convened multiple stakeholders 
to review the existing evidence on neonatal and young infant care. The goal was to identify 
simple, safe and effective treatment regimens that could be provided to young infants with 
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suspected infections when inpatient care was not feasible for families (24). The panel concluded 
that the current evidence was insufficient to recommend antibiotic treatment of severe infections 
at the community-level. Experts called for additional research on shorter-course antibiotic 
therapies, simple diagnostic algorithms, and optimal delivery strategies appropriate for severely 
resource-constrained health systems (24). 
In response to this call for additional research, three randomized, open-label, equivalency 
trials evaluated simplified antibiotic regimens—including fewer injections combined with oral 
amoxicillin—for managing PSBI in young infants in community settings when compliance with 
hospital referral was not feasible for families. These trials were conducted in Bangladesh, 
Pakistan and three countries in Africa— Democratic Republic of the Congo (DRC), Kenya and 
Nigeria. Study protocols were harmonized, but models for service delivery varied based on the 
context to allow integration into existing programs and test delivery strategies in different 
resource-constrained settings (25).  Investigators concluded that simplified antibiotic regimens 
were as efficacious as the standard regimen—procaine benzylpenicillin and gentamicin once per 
day for seven days—in treating clinical severe infection in young infants when the families 
refused hospital admission (7, 9, 26). The Africa trials also assessed a simplified treatment option, 
which included no injections, for young infants presenting with fast breathing as the only sign of 
PSBI. They found that oral amoxicillin twice per day for seven days was as efficacious as the 
standard injectable regimen for treating isolated fast breathing in these infants (9).   
Based on a systematic review of the evidence available from these trials, in 2015, the 
WHO issued new guidelines for resource-limited settings for outpatient management of PSBI in 
young infants when the family does not accept or cannot access hospital care (6, 7, 9, 26). The 
WHO recommends if inpatient care is not feasible for families, the sick infant should be managed 
in outpatient settings by trained providers according to one of two treatment regimens (6, 12, 13):  
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- Option 1: Intramuscular gentamicin (5–7.5 mg/kg [for low-birth-weight infants 
gentamicin 3–4 mg/kg]) once daily for seven days and twice daily oral amoxicillin (50 
mg/kg per dose) for seven days 
- Option 2: Intramuscular gentamicin (5–7.5 mg/kg [for low-birth-weight infants 
gentamicin 3–4 mg/kg]) once daily for two days and twice daily oral amoxicillin (50 
mg/kg per dose) for seven days. Close follow-up is essential. A careful assessment on day 
4 is mandatory. 
It is expected that individual countries will adapt the WHO recommendations based on their local 
social, economic and cultural contexts (6). For example, national governments are expected to 
select Option 1 or Option 2 based on the expected feasibility of providing seven versus two days 
of injectable antibiotics in their public sector outpatient facilities (6, 12, 13).  
National policy development—Bangladesh’s adoption of WHO’s guidelines and adaption 
into national guidelines 
Since the launch of Bangladesh’s National Neonatal Health Strategy in 2009, newborn 
health policies have been developed through a series of consultations with newborn health 
experts, development partners, and global stakeholders under the leadership of the National 
Technical Working Committee for Newborn Health (NTWC-NBH) (14, 27). In 2013, the 
Government of Bangladesh reinforced its commitment to ending preventable child deaths by 
2035 through the A Promise Renewed declaration and identified the need for scale-up of 
evidence-based newborn health interventions to reduce neonatal mortality (15). The NTWC-NBH 
recommended four key newborn health interventions targeting the top causes of neonatal death in 
the country: prematurity, infections, and intrapartum-related complications (1, 2, 14). These 
interventions were approved by the National Core Committee on Neonatal Health, and NTWC-
NBH guided the development of national guidelines for each of the four interventions—including 
prevention and timely treatment of neonatal infections—as part of a Comprehensive Newborn 
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Care Package (15, 16, 27). Bangladesh adopted the WHO recommendations and adapted them 
into national guidelines for inclusion in the Comprehensive Newborn Care Package (14, 16). 
Guidance on implementation strategies and implementation research to support rollout 
of guidelines in resource-constrained settings 
Findings from the globally coordinated studies on simplified antibiotic treatment also 
contributed to a new evidence-base of implementation strategies for safely delivering outpatient 
treatment in severely resource-constrained settings (4, 9-12) (Figure 1). In 2015, WHO 
spearheaded efforts to conduct implementation research studies across multiple country sites to 
prospectively study implementation outcomes and inform guidance on operationalizing the 
guidelines (12). Implementation research provides an opportunity to understand ‘how’ and ‘why’ 
evidence-informed interventions lead to health impact (17, 18). It involves working with multiple 
stakeholders including government managers, healthcare providers and the beneficiaries of 
services (18).  
The WHO-coordinated implementation research studies included multiple demonstration 
sites in Bangladesh, Pakistan, India, Nigeria, Malawi, DRC, and Ethiopia (12). An USAID-
funded implementation research study was undertaken in three different districts of Bangladesh to 
operationalize and evaluate adoption of the new guidelines in primary health facilities (4). Study 
protocols were harmonized across the study sites, but technical support varied based on the local 
context and health system. Mixed methods data collection was embedded in program rollout and 
lessons around implementation were shared across demonstration sites in periodic meetings with 
stakeholders (4, 6, 12).  
Implementation research outcome variables evaluated in dissertation objectives 
The study objectives of this dissertation focus on evaluation of the fidelity and 
acceptability of the intervention and relevant implementation strategies—shaded boxes in Figure 
1. Fidelity is defined as the extent to which an intervention is implemented as intended in the 
7 
 
original protocol (28, 29). Evidence-based practice often assumes that an intervention is being 
implemented in accordance with the published recommendations, which may be problematic in 
real-world delivery systems (29, 30). It has been suggested that implementation fidelity acts as a 
potential moderator of the relationship between a public health intervention and the intended 
health outcomes (17, 29, 30). In other words, understanding and measuring intervention fidelity 
enables researchers and practitioners to better understand how and why an intervention works and 
the degree to which outcomes can be improved (30).  
Implementation fidelity is described and defined in the literature by five dimensions: 
adherence, quality of delivery, program component differentiation (i.e., elements essential for 
program success), exposure to the intervention, and participant responsiveness (29, 30). For this 
study, implementation fidelity is assessed for provider adherence to the treatment guidelines and 
caregiver adherence to the oral amoxicillin regimen. 
Acceptability is the perception among implementation stakeholders that an intervention is 
agreeable or satisfactory and is typically measured based on different aspects of the intervention 
and through the perspectives of various stakeholders (31). Acceptability is an important precursor 
to adoption of an intervention and will likely affect the long-term sustainability of the 
intervention (18, 31).  In this study, we assessed caregiver acceptability of the guidelines from the 
perspective of both providers and caregivers.   
Expected health outcomes and impact 
The updated infection management guidelines aim to increase coverage of treatment for 
newborn infections through provision of public sector care that more affordable, accessible, and 
acceptable for families (6, 12, 32). The findings from this study will contribute to the global 
efforts to increase treatment access for families of young infants in low-resource settings that are 
unable to seek hospital care, which has the potential to reduce neonatal mortality globally due to 
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1.3 Figures for Introduction 
Figure 1. Conceptual framework for implementation research study objectives evaluated in this dissertation 
 
Figure legend: Implementation strategies recommended by WHO and adapted to local context (6, 12, 13). Shaded boxes include the 




Chapter 2. Methods 
The three objectives of this dissertation are discussed in the subsequent chapters 
(Chapters 3-5). Each aim was nested in the USAID-funded, JHU-led parent study Implementation 
research to support Bangladesh Ministry of Health and Family Welfare to implement its national 
guidelines for management of infections in young infants in two rural districts. This chapter 
provides and overview of the parent study including the study context and intervention, 
implementation support activities and embedded mixed methods evaluation. The objective-
specific implementation strategies, data collection methods, and analyses are discussed in the 
subsequent chapters to improve clarity for the objective-specific results and recommendations.  
2.1 Context and intervention 
 
Bangladesh is in the northeastern part of South Asia. Bangladesh is divided into eight 
administrative divisions, which are further divided into districts and sub-districts. In rural areas, 
sub-districts are divided into unions, then into wards (1). Our study area included union-level 
health centers in two sub-districts of Sylhet in Sylhet division and one sub-district in Lakshmipur 
in Chittagong division. Sylhet and Chittagong are historically low performing divisions of 
Bangladesh for maternal, newborn and child health indicators, including low rates of facility 
delivery and skilled attendants at birth (1). According to the 2014 DHS, Sylhet and Chittagong 
divisions had the highest fertility rates (2.9 and 2.5 respectively) and the highest proportion of 
unmet family planning need (18% and 17% respectively) in the country (1). Mothers in Sylhet are 
also the least likely to receive antenatal care from a medically trained provider. When compared 
with the rest of the country, these mothers also had the lowest proportion of births in facilities and 
lowest proportion of births attended by a skilled provider (27.1%) (1). In Chittagong, more 
mothers delivered in facilities (35.2%) and a higher proportion of births were attended by a 




Health services in Bangladesh are provided through both public and private sectors and 
involve multiple actors. The country’s pluralistic health system includes the MOHFW, the private 
sector (formal and informal), non-governmental organizations (NGOs), and there is significant 
influence from the international donor community (2, 3). These stakeholders are key actors in 
planning, financing and supporting service delivery of health programs (2). Bangladesh’s 
MOHFW is responsible for policymaking, while implementation of those policies is the 
responsibility of different directorate generals. The Directorate General of Health Services 
(DGHS) and Directorate General of Family Planning (DGFP) are the two most important ones in 
terms of service delivery (2-4). The MOHFW maintains a three-tier system for delivering public 
health care services at all administrative levels and follows the IMCI protocol for management of 
sick children in primary health facilities (Figure 1) (1-3, 5, 6).  
Targeted primary health facilities for implementation of Bangladesh’s national guidelines 
are Union Health & Family Welfare Centers (UH&FWC [catchment ~25,000 persons]) (7). In the 
past, UH&FWCs have been largely under-utilized by communities and many were not fully 
functional due to staff shortages and insufficient equipment (2, 3, 8). These facilities provide 
outpatient services and are generally staffed by 2-3 formally trained providers—the Sub-Assistant 
Community Medical Officers (SACMO) and the Family Welfare Visitor (FWV). Some of these 
facilities have a position for a doctor available, but these posts are often vacant (2, 3, 9). The 
SACMO training and position is equivalent to a Clinical Officer in other contexts, such as sub-
Saharan Africa. The SACMO has 3 years training on general healthcare, including child health, 
from a Government Medical Assistant Training School (3). The FWV has at least 18 months 
training from a private or government facility on midwifery and contraceptive management (2, 3, 
5).  In primary health care facilities, services are highly subsidized by the government, requiring 
no payments from patients (2, 4). 
The SACMO is the designated provider for assessing, classifying and treating young 
infants according to the adapted WHO guidelines. To aid these workers in identifying sick 
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infants, the Bangladesh guidelines include a clinical algorithm for classifying signs of infection in 
young infants, guidance on antibiotic treatment, referral advice and follow-up (7). The algorithm 
is designed to have high sensitivity—as to not miss cases—and includes seven signs of PSBI 
(fever, hypothermia, convulsions, respiratory rate ≥60 breaths per minute if infant is <7 days, 
severe chest in-drawing, no movement or movement only upon stimulation, feeding poorly or not 
feeding at all) as well as other important signs of serious illness (7, 10, 11). If signs of infection 
are identified, then the SACMO classifies the infant as one of four sub-categories of infection—
Critical Illness (CI), Clinical Severe Infection (CSI), Isolated Fast Breathing (IFB), or Local 
Bacterial Infection (LBI) (Figure 2). Accordingly, the SACMO provides the first dose of 
antibiotics based on the infant’s weight and refers the infants with signs of PSBI (i.e., CI, CSI, 
and very young infants [0-6 days] with IFB) to the sub-district hospital (Upazila Health Complex 
[UHC]; catchment area ~250,000 persons) for inpatient care (5, 7). According to the new 
guidelines, young infants aged 7-59 days with fast breathing as the only sign of illness are no 
longer referred to the sub-district hospital. These infants receive outpatient treatment with oral 
amoxicillin—twice per day for seven days (5, 7). 
Young infants classified as CSI or IFB (<7D) whose families decline hospital referral are 
eligible for simplified antibiotic treatment with injectable gentamicin once daily for two days and 
oral amoxicillin twice daily for seven days. Hospital referral is the only option for critically ill 
infants. Caregivers of infants with CSI that decline referral are instructed to return to the 
UH&FWC the next day for the 2nd gentamicin injection. Infants with IFB (<7D) only receive the 
oral amoxicillin regimen. The FWV may provide the 2nd injection if the SACMO is not present at 
the UH&FWC. The SACMO follows-up with caregivers over telephone on the fourth day, and if 
the infant’s condition has not improved, advises the caregivers to seek care at the UHC. On the 
eighth day of treatment, the family receives a home visit from the Family Planning Inspector 
(FPI), who are trained as supervisors of frontline workers, to assess treatment compliance and the 
condition of the infant (7). 
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2.2 Overview of parent study 
 
The parent study for this dissertation—Implementation research to support Bangladesh 
Ministry of Health and Family Welfare to implement its national guidelines for management of 
infections in young infants in two rural districts—was conducted as a part of partner support for 
early implementation of the PSBI guidelines in Bangladesh. Within the first year of 
implementation of the updated guidelines (August 2015-August 2016), the MOHFW received 
support from Projahnmo and the MaMoni Health Systems Strengthening (HSS) project in 3 sub-
districts of the selected districts, Sylhet and Lakshmipur respectively. Projahnmo is a partnership 
of Johns Hopkins University with the Bangladesh MOHFW and other Bangladeshi institutions 
including International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), Shimantik, 
and the Child Health Research Foundation (CHRF). Projahnmo has been working in Sylhet since 
2001 and has experience with conducting surveillance through a team of trained community 
health workers and local managers (12). The USAID-funded MaMoni HSS project is 
implemented by the Maternal and Child Health Program (MCHIP) in six districts of Bangladesh 
with the goal of improving utilization of integrated maternal, newborn, child health, family 
planning and nutritional services (13). The project inputs were primarily focused on improving 
the performance and capacity of health services at the district-level. Since 2003, MaMoni HSS 
project has been working in all upazilas in Lakshmipur to strengthen district-level health systems 
and promote scale-up on maternal, neonatal and child health, family planning and nutrition 
interventions (13). For this study, MaMoni HSS provided support to the implementation of the 
infection management guidelines in one sub-district of Lakshmipur (Ramganj). Both Projahnmo 
and MaMoni HSS partnered with the MOHFW to ensure the implementation readiness of 
UH&FWCs to manage infections in young infants, including support to the training and 
supervision of providers in the infection management guidelines 
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Health centers in the project areas were selected for targeted support based on the 
presence of the designated provider (i.e., SACMO) at the facility. Nine health centers in Zakiganj 
and Kanaighat sub-districts of Sylhet and 10 health centers in Ramganj sub-district of 
Lakshmipur received implementation support and were included in the implementation research 
study. Project partners’ implementation strategies focused on improving readiness of targeted 
health centers to implement the guidelines, supporting the MOHFW to build capacity of 
providers, and promoted awareness and community engagement with the public sector healthcare 
system. Additional details on our implementation strategies are provided in Supplemental Table 
1. 
 The measurement and evaluation component of this study was led by JHU with support 
of MaMoni HSS in Lakshmipur and Projahnmo in Sylhet, utilizing a mixed methods approach to 
assess the following implementation research objectives: 
1) Examine feasibility of implementation of the newly developed infection management 
guidelines in young infants at UH&FWCs through outpatient services when referral is not 
accepted 
2) Assess the acceptability of infection management services delivered on an outpatient 
basis at UH&FWCs among the parents and families of young infants 
3) Measure caregiver knowledge and coverage of infection management for young infants 
4) Assess the compliance of the families to the referral advice and new treatment regimen 
for young infant infections delivered at UH&FWCs 
5) Document the safety of the injectable antibiotic therapies delivered at union-level 
facilities as per national guidelines for infants classified as clinical severe infection who 
refuse referral advice 
6) Identify the enabling and hindering factors, and develop strategies to address barriers to 
the implementation of the national guidelines for management of infections of young 
infants at the union-level health facilities 
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To assess these outcomes, mixed methods data collection activities were carried out in 19 unions 
located in Sylhet (N=9) and Lakshmipur (N=10). In the parent study, quantitative data collection 
included rolling household surveys, health facility checklists, extraction of case data from health 
provider registers for young infants, and treatment adherence questionnaires with caregivers of 
infection cases in the community. Qualitative data was collected through process documentation 
activities, in-depth interviews with senior level program implementers, and in-depth interviews 
and focus group discussions with healthcare providers and caregivers. Over the course of the one-
year implementation research study, two stakeholder workshops were held in Dhaka. Through 
these workshops, implementation partners shared early learnings from implementation support 
and evaluation activities and worked together to develop solutions to better support subsequent 
implementation of the guidelines. 
2.3 Protection of human subjects 
 
The parent study was submitted and approved by the Johns Hopkins School of Public 
Health Institutional Review Board (JHSPH IRB) and the Ethical Review Committee of the 
Bangladesh Institute of Child Health (BICH) prior to study initiation. The JHSPH IRB granted a 
waiver for the health facility checklist as non-human subjects research. For the household survey 
and the follow-up with cases in the community, we developed written informed consents, in both 
English and Bengali, at an appropriate comprehension level for all respondents for each activity. 
The consent forms for all study activities were approved by JHSPH IRB as verbal consent forms. 
Thus, research assistants read aloud the informed consent document to respondents prior to 
beginning the survey, questionnaire or interview. Informed consent was obtained for each 
activity. As part of the informed consent procedure and document, the respondent was reassured 
that they may withdraw participation at any time without penalty or consequence to their infant’s 
care. Data collectors were trained in research ethics and the informed consent process following 
18 
 
the JHSPH IRB guide for training field researchers. Each data collector was also given a copy of 
the translated version in Bangla.  
The study activities were considered low risk to participants with the primary risk being 
to their privacy. Nevertheless, our research team took precautions to ensure the respondents’ 
privacy and sensitive information was protected throughout the study period. Data collectors 
informed the participants that the study team would work to keep their identity—and the identity 
of their infant—confidential. As part of the study team’s efforts to maintain confidentiality, all 
questionnaires and documents with identifiers were kept under lock and key and their names were 
not shared with people outside of the study. Additionally, we took precautions when sharing 
findings from the interviews with health providers to not disclose identifying information about 
their specific position or facility affiliation.   
2.4 Dissertation study objectives nested in parent study 
The subsequent chapters of this dissertation discuss mixed methods findings on 
implementation fidelity and acceptability of the guidelines from the perspectives of healthcare 
providers and caregivers (Table 1). Each paper will contribute to the larger study objectives 
through assessing health facility readiness and provider performance on the guidelines, caregiver 
acceptability of care provided according to the guidelines, and caregiver adherence to the home-
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2.6 Tables for Chapter 2 
 
Table 1. Framework of implementation research outcomes and measures by dissertation study objective 
 






Qualitative Themes Quantitative Qualitative 
Paper 1: Provider performance and facility readiness for managing infections in young infants in primary care facilities  
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providers could 
deliver the program 
as planned? 
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of facilities with 
essential commodities 
and frequency of 
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To what extent did 
providers adhere to 
the guidelines?  
Change in provider 
performance on the 
guidelines over the 
study period 
Paper 2: Caregiver acceptability of the guidelines for managing young infants with possible serious bacterial infections (PSBI) in 
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Qualitative Themes Quantitative Qualitative 
agreeable or 
satisfactory 
What was the 
uptake of the 
intervention by 
families in the 
community?  
Percent of expected 
PSBI cases that 
sought care at study 
area health centers 






Paper 3: Patterns and determinants of caregiver non-adherence to oral amoxicillin for sick young infants receiving simplified 
antibiotic treatment in rural Bangladesh 
Fidelity 
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protocol 
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caregivers adhere to 
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Project Partners Implementation Support Activities 
Ensure adequate 
supply of core 
equipment, medicine 




Prior to implementation 
of guidelines, adequate 
supply of essential 
drugs and equipment 
were not available at 
UH&FWCs  
Sub-district 
• The project provided interim support to the MOHFW to ensure core 
items were available in the upazila supply chains for disbursement 
at union level: 
o Equipment:  Thermometer, infant weighing scale, safety box 
for disposal of sharp instruments, ARI timer, insulin syringe  
o Medicine: Injectable gentamicin, oral amoxicillin pediatric 
drops  
o Job aids: Algorithm, dose calculation chart, saf kotha flip chart 
(counseling on Maternal and Newborn Health (MNH) 
messages) 
o Reporting tools: sick newborn and young infant service 
register, prescription forms, referral note, FPI surveillance 
forms  
Union 
• Collaborated with MOHFW throughout program period to fill gaps 
in supply of core items at UH&FWC 
Capacity building of 
health workers to 
manage infections in 
young infants 
Providers involved in 
implementation did not 
have previous training 




• Training in PSBI management followed a cascade approach from 
the national to sub-district level.  A pool of master trainers (MTs) 
were selected from district and sub-district level managers, in both 
DGHS and DGFP, and trained at the national level by a core trainer 
group. 
• Supported the MOHFW to strengthen the quality of care for sick 
infants at the referral facilities, which included training of clinical 
providers on PSBI management; emergency triage, assessment and 
treatment (ETAT); and functioning of Special Care Newborn Units 











Project Partners Implementation Support Activities 
Sub-district 
& Union 
• Provided 5-day training on PSBI management for 87 SACMOs 
including modules on the infection management guidelines 
o Organized an additional 2-day competency-based training 
focusing on completing registers and reporting forms (totaling 
7-days of training) 
• Provided 2-day training to FWV on PSBI management, including 
provision of 2nd dose of injectable gentamicin in the absence of the 
SACMO 
Union 
• Oriented FPIs (1-day) on home follow-up of PSBI cases receiving 
simplified antibiotic treatment 
Supervision of health 
workers managing 
PSBI in young infants 
Vacancies in MOHFW 
manager positions 




• In Lakshmipur, MaMoni HSS introduced a supervision and 
mentoring process to improve the quality of newborn care in the 
SCANU 
Sub-district 
• In each of the 10 sub-districts a medical officer working at the 
UHC was identified by their DGHS supervisor (i.e., Civil Surgeon) 
and appointed as the Newborn Focal Point (NBFP)  
o The NBFP, in coordination with the technical supervisor of 
DGFP (i.e., Medical Officer-MCH-FP), led the implementation 
of the PSBI management in their respective sub-district 
o Led monthly meetings with SACMOs at the UHC, which 
served as a platform for program monitoring, monthly report 










Project Partners Implementation Support Activities 
Union 
• Developed a supervision checklist for PSBI management through a 
consultation process with district and sub-district level managers. 
Sub-district managers used this checklist during onsite supervision 
visits at the UH&FWC  
• Performance on the checklist was reviewed monthly at the sub-
district level and quarterly at district level 
• Project staff periodically joined MOHFW supervisors during visits 
to UH&FWC  
Capacity building of 
CHWs in 
identification of 
newborn illness and 
referral 
Promote new services 
available at UH&FWC 
Ward/ 
Community 
• Oriented Community Clinic staff (e.g., Community Health Care 
Providers [CHCP]) and GoB frontline workers (e.g., Family 
Welfare Assistant [FWA], Health Assistant [HA]) on identification 
of infant illness and appropriate sources of referral. Community 
Clinics (catchment area ~6,000 persons) are at the ward level and 
provide limited outpatient services. FWA and HA provide MNH 
messages during monthly home visits, ANC consultations, and bi-
monthly satellites sessions for immunization and family planning 





• Print media, including billboards and posters, were placed in public 
places to disseminate newborn care messages, and broadcasted 
















Delays in recognition of 
infant illness and 
prompt care-seeking 
from appropriate 




• In Lakshmipur, MaMoni HSS developed a pool of unpaid 
Community Volunteers (CV) (1 per 250 persons) who work as an 
extended arm of GoB frontline workers  
o Oriented CVs on maternal and newborn danger signs and the 
process for community referrals  
• CVs facilitated a peer-led monthly community meeting to collect 
data on vital events and illness episodes (i.e., births, deaths, 
referrals, etc.)  
o Shared data with the GoB CHW during their monthly 
community Microplanning Meetings (cMPM)  
• CVs recorded treatment outcomes for young infants with suspected 
infection that were treated at the UH&FWC 
• In Sylhet, Projahnmo oriented their existing cadre of program 
supported CHWs on the guidelines. During bimonthly home visits, 
CHWs promoted care-seeking from the public sector facilities 
when signs of illness were identified.  
• Projahnmo also oriented members of community groups (i.e., the 
local governing body for the Community Clinics) on newborn 
danger signs, the importance of care-seeking and the new services 
available at the UH&FWC.  
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Chapter 3.  Paper 1: Provider performance and 
facility readiness for managing infections in young 
infants in primary care facilities in rural Bangladesh 
3.1 Abstract  
 
Background: Neonatal infections remain a leading cause of newborn deaths globally. In 2015, 
WHO issued guidelines for managing possible serious bacterial infection (PSBI) in young infants 
(0-59 days) using simplified antibiotic regimens when compliance with hospital referral is not 
feasible. Bangladesh was one of the first countries to adopt WHO’s guidelines for 
implementation. We report results of a prospective implementation research study that assessed 
facility readiness and provider performance in three rural sub-districts of Bangladesh during 
August 2015-August 2016. 
Methods: This study took place in 19 primary health centers. Facility readiness was assessed 
using checklists completed by study staff at three time points. To assess provider performance, 
we extracted data for all infection cases from facility registers and compared providers’ diagnosis 
and treatment against the guidelines. We plotted classification and dosage errors across the study 
period and superimposed a locally weighted smoothed (LOWESS) curve to analyze changes in 
performance over time. Focus group discussions (N=2) and in-depth interviews (N=28) with 
providers were conducted to identify barriers and facilitators for facility readiness and provider 
performance.  
Results: At baseline, none of the facilities had adequate supply of antibiotics. During the 10-
month period, 606 sick infants with signs of infection presented at the study facilities. 
Classification errors were identified in 14.9% (N=90/606) of records. For infants receiving the 
first dose(s) of antibiotic treatment (N=551), dosage errors were identified in 22.9% (N=126/551) 
of the records. Distribution of errors varied by facility (35.7% [IQR: 24.7-57.4%]) and infection 




Qualitative data suggest errors in early implementation may be due to providers learning new 
methods for assessment and treatment, confusion about classifying an infant with multiple signs 
of infection, and some providers’ concerns about the efficacy of simplified antibiotic regimens. 
Conclusion: Clinical supervision and mentoring are important implementation supports when 
introducing complex guidelines in new settings. Strategies to monitor early performance and 
targeted supports are important for enhancing implementation fidelity. Future research should 
examine providers’ assessment of effectiveness of simplified treatment and address 
misconceptions about superiority of broader spectrum antibiotics in treating community-acquired 
infections in young infants in this context.    
3.2 Introduction 
 
Bangladesh was among only a dozen lower-middle income countries to achieve the 
fourth Millennium Development Goal for child survival (1). Neonatal mortality, however, 
remains high (28 deaths per 1,000 livebirths). The slower annual rate of reduction in risk in this 
age group resulted in an increase as a proportion of all under-five deaths occurring in the neonatal 
period—from 44% in 1990 to 62% in 2015 (1-3). Newborn infections, including sepsis, 
meningitis and pneumonia, remain a major contributor to neonatal morbidity and mortality in this 
setting (4, 5). The signs and symptoms of neonatal sepsis are non-specific, which contributes to 
life-threatening delays in diagnosis and treatment, as newborns with severe infections can 
deteriorate rapidly if left untreated (6-8). 
The World Health Organization (WHO) recommends that all young infants (0-59 days) 
with possible serious bacterial infections (PSBI) be referred to hospitals and treated with a 7 to 
10-day course of a combination of two injectable antibiotics: gentamicin and either penicillin or 
ampicillin (9). In resource-limited settings, however, many infants with PSBI do not receive the 
recommended inpatient treatment (9, 10). In 2015, the WHO issued new guidelines for resource-




feasible—including a clinical algorithm for classifying signs of PSBI and guidance on empiric 
treatment with antibiotics (9). The revised guidelines are based on systematic review of the 
evidence, including randomized trials conducted in South Asia and sub-Saharan Africa (11-13). 
These trials demonstrated that simplified antibiotic regimens—including fewer injections 
delivered by care providers closer to the community—resulted in similar rates of clinical failure 
as the standard more complicated regimen (11-13). Individual countries are expected to adopt the 
WHO recommendations and adapt implementation strategies based on their local social, 
economic, and cultural contexts (9, 14-16). Bangladesh was one of the first countries to adopt the 
WHO recommendations based on studies that showed these guidelines could help achieve 20% 
reduction in neonatal mortality (11, 15).  
Bangladesh’s primary health centers targeted for this intervention (i.e., Union Health & 
Family Welfare Centers [UH&FWC]; catchment area 25,000 persons) provide outpatient 
services, including essential health, nutrition and family planning services to mothers and 
children, and are generally staffed by providers with paramedic or medical assistant training in 
allopathic care (17-19). The designated provider for treating pediatric patients in these facilities 
are the Sub-Assistant Community Medical Officers (SACMO)—typically 1 SACMO per 
facility—following the Integrated Management of Childhood Illness (IMCI) protocol. 
Bangladesh’s infection management guidelines will be integrated into the IMCI program, 
replacing the recommended protocol for young infants 0-2 months (9, 10, 20). In 1998, the 
government of Bangladesh (GoB) adopted the IMCI program as a strategy to reduce child 
mortality while improving the quality of care delivered at primary health facilities (21, 22). 
Evaluations of this related strategy identified that these facilities may not be well-equipped or 
supported to deliver IMCI services with notable gaps in provider performance, supervision and 
drugs (23-26). However, IMCI training combined with regular supportive supervision was found 




In 2015, the GoB partnered with funding agencies, implementation groups, and research 
organizations to operationalize the new guidelines in primary health care centers (15). Partner 
organizations undertook an implementation research study, following an adapted action learning 
cycle approach, or a Plan-Do-Study-Act (PDSA) approach, to assess early implementation and 
identify needed supports (29, 30). This study brought together a multidisciplinary stakeholder 
team to deliver a package of evidence-informed implementation strategies to support program 
rollout in rural primary health care centers (15, 31). Mixed methods data collection was 
embedded in study activities and lessons around implementation were shared with partners—
including the GoB—in periodic stakeholder meetings (9, 10, 15). Adjustments to implementation 
strategies were made in real-time based on recommendations developed through these 
stakeholder meetings and following the PDSA approach (15, 29, 30). 
As part of the implementation research study, we partnered with the Ministry of Health 
and Family Welfare (MOHFW) to support improvements in health facility readiness and capacity 
building of providers on the infection management guidelines in three rural sub-districts of 
Bangladesh during the first year of MOHFW-led program (August 2015-August 2016). In this 
paper, we present our implementation strategies and evaluation of fidelity—or the extent to which 
the intervention was implemented as intended in the original protocol (32). The objectives of this 
study were to: 1) assess facility readiness for managing infections in young infants at UH&FWCs 
over time; 2) assess provider performance on classification and providing the first dose(s) of 
antibiotic treatment over time; 3) to identify barriers and facilitators for facility readiness, 
provider performance, and quality of program delivery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
3.3 Methods 
 
Context and Intervention 
 
Bangladesh is divided into eight administrative divisions, which are further divided into 




Our study area included union-level health centers in two sub-districts of Sylhet in Sylhet division 
and one sub-district in Lakshmipur in Chittagong division. Sylhet and Chittagong are historically 
low performing divisions of Bangladesh for maternal, newborn and child health indicators, 
including low rates of facility delivery and skilled attendants at birth (3).  
Bangladesh’s MOHFW is responsible for policymaking, while implementation of those 
policies is the responsibility of different directorate generals—Directorate General of Health 
Services (DGHS) and Directorate General of Family Planning (DGFP) are the two most 
important ones in terms of service delivery (17, 18, 33). The MOHFW maintains a three-tier 
system for delivering public healthcare services at all administrative levels and follows the IMCI 
protocol for management of sick children in primary health facilities (34, 35). Implementation of 
the infection management guidelines targeted union-level primary health facilities (i.e., 
UH&FWCs), which are generally staffed by 2-3 formally trained providers—the SACMO and the 
Family Welfare Visitor (FWV). Some of these facilities have a position for a doctor available, but 
these posts are often vacant (17, 18, 23). The SACMO has 3 years training on general healthcare, 
including child health, from a Government Medical Assistant Training School (17). The FWV 
has at least 18 months training from a private or government facility on midwifery and 
contraceptive management (17, 18, 34). In primary health care facilities, health services are 
highly subsidized by the government, requiring minimal or no payments from patients (18, 33).  
The SACMO is the designated provider for assessing, classifying and treating young 
infants according to the adapted WHO guidelines. Most often, there is only one SACMO posted 
and available to treat pediatric patients at the UH&FWC. Thus, the individual knowledge and 
opinions of these provider will influence adoption and adherence to the guidelines.  To aid these 
workers in identifying sick infants, the Bangladesh guidelines include a clinical algorithm for 
classifying signs of infection in young infants, guidance on antibiotic treatment, referral advice 




and includes seven signs of PSBI as well as other important signs of serious illness (Table 1) (9, 
20, 36). If signs of infection are identified, then the SACMO classifies the infant as one of four 
sub-categories of infection—Critical Illness (CI), Clinical Severe Infection (CSI), Isolated Fast 
Breathing (IFB), or Local Bacterial Infection (LBI). Accordingly, the SACMO provides the first 
dose of antibiotics based on the infant’s weight and refers the infants with signs of PSBI (i.e., CI, 
CSI, and very young infants [0-6 days] with IFB) to the sub-district hospital (Upazila Health 
Complex [UHC]; catchment area ~250,000 persons) for inpatient care (Table 1) (20, 34). If 
referral is not feasible for families, then the guidelines provide guidance on outpatient 
management of CSI and IFB cases with simplified antibiotic regimens. Hospital referral is the 
only option for critically ill infants. Fidelity as an implementation research outcome variable is 
typically measured by comparing the evidence-based intervention to actual implementation (32). 
Here, our analysis focuses on classification and pre-referral antibiotic treatment on the day of 
assessment by the SACMO at the UH&FWC. Henceforth, we will refer to SACMOs as 
“providers,” UH&FWCs as “health centers,” and the UHC as the “sub-district hospital.” 
Implementation strategies 
 
This study was conducted as a part of partner support for early implementation of the 
PSBI guidelines in Bangladesh. Two non-governmental health programs— Projahnmo and 
MaMoni Health Systems Strengthening (HSS)—received USAID funding to support in a sample 
of health facilities in Sylhet and Lakshmipur districts. Projahnmo is a multi-institutional 
partnership including Johns Hopkins University (JHU), the MOHFW, International Centre for 
Diarrheal Disease Research, Bangladesh (icddr,b), Shimantik, and the Child Health Research 
Foundation (37). MaMoni HSS is a USAID-funded program to improve utilization of integrated 
maternal, newborn, child health, family planning and nutritional services (38). Henceforth, I will 




Project partners’ implementation strategies focused on improving readiness of targeted 
health centers to implement the guidelines and supporting the MOHFW to build capacity of 
providers. Health centers in the project areas were selected for targeted support based on the 
presence of a provider (e.g., SACMO) at the facility. Among the 31 health centers in the project 
areas within Sylhet and Lakshmipur, 12 were excluded because the SACMO post was vacant at 
the start of the study. The remaining 9 health centers in Zakiganj and Kanaighat sub-districts of 
Sylhet and 10 health centers in Ramganj sub-district of Lakshmipur received implementation 
support and were included in the implementation research study.  
Prior to rollout of the guidelines, project partners identified gaps in the availability of 
intramuscular gentamicin, oral amoxicillin, and functioning equipment at study area health 
centers. After August 2015, the necessary commodities procured by the project were integrated 
into the existing supply chains and stocks were monitored throughout the study period to ensure 
against stockout. Project partners supported the government’s training of supervisors and 
providers in the infection management guidelines following a cascade approach from the national 
to sub-district levels.  Project partners also supported the distribution of registers, referral slips, 
and job aides to health centers. After August 2015, the guidelines were integrated into the both 
supervision sessions and project partners occasionally joined supervision sessions throughout the 
project period to improve the technical quality of these visits. However, partners did not provide 
inputs to increase the frequency of supervision. Stakeholder meetings were held in January 2016 
and July 2016 to discuss program learnings after the initial rollout of the guidelines and study 
wrap-up respectively. Based on program monitoring data and sharing of learnings across study 
sites, project partners organized refresher trainings for providers in Sylhet (March 2016) and 
Lakshmipur (June 2016) to improve the quality of record keeping and provider adherence to the 
guidelines (Figure 1). 





This mixed methods study took place over a relatively short time period in order to 
inform the implementation of the PSBI guidelines nationally. As such, quantitative and 
qualitative data were collected concurrently following a convergent parallel design (39).  
Specifically, four data collection activities were undertaken: 1) a health facility checklist to assess 
readiness at baseline and over time; 2) weekly extraction of data from facility registers to monitor 
adherence to the guidelines for classification and treatment; 3) focus group discussions and 4) in-
depth interviews with facility providers to identify facilitators and barriers to implementation 
(Figure 1).  Data collection methods and measures are described by data source, below.  
Health Facility Checklist: The health facility checklist, developed in collaboration with 
study partners based on the updated guidelines for infection management, focused on capturing 
health systems data on service-specific readiness (20, 40). Our team piloted the checklist in July 
2015 and adapted questions prior to baseline data collection. The final checklist assessed the 
availability of the following requirements: 1) drugs for treatment of PSBI, including in injectable 
gentamicin and oral amoxicillin pediatric drops; 2) functioning equipment, including an infant 
scale and thermometer; 3) job aids developed for the PSBI guidelines; 4) facility infrastructure, 
including availability of electricity and clean water. The study team member completing the 
checklist physically observed and/or inspected relevant supplies and equipment on the checklist. 
Providers at each facility were also surveyed regarding the supervision that they had received and 
their participation in monthly meetings. The health facility checklist was administered at three 
points during the study period, six months after the start of implementation (March 2016) and 
then at the end of the study (August 2016).  
Case management register review:  To assess provider performance of the guidelines, we 
reviewed case data from a guideline-specific register. Register review was considered the most 
feasible method for assessing provider performance of the guidelines because the number of cases 




(41).  The young infant registers were developed specifically for the infection management 
guidelines and distributed to facilities as part of program rollout. Data collectors visited the 19 
health centers weekly to abstract data from the records of all young infants that sought services 
from October 2015-August 2016. Our team adapted the register into an electronic form and 
recorded data weekly using tablets. For this analysis we included data on the infant’s weight and 
body temperature, signs of illness, classification, and prescribed antibiotics and dosage. 
Qualitative data collection: Both focus group discussions (FGDs) and in-depth interviews 
(IDIs) were conducted with SACMOs to assess their perceptions and acceptability of the 
guidelines using semi-structured interview guides. FGDs were conducted at the sub-district 
hospital on a date that coincided with the providers’ monthly meetings or routine collection of 
medicines from this location. IDIs were conducted in the UH&FWC every 3-4 months during the 
study period.  
All qualitative data collectors were Bangladeshi and conducted the FGDs and IDIs in the 
local language. Following each IDI and FGD, research assistants participated in debriefing 
sessions led by the research officers, to refine the guides and identify emerging themes for follow 
up during subsequent interviews (42). Interviews were recorded and transcribed into English by 
trained translators.  Notes from the debriefing sessions were also translated into English and 
included in the analysis. All providers (N=19) trained in the guidelines and providing care in the 
study area were eligible to participate in the interviews. In the final months of data collection, 
follow-up interviews were conducted with providers for member checking of themes identified by 
the study team during analysis of interviews conducted during early implementation (43). 
Ethics Statement 
 
Ethical approval was obtained for this study from the Johns Hopkins Bloomberg School of Public 
Health Institutional Review Board (JHSPH IRB) and the Bangladesh Institute of Child Health 








Quantitative data were analyzed using Stata version 14 (StataCorp LP). We assessed the 
implementation readiness of the selected 19 health centers based on the health facility checklist. 
Our analysis of provider performance on practice outcomes—assessed by errors in classification 
and dosage—included all infants aged 0-59 days who presented with any signs of infection in the 
algorithm (20). We generated variables based on recorded measurement of the infant’s body 
temperature, respiratory rate and weight to identify signs of illness in the algorithm including 
fever, hypothermia, fast breathing (respiratory rate ≥ 60 breaths/min), and weight <1500 grams. 
Records were excluded if date of assessment or signs of illness were missing. We developed and 
applied a computer algorithm to our record review to assess if the providers assigned the correct 
illness classification based on the signs of illness recorded. If the providers’ classification did not 
agree with the algorithm, then we defined this as a classification error.  
We defined appropriate antibiotic treatment as the infant receiving the correct dosage of 
injectable gentamicin and/or oral amoxicillin based on the infection classification per the 
algorithm. We estimated the correct dosage of injectable gentamicin and oral amoxicillin 
according to the national guidelines and using the dosage chart provided as job aides to the 
providers (Table 1). We used the infant’s recorded weight to calculate the appropriate dose or 
dosage range. For oral amoxicillin, inappropriate dose was defined by if the infant received 20% 
more or less than the recommended dose, as has been used in previous studies (44, 45). We 
defined a dosage error as an incorrect amount of gentamicin and/or amoxicillin prescribed by the 
provider, or if the infant received treatment but their weight and/or antibiotic dosage were not 
recorded.  
Descriptive results for both the health facility checklist and young infant records are 




analyze changes in classification and treatment errors over time, we plotted the classification and 
dosage errors across the study period and superimposed a locally weighted smoothed (LOWESS) 
curve. We also examined variability in classification and dosage errors by facility/provider.   
Qualitative 
 
We adapted Damschoder’s Consolidated Framework for Implementation Research to 
guide our analysis of qualitative data on determinants of feasibility, fidelity and provider 
acceptability of the guidelines (46).  We employed an integrated approach to development of the 
coding framework (47). The framework was developed using a priori codes derived from the 
interview guides and the research questions related to feasibility, fidelity and acceptability of the 
guidelines. Emergent codes were added to the codebook as necessary to capture themes that were 
suggested in the data but not initially anticipated in the a priori codes. We coded transcripts using 
the computer software program Dedoose. This study employed analytical methods of continual 
analysis, coding, and memoing. To inform stakeholder meetings our team reviewed transcripts 
throughout the study period based on both inductive and deductive themes. After each study 
round, we adapted the questionnaire to explore emergent themes. Ultimately, we developed a 
coding framework—including a priori and emergent codes—based on continual review of the 
qualitative data. Each transcript was coded using this scheme and charting of the coded passages 
was used to facilitate interpretation of the data between two researchers. 
Merged analysis of quantitative and qualitative data 
After independent analysis of quantitative and qualitative data, we compared the strands 
based on dimensions of implementation readiness, healthcare providers’ behaviors including the 
assessment and classification of young infants, and acceptability of simplified antibiotic regimen. 
Inferences were drawn for both quantitative and qualitative strands of data and then across strands 






Our results are presented in three sub-sections, which report quantitative data from the 
health facility checklist and young infant records, and qualitative data from group discussions and 
interviews with providers to assess fidelity of the intervention through: 1) health center readiness 
and training of providers; 2) provider performance on practice outcomes (2a. classification and 
2b. antibiotic treatment); 3) influence of implementation strategies on practice outcomes. 
Health center readiness and training of providers 
 
As described above, we excluded 38.7% (N=12/31) of health centers at baseline due to 
the provider’s (i.e., SACMO) post being vacant at the time of study initiation. 19 health centers 
and providers from Sylhet (N=9) and Lakshmipur (N=10) were included in our analysis (Table 
2). We conducted 2 group discussions with providers in the early months of the study (November 
and December 2015), 19 interviews during the study period, and 9 follow-up interviews in the 
final months of the study. Providers participated in every round of the health facility checklist and 
at least one interview during the study period. Most providers were male (84%; N=16). Time in 
their position varied from 1 to more than 20 years with nearly half of the providers serving 1-5 
years in their current post (47%; N=9). 84.2% of the health centers (N=16/19) had the second 
health worker, the FWV, posted at baseline. Through group discussions and interviews, we 
learned that many of these providers also engaged in private practice, outside clinic hours, where 
they receive a fee for seeing patients and providing treatment. 
All providers in our study received at least a 5-day training session on the infection 
management guidelines. When asked about training received, providers reported comprehension 
of the guidelines including the algorithm, referral process, and simplified antibiotic regimen. 
They appreciated the revised register format, which includes a visual depiction of the clinical 
algorithm, and described the job aides as helpful decision-making tools for classifying infection 




interviews and group discussions, providers requested more “practical” demonstrations of a sick 
young infant visit. As one provider explained,  
The demonstration that we watched on the computer screen. It could have been more 
effective we could watch a live demonstration… standing close to the patients... If we 
could see this for real by going to hospital, it would have been better. –Provider in IDI  
 
Prior to implementation of the guidelines, none of the study area facilities had injectable 
gentamicin available. Oral amoxicillin, as pediatric drops, was available at 79% of the facilities, 
but none had an adequate supply (Table 3). Availability of functioning equipment required for the 
assessment of infants, including a baby weighing scale, thermometer, and ARI timer or 
secondhand clock for measuring respiratory rate, were not universally available in the facilities. 
Project partners collaborated with the MOHFW and other stakeholders to supply drugs and 
equipment to the health centers beginning after August 2015. However, distribution of equipment 
was not instantaneous for all health centers as it had to be procured by project partners and 
integrated into existing supply channels. For example, some providers, in interviews and group 
discussions, described delays at study initiation for receiving digital weighing scales. All health 
centers received functioning equipment by December 2015. 
 
Provider performance on practice outcomes: Classification and antibiotic treatment 
 
Data on infant’s age, weight, sex, signs of illness, infection classification, and antibiotic 
treatment were analyzed for 1,052 facility records. Records were excluded if date of assessment 
(N=2) or signs of illness (N=18) were missing. We also excluded young infants without signs of 
possible infection because they were not eligible to receive treatment according to the guidelines 
(N=426). Of these 426 records, 5 (1.2%) records were misclassified as IFB (N=2) and LBI (N=3), 
suggesting few infants were incorrectly classified with infection in the absence of signs from the 
clinical algorithm. Ultimately, 606 records from young infants with signs of infection were 




Nearly half of the infants (49%) were brought to the facility during the neonatal period 
(0-28 days). The signs of infection most frequently recorded in our sample included fast breathing 
(56%), umbilicus redness (19%) and fever (18%). The number of young infant records varied by 
health center with a median of 24 (IQR: 16.5 - 47) records per facility during the study period 
(Figure 2). The proportion of records with errors also varied by provider (1 per facility) with a 
median of 35.7% (IQR: 24.7-57.4%) per facility. When considering all errors in the records, we 
found that 3 providers contributed 39% of the total errors (Supplemental Table 1).  
Provider performance on classifying young infants according to the algorithm 
 
We identified classification errors in 14.9% (N=90) of the 606 infection cases. Records 
with signs of illness recorded, but missing classification contributed to 11.1% (N=10) of the 
classification errors. Providers correctly classified nearly all young infants with isolated fast 
breathing (97.7%; N=214/219) and local bacterial infection (97.7%; N=128/130), and 87% of 
young infants with critical illness (N=40/46) (Table 5). Providers’ performance on classification 
was poorest for infants presenting with signs of clinical severe infection, with only 63.5% 
(N=134/211) of these infants classified correctly. These infants were frequently misclassified 
with less severe types of infection—including isolated fast breathing (N=31) and local bacterial 
infection (N=11)—or were missed completely and not treated according to the infection 
management protocol (N=24) (Supplemental Table 2). For infants with signs of clinical severe 
infection, but incorrectly classified, the presence of fever (>37.5C or 99.5F) was the illness sign 
most frequently missed by providers (74.0% [N=57/77]). 
According to providers, in interviews and group discussions, implementation of the 
guidelines resulted in changes to their assessment practices for young infants, which may have 
contributed to errors in classification. For example, new strategies were introduced for measuring 
the infant’s weight—using a digital versus mechanical scale—and measuring body temperature. 




whereas it is now done for 3 minutes.” Providers consistently mentioned young infant visits take 
longer, and assessment is more challenging compared to older pediatric patients. For example, 
one provider described difficulties measuring the infant’s respiratory rate and body temperature, 
When an ill baby comes it doesn’t remain calm… then we face a problem in counting the 
baby’s breathing. When we measure the temperature, we can’t take the baby in our lap. 
The baby stays in its mother’s lap. Then we face a problem because when we start 
measuring temperature the baby moves and cries—Provider in interview 
 
When probed on barriers to classifying infants according to the algorithm, some providers 
expressed confusion about assigning classification when the infant has multiple illness signs 
overlapping infection sub-categories. One provider reflected on a case illustrating this challenge,  
A few days back, a newborn baby was brought to my [health center] with critical illness 
and he had clinical severe infection and local bacterial infection – three criteria were 
present in one baby. And along with this it had some other problems. In this case, what 
should I diagnose? —Provider in interview 
 
Provider performance on antibiotic treatment according to the dosage chart 
 
For infants that received antibiotic treatment (N=551), we identified 149 errors in 22.9% 
(N=126) of the records for antibiotic dosage (N=106) or missing weight or dosage (n=43). We 
identified dosing errors in nearly one quarter of the gentamicin injections (23.7% [N=129/169]) 
and one fifth of the amoxicillin drops (19.8% [N=442/551]). When taken together, our analysis of 
practice outcomes indicates that only 23.9% of critical illness cases (N=11/46) and 44.5% of 
clinical severe infection cases (N=94/211) were correctly classified and received appropriate 
antibiotic treatment on the day of assessment at the health center. Providers performed better on 
classification and treatment of infants with isolated fast breathing (82.6%; N=181/219) and local 
bacterial infection (75.4%; N=98/130) (Table 5).  
As discussed above, new practices for measuring the infant’s weight and using the dosage 
chart, may have contributed to some of the errors in antibiotic dosing. However, we assessed 
antibiotic errors based on the recorded weight and dosage, so the errors we identified were likely 




dosage chart. Prior to the new guidelines, providers were not authorized to treat young infants 
with PSBI in the public clinic (i.e., UH&FWC) when hospital referral was not feasible. However, 
some providers, in our group discussions and interviews, said they felt an ethical responsibility to 
treat these infants in their adjoining private practice when families were unable to seek care at the 
hospital. Therefore, they had previously established perceptions around “best practices” for 
treating young infants with serious infections. According to these providers, their preference was 
to treat sick infants with broader spectrum antibiotics (e.g., second or third generation 
cephalosporins) often prescribed at higher doses for a longer duration. As one provider discussed,  
Before training, we used to prescribe high dosed antibiotics to little children…Now we 
see that rather than using high dosed antibiotics, the medicines we have learned about in 
the training, gentamicin and amoxicillin, are more effective with better results.—Provider 
in group discussion 
 
Providers, in interviews and group discussions, also discussed the introduction of the dosage chart 
to calculate the antibiotic dose based on the infant’s weight. Some providers viewed this new 
practice as a positive change while others disagreed with the amount specified in the dosage 
chart,  
The Amoxicillin drop that we used to use 3 times a day, now we use twice a day. And 
before that we used to use the dose in a different quantity and now the dose is given a 
certain quantity according to baby’s weight…it is a positive change. –Provider in 
interview 
 
[Amoxicillin] needs to be measured based on the [infant’s] weight how much drop is 
required to be given for 7 days. My personal idea doesn’t match with the chart. –Provider 
in group discussion 
 
When probed on their opinions of the simplified antibiotic regimen, providers in interviews and 
group discussions expressed mixed perceptions of treatment efficacy. Providers that accepted and 
adopted the simplified regimen reported changing their prescribing behavior and highlighted the 
positives of the shorter course treatment, including cost-savings for families, and mothers’ 
preferences for fewer injections. Other providers expressed concerns that simplified antibiotic 




them to choose different courses of treatment, especially in their private practice. According to 
providers that did not agree with simplified treatment, they believe prescribing a higher number 
of doses of broad spectrum and newer generation antibiotics will result in quicker recovery time 
for patients. As one provider specified in an interview at the end of the study period, “If the 
babies get [oral antibiotic] of 3rd generation, they can recover earlier through a modern 
treatment.”  Providers often discussed pressure from caregivers and fear of losing patients as 
motivating factors for skipping recommended first-line treatment and opting for broad spectrum 
antibiotics. One provider explained his reasoning for starting antibiotic treatment with 
ceftriaxone—a third-generation cephalosporin recommended as a second-line antibiotic for 
treating neonatal sepsis (48)—due to fear of losing patients if sick infants do not recover quickly, 
 In the case of fast breathing we are supposed to give treatment only with amoxicillin. 
Here, in private chamber, we start with [ceftriaxone]. In private practice if one patient 
doesn’t get cured, they go to another doctor… that’s why we always want to give high 
dose treatment so that the patient gets well quickly. –Provider in interview 
 
These findings highlight some providers’ misconceptions around appropriate antibiotic use, 
which could serve as potential barriers to adoption of the simplified antibiotic regimen. 
Implementation pathway: Influence of implementation strategies on practice outcomes 
 
To assess provider performance on practice outcomes over time, we plotted the 
classification and dosage errors across the study period.  Based on this curve, we identified errors 
in classification and dosage were highest at the start of data collection and decreased over the 
study period (Figure 3). When we examined trends by infection sub-category, we found 
improvements in the providers’ ability to classify signs of clinical severe infection and calculate 
oral amoxicillin dosage for infants with fast breathing were key drivers to reducing errors 
(Supplemental Figure 1).  Qualitative data suggest that providers’ performance improved as they 
gained practice with the guidelines and received feedback to improve recordkeeping and 






Providers had two opportunities for government supervision each month—onsite visits 
and monthly small group meetings led by government managers at the sub-district hospital. 
Monthly meetings at the sub-district hospital bring together all SACMOs in a subdistrict (~10 
depending on the number of unions) and government managers. In addition to administrative 
activities (e.g., register review and completing reports), providers reported that these small group 
meetings provided an opportunity to discuss field implementation challenges with managers and 
served as group problem-solving sessions. Discussing the benefits of supervision, one provider 
said, “many things can be skipped or errors [made], by this inspection one benefit happens…our 
work gets more accurate.”  Most providers reported attending the monthly meetings at sub-
district hospital regularly at baseline (78.9% [N=15]), midline (89.5% [N=17]), and endline 
(84.2% [N=16]) (Table 3). Onsite visits at the health center, however, occurred less frequently 
than planned with 42.1% - 63.2% of facilities reporting a visit in the previous 3 months (Table 3). 
15.8% (N=3) of the providers reported not receiving an onsite supervisory visit in over one year. 
Providers attributed gaps in onsite supervision to lack of human resources at the manager level.  
The first stakeholder meeting in Dhaka (January 2016) encouraged project partners to 
identify barriers to implementation, discuss early learnings with the GoB and other implementing 
partners, and develop local solutions. Recommendations from this meeting were integrated into 
subsequent supervision visits and shaped the agenda of refresher training sessions for providers 
(March and June 2016). For example, according to providers in interviews, confusion about 
overlapping signs of illness was addressed in both monthly supervision meetings and refresher 
trainings.  
3.6 Discussion  
 
This study presents implementation research findings on primary health centers’ (i.e., 




guidelines throughout the first year of the program. Quantitative data indicate that providers’ (i.e., 
SACMO) performance on the guidelines was high overall. When disaggregated by infection 
classification, however, infants with serious signs of infection were less likely to receive 
appropriate antibiotic treatment on the day of assessment due to combined errors in classification 
and dosage. However, providers’ performance on the guidelines improved over the study period, 
particularly for classification of clinical severe infection cases and calculating dosage of oral 
amoxicillin. Qualitative data indicate that errors in the beginning of the study period may be due 
to delays in receiving essential commodities, introduction of new practices for assessment and 
calculating antibiotic dosage, providers’ confusion about classifying an infant with multiple signs 
of infection, and providers’ concerns about the efficacy of simplified antibiotic regimens. Multi-
stakeholder collaboration to deliver implementation strategies improved facility readiness and 
may have accelerated improvements in provider performance on the guidelines. As the guidelines 
are scaled-up in Bangladesh, our findings highlight opportunities and recommendations for 
tailoring implementation strategies to improve health center readiness and fidelity of the program 
(Table 6). 
Provider performance on classification was poorest for severe infection categories—
critical illness and clinical severe infection—often resulting in lapses in pre-referral treatment 
with gentamicin. When combined with errors in antibiotic dosage, we found that only 23.9% 
(N=11/46) of critical illness cases and 44.5% (N=94/211) of clinical severe infection cases 
received appropriate antibiotic treatment on the day of assessment. Our findings are consistent 
with previous studies showing poor provider performance on the related IMCI guidelines 
contributed to misclassification of severe illness and lapses in treatment of infants and children 
(23-26). Classification of severe infection depends on the providers’ ability to recognize and 
interpret subtle presentation of signs of PSBI, while less severe classifications are based on the 




of clinical severe infection were incorrectly classified due to providers not recognizing the 
presence of fever in these infants. Since our study was limited to record review, we expect that 
classification errors were underestimated, particularly for severe illness cases requiring referral 
and treatment with gentamicin. Given the low number of cases and subtle presentation of signs of 
severe infection in young infants, emphasis on recognizing and interpreting the signs of PSBI 
should be prioritized in training and supervision to improve classification and subsequent 
management (49, 50).   
A recent systematic review on effectiveness of strategies to improve healthcare provider 
practices in LMIC found packages of strategies—including training, group problem-solving 
and/or supervision, and providing job aides—were associated with larger improvements in 
provider performance than any of these strategies alone (51). Our study employed a similar 
package of implementation strategies to build capacity of provider and improve the technical 
quality of supervision. Trends in reduction of classification and dosage errors suggest that 
providers’ performance on the guidelines improved as they gained practice with the guidelines. 
Errors in antibiotic dosage, however, declined at a slower rate than classification errors. During 
interviews, providers described the monthly supervision visits at the sub-district hospital as an 
opportunity for discussing field challenges and working with mangers to develop local solutions. 
Unlike errors in dosage, classification errors were identified as an early barrier during the study 
period and therefore were discussed during supervision and in-service training sessions, which 
may have accelerated decline of these errors. In areas suffering from severe health worker 
shortages, like rural Bangladesh (17, 52), our findings suggest monthly meetings could be used as 
a platform for mentoring providers to improve their technical knowledge of the guidelines and 
clinical skills. Furthermore, we found variations in provider performance with three facilities 
contributing 39% of the errors in our study area. Given human resource constraints limiting onsite 




integrating case scenarios and practice with calculating antibiotic dosage may accelerate the 
learning curve.   
Like many LMIC settings, ensuring appropriate access to antibiotics, while also avoiding 
excess use, is a major challenge in this context (53-55). Bangladesh has a high degree of 
antibiotic resistance, posing a global and regional threat, due to misuse and overuse of antibiotics 
in healthcare and agricultural sectors (56). Hospital-based studies of neonatal sepsis in South Asia 
report a high degree of resistance to important WHO-recommended first-line drugs (e.g., 
gentamicin and ampicillin) and third generation cephalosporins. Community-based studies of 
neonatal sepsis, however, have found low rates of resistance to these drugs allowing for effective 
outpatient treatment with first-line antibiotics in this context (48, 56-58). Our findings are 
consistent with previous studies that have identified irrational use and inappropriate prescribing 
of antibiotics by outpatient healthcare providers is common (56, 59-62). In interviews and group 
discussions, some providers related that simplified regimens are sub-optimal for treating severe 
infection, indicating their preference for higher doses of broader spectrum antibiotics to promote 
quicker recovery. Provider preference to begin treatment with higher doses of unnecessarily 
broad-spectrum antibiotics may result in higher drug costs for caregivers (limiting access) and 
promotes antibiotic resistance (through excess use).  Steps to prevent misuse of antibiotics and 
preserve the effectiveness of first-line treatment in this setting will require interventions to restrict 
over-the-counter antibiotic use; engagement with the agricultural sector to reduce use in food 
animal production and pharmaceutical sector to curb aggressive marketing of broader spectrum, 
more expensive antibiotics; and improved surveillance systems (55, 56, 59). The revised 
guidelines, however, provide an opportunity to integrate antibiotic stewardship principles into 
training and supervision of outpatient providers to address misconceptions about the efficacy of 
simplified antibiotic regimens and target widespread irrational prescribing practices in 




This mixed methods analysis presents data from early implementation of the guidelines, 
which is important for exploring contextual-specific challenges and data driven problem-solving. 
A key strength of this study is the use of both quantitative and qualitative approaches to provide a 
deeper understanding of the research questions than either method separately (39, 65).  However, 
our study had several limitations including a short study period, lack of direct observations of 
care, and lack of a comparison group. Our study period was limited to one-year, which was 
necessary based on the government’s plans for scale-up. The estimated incidence of PSBI in 
young infants (95.4/1000) in this setting, coupled with low care-seeking rates from this level of 
health facility, led us to expect few infants would seek care from study area public health 
facilities during the initial implementation period (3, 58). Thus, direct observations of care were 
not feasible, and we were limited to analysis of facility records. As a result, we were unable to 
measure providers’ performance on clinical assessment including if any signs of infections were 
missed or incorrectly indicated in the register. Additionally, the quantitative data presented in this 
analysis may be subject to reporting bias. We aimed to improve the validity of our data by 
reviewing registers on a weekly basis rather than aggregated data from monthly reports. Our 
analysis of trends in errors and qualitative data allowed us to explore possible reasons for poor 
provider performance, but we were unable to causally link implementation strategies to changes 
in practice outcomes due to lack of a comparison group. Despite these limitations, our study has 
identified important barriers to early implementation and recommendations for improving the 
quality of care to sick young infants at health centers. 
Since the conclusion of our study, Bangladesh has incorporated the infection 
management guidelines into their current National Newborn Health Program as part of the 4th 
Health, Population and Nutrition Sector Program and secured the necessary budget for 
procurement of the essential drugs and equipment under this plan (35).  While this policy 




study findings suggest other potential challenges to the structure of healthcare provision, 
including shortages of health workers and poor facility infrastructure. For example, we had to 
exclude 38.7% (N=12/31) of the health centers at baseline because the SACMO post was vacant 
and 15.8% (N=3/19) of the included health centers did not have a FWV posted at study initiation. 
Furthermore, clean water is important for reconstituting the oral amoxicillin powder, but few 
health centers in our study area facilities had provision for clean water. It is possible that these 
factors had unmeasured effects on providers’ motivation and performance, which should be 
investigated in future studies. Development partners should continue to monitor and advocate for 
facility strengthening as bottlenecks in supply chains and health worker vacancies threaten scale-
up and sustainability of the program.  
Quality of care is a broad construct that includes the structure of the healthcare provision, 
process of providing care, and outcomes of care (66). Our study provides important insights about 
the structure of healthcare provision in the health centers, provider performance on the guidelines 
on the day of assessment, and recommendations for improving fidelity of implementation in rural 
Bangladesh. Future studies should examine caregiver acceptability of the guidelines—including 
their relationship with providers and opinions of care received at the health centers—and 
treatment outcomes for young infants receiving simplified antibiotic regimen. Future program 
support to the guidelines should integrate our recommendations to strengthen supportive 
supervision, test strategies to improve rational prescribing practices, and address misconceptions 
about superiority of newer generation antibiotics in treating community-acquired infections in 
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3.8 Tables for Paper 1 
 
Table 1. Infection classification according to the clinical algorithm and antibiotic treatment on 




Clinical signs per algorithm 
Antibiotic treatment at health 
center on day of assessment 
Critical Illnesses (CI) 
• Convulsion/history of 
convulsion* 
• Unconscious/drowsy  
• Unable to feed 
• Persistent vomiting  
• Central Cyanosis 
• Bulging Fontanel 
• Weight <1500 gm 
• Intramuscular gentamicin (5.0-7.5 
mg/kg body weight) 
• Oral amoxicillin 50 mg /kg body 
weight (twice daily) 
Clinical Severe 
Infection (CSI) 
• Severe chest in-drawing* 
• Hypothermia (<95.90F or 
35.50C)* 
• Raised temperature (>99.50F or 
37.50C)* 
• Less movement/ movement only 
when stimulated*  
• Not feeding well (depending on 
history and observation)* 
• Intramuscular gentamicin (5.0-7.5 
mg/kg body weight) 
• Oral amoxicillin 50 mg /kg body 
weight (twice daily) 
Isolated Fast 
Breathing (IFB) 
• Young infants 0-6 days old with 
fast breathing (≥60 
breaths/min)* 
• Oral amoxicillin 50 mg /kg body 
weight (twice daily) 
• Young infants 7-59 days old 
with fast breathing (≥60 
breaths/min) 
• Oral amoxicillin 50 mg /kg body 
weight (twice daily) 
Local Bacterial 
Infection (LBI) 
• Umbilical redness 
• Draining pus from umbilicus 
• Skin pustules 
• Oral amoxicillin 50 mg /kg body 
weight (twice daily) 
















   Sylhet 47% (9) 
   Lakshmipur 53% (10) 
Managing Directorate  
Directorate General Health Services 53% (10) 
Directorate General Family Planning 47% (9) 
PROVIDER  
Sex  
Male  84% (16) 
Female  16% (3) 
Age  
20-29 16% (3) 
30-39 11% (2) 
40-49 0 
50-59 42% (8) 
Time in current posting   
1-5 years 47% (9) 
5-10 years 16% (3) 
10-15 years 5% (1) 
15-20 years 21% (4) 






Table 3. Availability of core drugs and equipment at study area health centers for infection 
management and frequency of supervision visits throughout the study period (N=19) 
 
Characteristics %(n) 
Date of Assessment 
August 2015 March 2016 August 2016 
Drug supply  
Injectable gentamicin  0 100% (19) 100% (19) 
- Adequate supply 0 89.5% (17) 100% (19) 
Oral amoxicillin pediatric drops 78.9% (15) 94.7% (18) 100% (19) 
- Adequate supply 0 94.4% (17) 100% (19) 
Functioning Equipment  
Infant scale 47.4% (9) 100% (19) 100% (19) 
Thermometer  10.5% (2) 84.2% (16) 100% (19) 
ARI Timer/Watch  26.3% (5) 100% (19) 100% (19) 
Job aides  
Algorithm visible during visit 0 84.2% (16) 100% (19) 
Dose chart visible during visit 0 100% (19) 100% (19) 
Infrastructure 
Clean water available 26.3% (5) 21.1% (4) 10.5% (2) 
Electricity available 84% (16) 79% (15) 73.7% (14) 
- Uninterrupted in last week 5% (1) 0 0 
Supervision  
Government supervision in previous 3 
months 
63.2% (12) 42.1% (8) 63.2% (12) 
- Discussed infection management  50% (6) 100% (8) 100% (12) 
Attended monthly meeting  78.9% (15) 89.5% (17) 84.2% (16) 
- Discussed infection management  33.3% (5) 94.1% (16) 100% (16) 











N=606   
Age (in days)   
<7 days 9.7% (59) 
7-28 days 39.1% (237) 
29-59 days 51.2% (310) 
Sex of infant  
Male 53.3% (323) 
Female 46.7% (283) 
Signs of illness recorded by provider  
Respiratory rate ≥60/min 55.8% (338) 
Umbilicus redness 19% (115) 
Fever (>37.5C) 17.8% (108) 
Severe chest in-drawing 14.7% (89) 
Not feeding well 13.5% (82) 
Less movement than normal 6.1% (37) 
Skin pustules 5.8% (35) 
Hypothermia (<35.5C) 5% (30) 
Unable to feed 4.3% (26) 
Unconscious/Drowsy 3.3% (20) 
Convulsions or history of convulsions 1.3% (8) 
Persistent Vomiting 1.3% (8) 
Weight<1500 g 0.8% (5) 
Bulging fontanelle 0.5% (3) 
Central cyanosis 0.5% (3) 
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Critical Illness (CI) 
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Table 6. Results of qualitative investigation into reasons for high and low values of health facility readiness indicators and practice 
outcomes 
 
Quantitative Results Qualitative Themes Recommendations 
 Facilitators Barriers  
Health center readiness and capacity building  
Study area health centers did not 
have adequate supply of injectable 
gentamicin nor oral amoxicillin 
and 89.5% did not have 
functioning equipment at baseline. 
- Guidelines provided a 
discrete list of 
commodities (e.g., 
antibiotics, syringes, 
equipment) that should be 
provided to health centers 
which required minimal 
inputs from project 
partners for procurement 
and distribution to sub-
district level stores. 
 
- Distribution of drugs and 
equipment was not 
instantaneous as it was 
being integrated into 
existing supply chains 
from the sub-district 
level, which may have 
contributed to early 
errors in classification 
and treatment. 
- The MOHFW has incorporated 
plans for training providers 
under the recent National 
Newborn Health Program and 
there is provision in the budget 
for drugs and equipment. As 
guidelines are scaled-up, 
development partners may 
continue to support rollout of the 
guidelines in health center to 
ensure readiness and promote 
sustainability. 
 
Government supervision visits to 
health centers were infrequent 
during the study period, whereas at 
least 79% of provider reported 
attending monthly meetings at the 
sub-district level  
- Providers discussed 
receiving benefits from 
supervision  
- Monthly meetings served 
as small group mentoring 
sessions to discuss 
problems and develop local 
solutions 
- Onsite government 
supervision is infrequent 
due to human resource 
constraints at the 
manager level 
 
- Monthly meetings provide a 
regular opportunity for 
mentoring, which could include 
skills assessment and correction 
Practice Outcomes: Classification & antibiotic treatment 
Providers correctly classified 
85.1% (N=516/606) of the 
infection cases. 85.6% (N=77/90) 
of all classification errors were 
- Providers report 
comprehension of the 
algorithm and appreciate 
- Some SACMOs said they 
were unsure of how to 
classify infants when 
multiple signs of illness 
- Training and supervision should 
include case scenarios 
incorporating challenges specific 




identified in infants presenting 
with signs of CSI. Fever was 
missed in 74% (N=57/77) of the 
CSI cases that were misclassified. 
the job aides as decision-
making tools  
- Providers requested 
additional training with 
practical demonstrations 
 
were present and/or 
overlapped 
classifications 
- Assessment of a young 
infant is more complex 
and time-consuming than 
other pediatric patients 
 
of young infants, coaching on 
communication with caregivers, 
and when possible direct 
observations of care  
 
For infants that received antibiotic 
treatment (N=551), we identified 
149 errors in 22.9% (N=126) of 
the records for antibiotic dosage 
(N=106) or missing weight or 
dosage (n=43).  
- Guidelines provide 
instruction on outpatient 
treatment of infections in 
young infants, which was 
not available previously 
- Many providers report that 
they are satisfied with 
providing fewer medicines 
and fewer doses of first-
line antibiotics  
 
- New methods for 
calculating dosage with 
digital scales and the 
dosing chart required 
practice and time to learn 
- Some providers do not 
agree with the simplified 
treatment and think that 
higher or more frequent 
doses of more powerful 
antibiotics are better 
 
- Training should include a 
module on rationale use of 
antibiotics in outpatient settings 
- Record review with dosage chart 
during supervision may aid in 
identification and correction of 
dosage errors.    
Provider performance on the 
guidelines varied by facility with 
three facilities contributing 39% of 
the errors in our study area.  
 
Provider errors in classification 
and antibiotic dosage decreased 
over the study period, largely due 
to improvements in classifying 
CSI cases and calculating dosage 
of oral amoxicillin for IFB cases. 
 
- SACMOs reported fewer 
challenges as they gained 
practice with the guidelines 
(algorithm, equipment, 
dosage chart) and received 
feedback in supervision 
and refresher trainings  
 
- In follow-up interviews, 
at the end of the study 
period, some providers 
continued to report they 
believed more powerful 
antibiotics resulted in 
quicker recovery time 
and better met caregiver 
demands 
- Refresher trainings and monthly 
meetings provide an opportunity 
to visually check records, 
identify and correct errors, and 
improve provider performance 
on the guidelines 
- Increased supervision in the 
beginning of rollout may 
accelerate the learning curve 
- Given human resource 
constraints limiting frequent 
supervision, targeting poor 
performing facilities for 
additional support could reduce 





Supplemental Table 1. Errors in classification and antibiotic dosage by facility 
 




Facility records with errors %(n) Cumulative 
% errors in 
all records  
Total Classification Dosage 
Facility A*† 59 55.9 (33) 11.9 (7) 50.8 (30) 17.1 
Facility B † 53 50.9 (27) 39.6 (21) 11.3 (6) 12.5 
Facility C † 86 24.4 (21) 2.3 (2) 22.1 (19) 9.7 
Facility D* 22 77.3 (17) 54.5 (12) 27.3 (6) 8.3 
Facility E 57 26.3 (15) 19.3 (11) 7 (4) 6.9 
Facility F 19 78.9 (15) 31.6 (6) 47.4 (9) 6.9 
Facility G& 59 23.7 (14) 3.4 (2) 20.3 (12) 6.5 
Facility H* 23 47.8 (11) 30.4 (7) 21.7 (5) 5.6 
Facility I 36 25.0 (9) 19.4 (7) 5.6 (2) 4.2 
Facility J 19 36.8 (7) 5.3 (1) 31.6 (6) 3.2 
Facility K 11 63.6 (7) 0 63.6 (7) 3.2 
Facility L 36 16.7 (6) 2.8 (1) 13.9 (5) 2.8 
Facility M 24 25.0 (6) 16.7 (4) 8.3 (2) 2.8 
Facility N* 14 28.6 (4) 28.6 (4) 7.1 (1) 2.3 
Facility O 41 12.2 (5) 0 12.2 (5) 2.3 
Facility P*& 4 75 (3) 75 (3) 25 (1) 1.9 
Facility Q* 8 37.5 (3) 12.5 (1) 37.5 (3) 1.9 
Facility R 6 33.3 (2) 16.7 (1) 16.7 (1) 0.9 
Facility S& 29 6.9 (2) 0 6.9 (2) 0.9 
Total 606 35.6 (216) 14.9 (90) 22.9** (126)    
*Denotes a facility that contributed records (N=9) containing both errors in classification and dosage 





Supplemental Table 2. Correct classification according to computer algorithm vs. classification 
recorded in the register 
 
SACMO Classification 
Correct Classification based on Signs Recorded in Register   
CI CSI IFB LBI Total 
            
CI 40 (87.0 %) 3 0 0 43 
CSI 2 134 (63.5%) 2 0 138 
IFB 1 31 214 (97.7%) 0 246 
LBI 1 11 1 128 (97.7%) 141 
Other 2 24 2 0 28 
Missing classification 0 8 0 2 10 




3.9 Figures for Paper 1 
 




Figure 2. Distribution of young infant records and errors by health center 
 













































Chapter 4. Paper 2: Caregiver acceptability of the 
guidelines for managing young infants with possible 
serious bacterial infections (PSBI) in primary care 
facilities in rural Bangladesh 
4.1 Abstract  
 
Introduction: Many infants with possible serious bacterial infections (PSBI) do not receive 
inpatient treatment because hospital care may not be affordable, accessible, or acceptable for 
families. In 2015, WHO issued guidelines for managing PSBI in young infants (0-59 days) with 
simpler antibiotic regimens at primary healthcare centers when hospital care is not feasible. 
Bangladesh adopted WHO’s guidelines for implementation in outpatient primary healthcare 
facilities. We report results of an implementation research study that assessed caregiver 
acceptability of the guidelines in three rural sub-districts of Bangladesh during early 
implementation (October 2015-August 2016). 
Methods: We included 19 outpatient primary health centers involved in the initial rollout of the 
infection management guidelines. We extracted data for all PSBI cases (N=192) from facility 
registers to identify gaps in referral feasibility, simplified antibiotic treatment and follow-up. 
Focus group discussions (FGD) and in-depth interviews (IDI) were conducted with both 
caregivers (6 FGDs; 23 IDIs) and providers (2 FGDs; 28 IDIs) to assess caregiver acceptability of 
the guidelines.  
Results: Referral to the hospital was not feasible for many families (83.3%; N=160/192) and 
acceptance varied by infection severity. Barriers to referral feasibility included economic and 
household factors, and previous experiences with poor quality of care at the sub-district hospital. 
Conversely, providers and caregivers indicated high acceptability of simplified antibiotic 
treatment. 80% (N=96/120) of infants with clinical severe infection for whom referral was not 
feasible returned to the facility for the second antibiotic injection. Some providers reported 
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developing local solutions—including engaging informal providers in treatment of the infant—to 
address organizational barriers and promote treatment compliance.  Follow-up of young infants 
receiving simplified treatment is critical, but only 67.4% (N=87/129) of infants received fourth 
day follow-up. Some providers’ reported deviations from the guidelines that shifted responsibility 
of follow-up to the caregiver, which may have contributed to lapses.  
Conclusion: Caregivers’ perception of trust and communication with providers were influential 
in caregiver acceptability of care. Few caregivers accepted referral to the sub-district hospital, 
suggesting low acceptability of this option. When referral was not feasible, many caregivers 
reported satisfaction with simplified antibiotic treatment. Local solutions described by providers 
require further examination in this context to assess the safety and potential value of these 
strategies in outpatient treatment. Our findings suggest strengthening providers’ interpersonal 
skills could improve caregiver acceptability of the guidelines.  
4.2 Introduction 
 
Bangladesh has made tremendous progress in reducing sepsis-related deaths during the 
neonatal period. Between 1990 and 2015, newborn deaths due to sepsis reduced by more than 
half, which is largely attributable to interventions to prevent and manage community-acquired 
newborn infections in this context, including promotion of clean delivery, essential newborn care 
practices and improved access to timely treatment with antibiotics (1-6). However, implementing 
these interventions at scale is challenging, resulting in sub-optimal coverage (7). As a result, 
newborn infections—including sepsis, meningitis and pneumonia—remain a major contributor to 
neonatal morbidity and mortality in Bangladesh and globally (1, 8, 9).  
The World Health Organization (WHO) recommends that all young infants (0-59 days) 
with possible serious bacterial infections (PSBI) be referred to hospitals and treated with a 7 to 
10-day course of a combination of gentamicin and either penicillin or ampicillin (10). In 
resource-limited settings, however, many infants with PSBI may not receive the recommended in-
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patient care due to limited access to hospital facilities, social and cultural practices that may 
impede care-seeking, financial constraints and low acceptability of hospital care (10-13). The 
revised guidelines provide guidance on outpatient management of PSBI in young infants with 
simplified antibiotic regimens—including fewer injections combined with oral antibiotics—at 
primary healthcare facilities closer to the community (10).  
 Bangladesh was one of the first countries to adopt the WHO recommendations (14). In 
2015, the government of Bangladesh partnered with funding agencies, implementation groups, 
and research organizations to operationalize the guidelines in primary health facilities in a few 
selected districts (14). A mixed methods implementation research study was embedded in 
program rollout to document lessons around implementation and inform nationwide scale-up. The 
updated infection management guidelines aim to increase coverage of treatment for newborn 
infections through provision of public sector care that more affordable, accessible, and acceptable 
for families (10, 11, 15). 
In Bangladesh, health care is sought from a mix of sources including public and private 
providers in both the formal and informal sector, as well as traditional medicine (16-18). Rural 
and disadvantaged populations in Bangladesh commonly first seek care from a wide array of 
informal providers including village doctors, traditional healers, drug sellers, and homeopathic 
doctors (15, 16, 19, 20). Village doctors are prominent providers in rural communities—
approximately 12.5 per 10,000 population. Most village doctors have limited or no standard 
training and are connected to unlicensed pharmacies where they diagnose patients and sell 
prescription medicines (15, 16). Public healthcare is highly subsidized by the government, 
requiring minimal or no payments from the clients, especially in the outpatient centers targeted 
for this intervention (i.e., Union Health & Family Welfare Centers [UH&FWC]; catchment area 
~25,000 persons) (21, 22). Despite adequate geographic distribution of these outpatient health 
centers, UH&FWCs have been largely under-utilized by the communities, and many were not 
fully functional due to staff shortages, insufficient equipment, poor infrastructure, unavailability 
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of water and electricity, and perceived low quality of care (16, 18, 23-25). Families often prefer to 
seek care from the private sector, informal and formal, due to convenience and acceptability 
services, but informal providers are highly unregulated and formal care comes at high out-of-
pocket costs for families (15, 16, 21, 26). With the rollout of the new guidelines, there is an 
urgent need to strengthen existing public sector facilities to improve the quality of care and 
acceptability of health services for families of sick young infants.  
The guidelines are not designed to replace hospital care, which remains the first-line 
treatment for PSBI and only treatment option for critically ill infants. Bangladesh’s national 
referral system is designed so that patients move up through the pyramid of care, typically 
beginning at the community level—at the base of the pyramid— with referrals to a larger facility 
for more specialized care at the sub-district or district-level. Referral is necessary when a 
patient’s condition requires management that supersedes the training and/or resources at the basic 
level of care (27). The optimal situation is for patients to receive appropriate care at the lowest 
level possible to conserve resources for the patient and health system (27, 28). However, 
complexities around referral feasibility are well-documented in the literature and barriers may 
vary by context (27, 29, 30). The infection management guidelines aim to improve accessibility 
and quality of care at lower levels of the pyramid when referral is not feasible. WHO also 
emphasizes the need to understand barriers to referral feasibility, strengthen referral linkages, and 
improve the quality of care at referral facilities (10, 11).  
Previous analyses from our implementation research study provide insights about quality 
of care from the supply-side, including the structure of healthcare provision in the UH&FWCs 
(e.g., drug supply, infrastructure, number and training of providers), providers’ performance on 
the guidelines over time, and recommendations to enhance implementation fidelity (Applegate, 
Paper 1). In this paper, we present mixed-method findings to assess caregiver acceptability of the 
infection management guidelines during early implementation (October 2015-August 2016). 
Acceptability as an implementation research outcome differs from the larger construct of 
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satisfaction in that it focuses on a particular intervention or treatment—rather than general service 
experience—and is typically measured based on different aspects of the intervention and through 
the perspective of various stakeholders (31). In the early stages of implementation, acceptability 
is an important precursor to adoption of an intervention and will likely affect penetration and 
sustainability in the later stages (31, 32). Previous studies have shown multiple measures are 
beneficial for assessing client acceptability of health interventions, understanding the 
interpersonal relationship between provider and client, and developing strategies to improve 
quality of care (24, 31, 33). We posit that multi-level factors will affect caregiver acceptability of 
the updated treatment guidelines. Thus, we explored caregiver acceptability through application 
of the socioecological model (SEM), which accounts for multiple levels of influence on behavior 
(Supplemental Table 1). Here, we discuss caregiver acceptability of the infection management 
guidelines through identifying gaps in care of PSBI cases and examine barriers and facilitators to 
acceptability from the perspective of providers and caregivers in three sub-districts of rural 
Bangladesh.   
4.3 Methods 
 
Context and Intervention 
 
Details on the context and intervention for this study have been described previously 
(Applegate, Paper 1) Briefly, our study area included union-level health centers in two sub-
districts of Sylhet in Sylhet division and one sub-district in Lakshmipur in Chittagong division. 
Sylhet and Chittagong are historically low performing divisions of Bangladesh for maternal, 
newborn and child health indicators (34).  
The MOHFW maintains a three-tier system for delivering public healthcare services at all 
administrative levels and follows the Integrated Management Childhood Illness (IMCI) protocol 
for management of sick children in primary health facilities (19, 35). Implementation of the 
infection management guidelines targeted union-level primary health facilities (i.e., UH&FWCs), 
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which are generally staffed by 2-3 formally trained providers—the Sub-Assistant Community 
Medical Officer (SACMO) and the Family Welfare Visitor (FWV). Some of these facilities have 
a position for a doctor available, but these posts are often vacant (16, 18, 25). The SACMO has 3 
years training on general healthcare, including child health, from a Government Medical 
Assistant Training School (16). The FWV has at least 18 months training from a private or 
government facility on midwifery and contraceptive management (16, 18, 19).   
The SACMO is the designated provider for assessing, classifying and treating young 
infants according to the guidelines. To aid these workers in identifying sick infants, the 
Bangladesh guidelines include a clinical algorithm for classifying signs of infection in young 
infants, guidance on antibiotic treatment, referral advice and follow-up (22). Infants with signs of 
PSBI (fever, hypothermia, convulsions, respiratory rate ≥60 breaths per minute if infant is <7 
days, severe chest in-drawing, no movement or movement only upon stimulation, feeding poorly 
or not feeding at all) are classified as Critical Illness (CI), Clinical Severe Infection (CSI), or 
Isolate fast breathing <7 days (IFB <7). Accordingly, the SACMO provides the first dose of 
antibiotics based on the infant’s weight and refers the infants with signs of PSBI (i.e., CI, CSI, 
and IFB [<7D]) to the sub-district hospital (Upazila Health Complex [UHC]; catchment area 
~250,000 persons) for inpatient care (19, 22). Young infants classified as CSI or IFB (<7D) 
whose families decline hospital referral are eligible for simplified antibiotic treatment with 
injectable gentamicin once daily for two days and oral amoxicillin twice daily for seven days. 
Hospital referral is the only option for critically ill infants. Caregivers of infants with CSI that 
decline referral are instructed to return to the UH&FWC the next day for the 2nd gentamicin 
injection. The FWV may provide the 2nd injection if the SACMO is not present at the UH&FWC. 
The SACMO follows-up with caregivers over telephone on the fourth day, and if the infant’s 
condition has not improved, advises the caregivers to seek care at the UHC. On the eighth day of 
treatment, the family receives a home visit from the Family Planning Inspector (FPI), who are 
trained as supervisors of frontline workers, to assess treatment compliance and the condition of 
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the infant (22). Henceforth, we will refer to SACMOs as “providers,” UH&FWCs as “health 
centers,” and the UHC as the “sub-district hospital.” 
Design and Data Collection 
 
Project partners—Projahnmo and MaMoni Health Systems Strengthening (HSS)—
supported the MOHFW to implement the guidelines in 3 sub-districts of the selected districts, 
Sylhet and Lakshmipur respectively. Both implementation partners have extensive experience 
supporting maternal, newborn and child health (MNCH) interventions and health system 
strengthening in rural Bangladesh, which has been described previously (36, 37). The supportive 
inputs from these two partners primarily focused on improving the performance and capacity of 
health services, including collaborating with the MOHFW to ensure the implementation readiness 
of health centers to manage infections in young infants, and supporting training and supervision 
of providers.  
Our study employed a mixed methods approach to data collection following a convergent 
parallel design where quantitative and qualitative data were collect concurrently (38). We adapted 
the SEM to inform the development of interview guides to examine caregivers’ acceptability of 
key components of the intervention—decision to seek care and perception of public sector care, 
referral feasibility, simplified antibiotic treatment and follow-up (Figure 1). Specifically, three 
data collection activities were included: 1) weekly extraction of data from facility registers to 
monitor adherence to the guidelines for referral feasibility, simplified antibiotic treatment, and 
follow-up; 2) focus group discussions (FGD) and in-depth interviews (IDI) with facility provider; 
and 3) FGD and IDI with caregivers of infants to examine facilitators and barriers to caregiver 
acceptability of the infection management guidelines. 
Case management register review:  Data collectors visited the 19 UH&FWCs weekly to 
abstract data from facility records of all young infants that sought services from October 2015-
August 2016. The young infant registers used by providers were developed specifically for the 
infection management guidelines and distributed to facilities as part of program rollout (22). Our 
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team adapted the register into an electronic form and recorded data weekly using tablets. For this 
analysis we included data on the infant’s age, provider classification of illness, referral feasibility, 
antibiotic treatment and follow-up. 
FGDs and IDIs with providers: FGDs and IDIs with providers were conducted in both 
study areas to assess their perceptions of acceptability of the guidelines using semi-structured 
interview guides. The goal of these interviews was to assess the facilitators and barriers to 
implementation of the guidelines in the health centers. FGDs were conducted at the sub-district 
hospital on a date that coincided with their monthly meetings or routine collection of medicines 
from this location. IDIs were conducted in the health center every 3-4 months during the study 
period. All providers (N=19) trained in the guidelines and providing care in the study area health 
centers were eligible to participate in the interviews. In the final months of data collection, 
follow-up interviews were conducted with providers to explore themes identified by the study 
team through the analysis of interviews conducted during early implementation. 
FGDs and IDIs with caregivers: FGDs with caregivers aimed to explore motivators and 
barriers to care-seeking from primary health facilities including specific questions about their 
previous experiences with care. For group discussions, caregivers were selected through 
convenience sampling of mothers (13-49 yrs.) of infants under six months of age who were 
willing and able to share their experiences with care-seeking for infant illness. The number of 
participants for each focus group ranged from 6 to 8 mothers. When selecting caregivers for 
participation in the FGDs we originally tried to select caregivers of young infants (<2 months) 
since this age group is the focus of the intervention. However, we had difficulty recruiting 
mothers with infants in this age group because many women in rural Bangladesh predominantly 
spend their time at home the first two months postpartum, which limits their ability to join a 
group discussion in the community (20, 39). We adjusted our inclusion criteria to allow mothers 
of infant under 6 months of age to participate in the FGDs. The goal of FGDs was to obtain 
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community perceptions about young infant illness, patterns of care-seeking and perceptions of 
care provided in government facilities.   
The study team used facility records to identify young infants for follow-up in the 
community and select caregivers for IDIs. Caregivers were purposively selected based on their 
infant’s categorization of infection. We conducted in-depth interviews with caregivers of infants 
for each category of PSBI. However, we prioritized reaching a point of saturation for the clinical 
severe infection cases because these infants receive referral to the hospital and are eligible for 
simplified antibiotic treatment, including two gentamicin injections, when referral is not feasible 
for families. The goal of these interviews was to assess the facilitators and barriers to referral 
feasibility and simplified antibiotic treatment from the perception of caregivers of young infants 
receiving treatment according to the guidelines.  
All qualitative researchers were Bangladeshi and conducted the FGDs and IDIs in the 
local language (Sylheti in Sylhet, and Bangla in Chittagong). Interviews were recorded and 
transcribed into English by trained translators for analysis. Following the interviews, research 
assistants also participated in debriefing sessions led by the research officers utilizing a thematic 
framework. Notes from these debriefing sessions were also translated into English and included 
in the analysis. 
Ethics Statement 
Ethical approval was obtained for this study from the Johns Hopkins Bloomberg School of Public 
Health Institutional Review Board (JHSPH IRB) and the Bangladesh Institute of Child Health 
(BICH) Review Board. Written informed consent was obtained from all providers in the study, 
while oral informed consent was obtained from caregivers. Verbal consent was chosen for 
caregivers due to low literacy rates in this population. JHSPH IRB and BICH reviewed and 







Quantitative data were analyzed using Stata version 14 (StataCorp LP). Records were 
excluded if date of assessment or illness classification were missing. Descriptive results are 
summarized as frequencies and proportions for referral feasibility, caregiver return to the health 
center for the second injection, and follow-up according to the guidelines. We estimated the 
percent of PSBI cases captured at service delivery points in our study area based on the expected 
annual number of births for both Sylhet and Chittagong Divisions (34) and incidence of PSBI in 
young infants (95.4/1000) (40) in this setting. 
Qualitative 
 
We employed an integrated approach to development of the coding framework (41). The 
framework was developed using a priori codes derived from the interview guides and the 
research questions related to acceptability of the guidelines and application of SEM. Emergent 
codes were added to the codebook as necessary to capture themes that were suggested in the data 
but not initially anticipated in the a priori codes. We coded transcripts using the computer 
software program Dedoose. This study employed analytical methods of continual analysis, 
coding, and memoing. Our team reviewed transcripts of respondents throughout the study period 
based on both inductive and deductive themes. We adapted the questionnaire to explore emergent 
themes (42). Ultimately, we developed a coding framework—including a priori and emergent 
codes—based on continual review of the qualitative data, which was used for the final analysis. 
Each transcript was coded using this scheme and charting of the coded passages was used to 







We analyzed data on the infant’s age and sex, infection classification, referral decision 
and antibiotic treatment for 1052 facility records. Records were excluded if date of assessment 
(N=2) or illness classification (N=99) were missing. We included records of young infants 
classified with PSBI (i.e., CI, CSI, IFB <7D) that required referral according to the guidelines 
(N=192) (Table 1). Based on expected PSBI incidence for young infants in this context, we 
estimated that only 16.3% [95% CI: 14.4, 18.5] of the expected cases sought care from the study 
area health centers from October 2015-August 2016. Referral to the hospital was not feasible for 
many families (83.3%; N=160/192) and acceptance varied by infection severity: CI (28%; 
N=12/43), CSI (14%; N=20/140), IFB <7D (0) (Figure 2). For infants classified with clinical 
severe infection receiving simplified antibiotic treatment, 80% (N=96/120) of caregivers returned 
to the facility for the second injection. When referral was not feasible for families, 68% 
(N=82/120) of infants with CSI and (56%; N=5/9) of very young infants with IFB received 
follow-up from the provider on the fourth day of treatment. Our quantitative results indicate that 
day 8 follow-up in the community by the FPI was low for both CSI (36%; N=43/140) and IFB 
(56%; N=5/9). No caregiver in our interviews reported receiving a day 8 follow-up visit from the 




We analyzed qualitative data from 6 FGDs, 3 in each study area, and 23 IDIs with 
caregivers to explore their perceptions of care provided to sick young infants at public primary 
health facilities (e.g., UH&FWC and UHC) and acceptability of the infection management 
guidelines. All mothers completing an interview received care for their young infant according to 
the infection management guidelines. To understand providers’ perspective of care provision, we 
conducted 2 focus group discussions with providers in the early months of the study (November 
and December 2015), 19 interviews during the study period, and 9 follow-up interviews in the 
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final months of the study. All providers in the study area participated in at least one interview 
during the study period. Our qualitative findings are presented in four sub-sections: 1) decision to 
seek care and experience at public health centers; 2) referral feasibility for families of infants with 
PSBI; 3) simplified antibiotic regimen and caregiver return for second day injection; 4) follow-up 
on the fourth day for infants receiving outpatient treatment. Table 2 presents our mixed methods 
findings around acceptability for each component included in this analysis. 
Decision to seek care and experience at public health centers 
 
According to caregivers and providers, mothers’ autonomy to seek care for their infant 
outside the home is limited, oftentimes she must first obtain the consent of her husband. As one 
mother noted, “I won’t be able to go outside of home without my husband’s permission.” Rather, 
the decision about when and where to seek care for the infant was described as a collective 
process that frequently included the baby’s mother, father and/or grandparents (maternal or 
paternal). Informal providers residing in the community, especially village doctors, were often 
cited by caregivers in group discussions and interviews as the first source of care because services 
are provided at a reduced cost (no consultation fee, shorter distance to travel, no wait times) and 
they have a good relationship with the family. Of the village doctor, one mother said, “He calls us 
by name, even our husbands. He is very familiar.” Mothers in our study all sought care from a 
study area health center and frequently reported the village doctor as their source of referral due 
to severity of the illness (e.g., pneumonia, convulsions), or if the illness persisted after the village 
doctor’s treatment. Economic factors (consultation fee, cost of medicines, travel costs) were key 
drivers in the family’s decision to choose public versus private sector facilities.  
Mothers in interviews and group discussions often reported choosing the union-level 
health centers versus the sub-district hospital when the health center was closer to the community 
and they trusted the provider—often referring to him or her by name. As one mother said in a 
group discussion, “We think the treatment [the] doctor provides is trustworthy. That’s why we 
come to UH&FWC [health center].” According to mothers, in group discussions, the quality of 
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care at the government primary health centers can vary across visits and locations. Caregivers, in 
interviews and group discussions, mentioned organizational factors (e.g., inconsistent availability 
of providers, long wait-times, medicine stock-outs) for dissatisfaction with public sector services, 
but reported these barriers occurred less frequently at the union-level health centers than at the 
sub-district hospitals.   
Providers acknowledged that the guidelines provide an opportunity to improve families’ 
access to and affordability of treatment. As one provider noted in a group discussion, 
In this treatment method, cost is minimal. Earlier, it was very difficult for a poor family 
to bear the treatment cost. –Provider in group discussion   
 
Mothers were aware that services and medicines at government hospitals should be free of cost, 
but some reported paying a “visit fee” ranging from 10-500 Taka (0.12 to 6.00 USD). One mother 
reported asking the provider about the fee, smiling as she recounted her story,  
He said, ‘We need money to bear the costs’ I said, ‘Sir, I thought it is government 
hospital. Why should I give you money?’ He said, ‘The government bears the cost of 
medicine only. There are some other costs too.’ I said, ‘Is it so? Sir, I don't have money 
with me today. I didn't know. I’ll bring next time when I’ll come. During the [follow-up] 
visit, I gave 50 Taka to Sir and said, ‘Sir, please have it for tea.’ –Mother of sick young 
infant 
 
Providers did not discuss requesting a visit fee or accepting payment from the caregivers seen 
outside their private practice.  When discussing the caregivers’ satisfaction with treatment, one 
provider in a group discussion said,  
Being pleased they like to give us some money. But I tell them that this treatment is 
absolutely free for you. If any babies around you become ill, inform this news to them. 
Thus, we publicize. —Provider in group discussion 
 
Providers in interviews and group discussions said they regarded the revised guidelines as an 
opportunity to improve care-seeking from these health centers and encouraged caregivers to share 
their positive experiences with family members and others in the community.   




Our analysis of health center records indicate referral to the sub-district hospital was not 
feasible for many families (83.3%; N=160/192). According to providers, in interviews and group 
discussions, caregivers do not comply with referral primarily due to cost, household 
responsibilities, requiring their husband’s consent, and lack of understanding about the severity of 
the infant’s condition. Providers in interviews also acknowledged families’ past negative 
experiences at the sub-district hospital as an important barrier to referral feasibility. One provider 
noted,  
There is lack of cordiality to provide service in the higher health care center. As a whole 
it is seen that they [families] have bitter experience. For these reasons they do not like to 
go there. —Provider in interview 
 
When probed on referral feasibility, caregivers of sick infants in interviews, acknowledged 
economic hardships associated with accepting referral, but insisted these factors would not stop 
them from seeking higher level care for serious illnesses (e.g., pneumonia). For example, one 
mother said, 
He [SACMO] told me to take it [baby] to sub-district hospital, I agreed. I was ready to 
take any risk for my child. I didn’t worry about money. But I wanted my baby to be well 
again. – Mother of sick infant 
 
Some caregivers, in interviews, reported not accepting referral or delays in reaching the referral 
facility because permission of their husband, mother, or mother-in-law was needed. More often 
caregivers, in interviews and group discussions, cited inconsistent availability of services and 
community distrust in government doctors as reasons for not accepting referral to the sub-district 
hospital. Specifically, mothers reported previous dissatisfaction with government hospital 
services when their expectations were not met due to doctors not being available during regular 
service hours, long wait times, high consultation fees, medicine stock-outs, and doctors 
“misbehaving.” When discussing her experience seeking care for her infant at the sub-district 
hospital, one mother said,  
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Suppose they talk with us angrily, ‘There is no medicine. Why have you come here? 
Government does not give us medicines.’ When they tell us these, we get hurt. So we do 
not go. – Mother of infant in group discussion 
 
Caregivers, in group discussions and interviews, often referred to government hospital providers 
as “bad doctors.” This label, however, was not assigned based on a perceived lack of technical 
knowledge or skills. Rather, mothers explained they considered them to be “bad doctors” because 
of their disrespectful demeanor. Caregivers, in one group discussion, voiced agreement when one 
mother explained, 
The doctors at government hospitals have so mean behavior, they feel annoyed when 
visited, won’t speak two words in place of one… But they are not bad as doctors. It is not 
like they don’t have proper medical knowledge. I don’t go to them for their behavior.  
—Mother of infant in group discussion 
 
Occasionally mothers accepting referral advice reported choosing to seek care from private 
hospitals instead of the government hospitals due to the perceived higher quality of care.  
When probed on facilitating referral for the 16.7% (N=32/192) of PSBI cases whose 
families accepted, providers reported mixed perceptions of their responsibility to follow-up with 
these families. Providers, in interviews, often reported giving the family a referral slip, their 
phone number, and the address and phone number of the referral facility. Some providers, 
however, also reported calling the doctor at the referral facility to say the family was on the way, 
then later calling the family to ensure they reached the facility. In these cases, the provider 
reported knowing the outcome of the patient, although there is not a field to record the outcomes 
of referred cases in the register. Caregivers that accepted referral reported in interviews that they 
faced fewer delays at the sub-district hospital when the provider called ahead and felt their 
infant’s health was valued when a provider—either the SACMO or FWV—called to check on the 
baby’s condition.  
Simplified antibiotic regimen and caregiver return for second day injection  
 
Providers, in interviews and group discussions, highlighted the positives of the simplified 
antibiotic regimen for caregivers including mothers’ preference for fewer injections and treatment 
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with oral antibiotics on an outpatient basis, cost-savings for families, and less time away from 
their household and other children. When comparing the simplified regimen to standard inpatient 
treatment, one provider noted,   
No mother wants her child to be pricked again and again. The revolutionary thing here is 
one injection for two days. – Provider in group discussion 
 
According to providers, mothers do not return to for the second injection due to lack of 
knowledge about allopathic medicine which placed onus on the caregiver for “not understanding 
many things,” being “superstitious,” and having “fear of modern treatment.” Specifically, 
providers cited caregiver concerns that the baby’s symptoms are not serious enough to warrant 
the injection and fear that the baby’s condition will worsen after receiving the injection. For 
example, one provider highlighted,  
 We have to make the mothers understand…They think that the child might die after 
taking injection… They actually don’t know why [a] injection is being provided. 
 –Provider in interview 
 
Caregivers, in interviews and group discussions, were cognizant of the value of modern medicine 
to treat the sick infant especially when Ayurvedic—or traditional medicine—had not worked. 
However, caregivers indicated a clear preference for oral antibiotics given at home versus 
injections provided at facilities. Some caregivers, in interviews, expressed not returning for the 
second injection because permission of the husband, mother or mother-in-law was not granted for 
the return visit and/or injection. Mothers also discussed fears around providing antibiotic 
injections to young infants and concerns that these medicines could weaken the baby. As one 
mother described,  
They gave the injection and I returned home…After giving medicines it [baby] became 
weak. I thought it was the side effects of the injection—Mother of sick young infant 
   
Providers also discussed organizational barriers to the second day injection when the 
scheduled return visit occurred on a weekend, or when the provider would be absent from the 
facility due to other duties (e.g., training, supervision meeting at the sub-district hospital). In the 
provider’s absence, the guidelines allow for the FWV to provide the second injection, but 
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providers reported this rarely occurred. Rather, some providers reported dispensing the 
gentamicin injection to the caregiver and requesting they take it to their village doctor to be 
“pushed,” or writing a prescription to be purchased at an outside pharmacy. Some caregivers of 
clinical severe infection cases confirmed receiving this guidance from the provider and in these 
cases confirmed visiting a pharmacy, or the village doctor, to have the injection administered. Of 
the few caregivers that described this experience, some expressed favorable reactions to 
continuing care with their village doctor closer to their home, while others highlighted potential 
barriers to this strategy. For example, one mother described the delay she faced when instructed 
to obtain the second injection from an outside pharmacy, 
[SACMO] advised me to take the 2nd dose of injection from any pharmacy on the 2nd 
day. The reason was that [SACMO] would be on training on that day…At first we went to 
pharmacy. They said they cannot give the injection. Then, going to the [Bazar], we got 
the injection from another pharmacy. – Mother of sick infant in interview 
 
When probed on strategies to improve acceptability of the guidelines, providers in 
interviews and group discussions, discussed the need for strengthen counseling and 
communication skills with caregivers to improve compliance with referral and return visits to the 
health center, and acknowledged that the counseling should include other family members. 
Follow-up on the fourth day for infants receiving outpatient simplified antibiotic 
treatment 
 
Follow-up of PSBI cases on the fourth day of simplified antibiotic regimen is critical to 
ensure safe and effective treatment (10). The Bangladesh National Guidelines specify this follow-
up be initiated by phone between the provider and caregiver (22). Based on our review of records, 
we found about two-thirds (67.4%; N=87/129) of these infants received follow-up on the fourth 
day of treatment. Providers, in group discussion and interviews, agreed with the importance of 
this visit for monitoring the infant’s recovery, but reported various strategies for completing this 
visit. Some providers reported in interviews that they did not agree with initiating follow-up over 
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the phone, but instead requested the family to return to the facility on the fourth day, or said they 
would travel to the family’s home, so they can clinically assess the child. As one provider 
described, 
Calling on 4th day to follow-up, I can’t accept this. This is not right following-up over 
mobile phone. For example, a patient has arrived with low temperature if I don’t check 
his temperature then how can I tell that his condition is improved or not? …So I tell them 
[families] to come directly rather than talking over phone. —Provider in interview 
 
When probed on the feasibility of families’ return to the health center, providers stated that 
caregivers often comply. If the caregiver does not agree to return, then providers said they request 
the caregiver to call or the provider will initiate follow-up by phone. Occasionally, providers in 
interviews discussed requiring families to return on the fourth day to obtain the full course of oral 
amoxicillin. One provider discussed using this technique to promote caregiver compliance, 
“sometimes we state, ‘Here is a file of medicine. Kindly come to see me on the 4th day and 
collect another file of medicine too’.”  
Caregivers of infants receiving outpatient treatment confirmed in interviews that they 
received varying instructions from the providers regarding follow-up on the fourth day of 
treatment including phone calls and return visits. Caregivers that participated in this follow-up 
reported returning to the health center or discussing the infant’s condition with the SACMO or 
FWV over the phone. All caregivers that received follow-up were satisfied with this aspect of 
care. When probed on the content of the day 4 follow-up phone call, one mother recalled,  
She asked me how was my baby, whether I have fed my baby medicine and whether the 
2nd dose injection was administered…I liked the treatment of [SACMO] very much. In a 
short period, I got very good treatment. —Mother in interview 
 
Barriers to follow-up, according to caregivers in interviews, included the provider not initiating 
the phone call or the caregiver not being given the phone number of the provider. Caregivers said 
they appreciated the provider giving their mobile phone number and indicated they would call 





This study aimed to explore acceptability of the infection management guidelines from 
the perception of caregivers and providers during the first year of implementation in primary 
health facilities in Bangladesh. Few caregivers accepted referral to the sub-district hospital, 
suggesting low acceptability of this option for continued care and reinforcing the value of the 
option for simplified antibiotic treatment. Caregivers indicate distrust in hospital doctors, 
inconsistent availability of medicines, and financial constraints as the primary barriers to referral 
feasibility. However, caregivers insisted they would seek higher level care, from either the public 
or private sector, when they believed the infants’ illness was severe. Providers and caregivers 
indicated high acceptability of simplified antibiotic treatment for infants receiving outpatient 
treatment, which they attributed to caregiver preference for providing oral antibiotics at home 
versus continued parenteral treatment at the hospital, reduced medical and travel costs, and less 
time away from their household and other children. More than three-quarters of infants with 
clinical severe infection for whom referral was not feasible returned to the facility for the second 
injection. Providers and caregivers attributed gaps in antibiotic treatment to caregiver concerns 
around providing injections to young infants and unavailability of the provider. Some providers 
reported developing local solutions—including engaging village doctors in treatment of the 
infant—to address organizational barriers and promote treatment compliance. Follow-up of 
young infants receiving simplified treatment is critical for monitoring the safety of the regimen, 
but only about two-thirds of families received follow-up from the provider on the fourth day of 
treatment. Provider deviations from the guidelines (e.g., requesting the caregiver return to the 
facility or initiate the phone call to the provider) may have contributed to gaps in follow-up since 
the responsibility of communication was deferred from the provider to the caregivers. Mothers 
reported greater satisfaction with care when they had a good interpersonal relationship and 
communication with the provider. These findings suggest strengthening providers’ interpersonal 
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skills—including training on counseling that is culturally sensitive—and reinforcing the 
responsibility of the provider to initiate and continue follow-up could improve compliance and 
acceptability of the guidelines.  
Our findings indicate informal providers were the preferred first choice in care due to 
their ability to meet the caregivers’ emotional and social needs, reliability in providing drugs, and 
accessibility. Our findings are consistent with other studies that have found village doctors as an 
important first source of care and referral in the community (15, 24, 26, 43). Caregivers and 
providers also discussed utilizing village doctors for administering the second injection when 
mothers were unable to return to the facility due to unavailability of the provider. In areas 
suffering from severe health worker shortages, like rural Bangladesh, engaging informal 
providers in referral and management of sick young infants may feasibly improve reach and 
acceptability of the guidelines for caregivers (15-17, 22). However, previous efforts to engage 
informal providers in health service delivery have encountered complex barriers to 
implementation including lack of appropriate training, high rates of inappropriate prescribing due 
to market influences, and the absence of regulation and monitoring systems (15, 24, 33, 44, 45). 
For example, one study assessing the feasibility of engaging village doctors to implement 
Community-based Integrated Management of Childhood Illness (C-IMCI) guidelines in rural 
Bangladesh found village doctors’ knowledge could be improved and retained through training 
and routine supervision (15). Despite their increase in knowledge, however, village doctors still 
engaged in inappropriate prescribing practices for children—especially for antibiotics. Authors 
suggested inappropriate prescribing behavior was likely influenced by these practitioners’ 
reliance on profits from drug sells and incentives from pharmaceutical companies, highlighting 
some of the complexities associated with these types of interventions (15). However, the role of 
village doctors as the predominate providers for the poor in this context cannot be ignored and 
our findings suggest they are already integrated in infection management practices for young 
infants in the community. Previous research has promoted public-private partnerships (PPP) to 
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improve nationwide coverage of emergency obstetric and newborn care in Bangladesh (46). 
Future studies are needed to examine the potential for engaging informal and formal private 
providers, including the potential for fostering public-private partnerships (PPP) in this context 
(15, 44, 45). Previous research has promoted PPP to improve nationwide coverage of emergency 
obstetric and newborn care in Bangladesh (46). Additionally, public sector providers’ opinions 
around engaging with private providers as allies should be explored as this has previously been 
identified as a barrier to implementation of PPP (47). 
Our findings suggest referral feasibility is complex for both the families and health 
system contributing to life-threatening delays in care. Previous research in rural Bangladesh 
found acceptance of hospital admission for infants with signs of clinical severe infection sub-
district hospital outpatient department was less than 20% (48). Referral acceptance in our study 
was lower (14%) for infants with signs of clinical severe infection. Families with critically ill 
infants accepted referral more frequently than infants with less severe signs of PSBI, but 
acceptance was still low (28%), resulting in 72% (N=31/43) of critically ill infants not receiving 
continued treatment or seeking care from the private sector—formal or informal—despite 
knowing there would be additional out-of-pocket costs. Caregivers’ previous experiences with 
disrespectful treatment by providers and inconsistent availability of medicines at sub-district 
hospitals negatively affected referral feasibility. A study with sub-district hospital providers in 
rural Bangladesh found more than one quarter of the respondents did not believe the sub-district 
hospital was the right place to manage sick newborns, so they preferred to refer the family to a 
higher-level facility (49). Strengthening care at public sector referral facilities is needed to 
promote high quality, timely care for young infants with PSBI requiring inpatient treatment. At 
the union-level, providers should provide referral slips and follow-up with families to ensure they 
reached the referral facility, but follow-up is not recorded in the register and cases are not 
routinely tracked. We found providers reported varying levels of motivation to facilitate referral 
as demonstrated by connecting with doctors at the sub-district hospital and following up with 
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families to ensure they reached the facility. The few caregivers that described this level of referral 
facilitation reported improved experiences with care at the hospital and felt their baby’s health 
was valued. As the guidelines are scaled-up, future implementation activities should aim to 
improve the quality of care at sub-district hospitals, establish systems for tracking referral cases, 
and reinforce the union-level providers’ role to follow-up with referred cases to ensure they reach 
the higher-level facility.  
We found caregivers’ perception of the interpersonal nature of care—including 
communication and trust in providers—were influential in caregivers’ acceptability of simplified 
antibiotic treatment and follow-up. Familial and social factors also influenced caregivers’ 
decision to accept referral and return for the second day injection. Our findings are consistent 
with previous studies on quality of care in Bangladesh echoing the challenges of achieving 
optimal care that meets both medical and psychosocial needs of the users (15, 24, 33, 50). 
Providers have suggested that improved training in counseling of caregivers, husbands and other 
influential family members may improve acceptability and compliance with return visits for the 
second injection. Some providers also discussed developing local solutions to improve treatment 
compliance and the technical quality of follow-up on the fourth day. It has been suggested by 
Proctor, that providers’ ability to adapt an intervention for local use may increase its acceptability 
(31, 51). For example, in the case of fourth day follow-up, providers’ request for families to 
return to the facility for a clinical visit may improve their acceptability of the guidelines. 
However, further research into the feasibility of this strategy is needed. Additionally, training and 
program feedback should reinforce the importance of giving the full dose of antibiotics on the day 
of assessment and responsibility of the provider to initiate follow-up on the fourth day (22).  
This mixed methods analysis presents findings on acceptability of the guidelines and 
identifies barriers and facilitators to simplified treatment and referral feasibility. However, our 
study had several limitations including lack of direct observations of care. The estimated 
incidence of PSBI in young infants (95.4/1000) (40) in this setting, coupled with low care-seeking 
91 
 
rates from the primary health facilities, led us to expect few infants would seek care at the study 
area health centers during the initial implementation period. Thus, direct observations of care 
were not feasible, and we were limited to analysis of facility records and qualitative interviews to 
assess compliance with the guidelines. Our study did not include implementation support 
activities or data collection at the sub-district hospital (i.e., UHC)—the recommended referral 
facility. Thus, we do not have data from the referral facilities to assess referral compliance, 
quality of care provided, or treatment outcomes for families accepting referral. Given referral 
complexities identified in this study, we anticipate referral compliance to be lower than 
acceptance rates recorded in the union-level health center records. Future studies should include 
data collection at public sector referral facilities to better understand barriers to referral 
compliance, quality of care, and identify opportunities for strengthening management of newborn 
infections. The eighth day visit is important for assessing treatment compliance and outcomes of 
infants receiving simplified antibiotic treatment. However, few infants received the day 8 follow-
up visit, which limited our ability to explore the acceptability and functionality of this visit in 
qualitative interviews. Future analyses should include interviews with health workers responsible 
for this visit (i.e., FPIs) and explore barriers to completion. Finally, we found very few infants 
aged 0-6 days with IFB sought care at study area health centers, which limited our ability to 
assess caregiver acceptability of simplified antibiotic treatment for these cases.  
There is growing interest around the importance of client’s perceived quality of care in 
facilities, including the components of respectful care, communication, and responsiveness of 
providers (52-55). Similar to other studies, we found caregivers’ perceptions of quality of care 
influences care decisions and may be shaped by community, family and societal expectations and 
values (52, 55-57). The health provider and caregiver’s interpersonal relationship influenced 
caregivers’ acceptability of the guidelines—including compliance with referral and simplified 
antibiotic treatment—which may affect treatment outcomes. Future trainings of providers should 
discuss strategies for including influential family members in the infant’s care, incorporate 
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culturally sensitive counseling messages (e.g., acknowledging caregiver fears around injections), 
and reinforce the responsibility of the provider to initiate follow-up communication (e.g., referred 
cases, fourth day phone call) with the caregiver. Local solutions described by providers in our 
study—including requesting caregivers return for a clinical visit on the fourth day and engaging 
village doctors in providing the second gentamicin injection—require further examination in this 
context to assess the safety and potential value of these strategies. Inconsistent tracking of referral 
cases and perceived poor quality of care from public sector facilities are major barriers to referral 
acceptability, especially for critically ill infants whom are not eligible for the simplified regimen. 
As the guidelines are scaled-up, future implementation activities should aim to improve the 
quality of care at sub-district hospitals and strengthen linkages between public sector primary 
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4.8 Tables for Paper 2 
 





Age (in days)   
<7 days 27.6% (53) 
7-28 days 28.7% (55) 
29-59 days 43.7% (84) 
Sex of infant 
 
Male 57.8% (111) 
Female 42.2% (81) 
Signs of illness recorded by SACMO  
Respiratory rate ≥60/min 52.1% (100) 
Severe chest in-drawing 45.8% (88) 
Not feeding well 42.2% (81) 
Fever (>37.5C) 27.6% (53) 
Less movement than normal 19.3% (37) 
Unable to feed 12.5% (24) 
Unconscious/Drowsy 9.9% (19) 
Hypothermia (<35.5C) 6.3% (12) 
Convulsions or history of convulsions 4.2% (8) 
Persistent Vomiting 3.6% (7) 
Umbilicus redness 2.1% (4) 
Weight <1500 g 2.1% (4) 
Bulging fontanelle 1.6% (3) 
Central cyanosis 1.6% (3) 
Other signs 0.5% (1) 





Table 2. Results of qualitative investigation into reasons for high and low values of caregiver acceptability for key components of the 
guidelines 
 
Quantitative Results Qualitative Themes 
Provider adaption to 
strategies 
 Facilitators Barriers  
Decision to seek care and experience at the public health center 
Only 16.3% of the expected 
number of PSBI cases sought 
care from the study area health 
centers 
- Caregivers reported 
seeking care from health 
centers when they had trust 
in the provider 
 
- Village doctors were often 
the first source of care and 
frequently reported as a 
source of referral to the 
health center when their 
treatment failed 
- Previous negative 
experience with public 
sector care, including 
inconsistent availability of 
providers and lack of 
medicines, discouraged 
care-seeking  
- Providers encouraged 
caregivers to publicize 
services available at health 
centers 
Referral feasibility  
Referral was not feasible for 
83.3% (N=160/192) of PSBI 
cases 
- Providers and caregivers 
reported outpatient 
treatment with fewer 
injections and oral 
antibiotics was more 
affordable and acceptable 
than inpatient care 
 
- Some caregivers reported 
not accepting referral 
because permission was 
not obtained from their 
husband, mother-in-law, 
or other influential family 
member 
 
- Providers and caregivers 
reported previous 
experiences with 
disrespectful care and 
inconsistent availability of 
medicines at the sub-
district hospital 
- Some providers called the 
sub-district hospital to 
advise the families were 
coming and followed-up 
with caregivers to check on 
the baby 
 
- Caregivers reported fewer 
delays and higher 
acceptability of care 
received when the provider 
called the hospital and 




seeking from this facility 
16.7% (N=32/192) of PSBI 
cases families accepted referral 
- Caregivers reported they 
would seek care if they 
believed the illness to be 
serious 
- Many providers reported 
giving caregivers referral 
slips and their phone 
numbers for follow-up 
 
- Referral is not routinely 
tracked by providers or 
recorded in the registers, 
so these infants are more 




Simplified treatment regimen and return for second day injection  
80% of infants with CSI for 
whom referral was not feasible 
returned to the health center for 
the for the second injection on 
the next day 
- Simplified treatment was 
more affordable and 
acceptable for continued 
care than inpatient 
treatment 
- Providers and caregivers 
reported caregivers did not 
return due to fear around 
injections, perceptions that 
the infant’s illness did not 
warrant a return 
visit/second injection, or 
permission was not 
obtained from an 
influential family member 
 
- Logistical barriers posed a 
challenge to follow-up 
when the visit fell on a 
weekend or a day when 
the provider was 
unavailable due to absence 
or training 
- When the provider knew it 
would not be possible for 
the caregiver to return the 
next day, often due to 
unavailability of provider, 
some providers gave the 
caregiver the gentamicin 
injection to be 
administered by the village 
doctor or instructed them 
to purchase it at the 
pharmacy 
Fourth day follow-up for PSBI cases receiving simplified treatment 
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67.4% (N=87/129) of PSBI 
cases receiving outpatient 
treatment received follow-up on 
the fourth day  
- Some providers said they 
requested the caregivers to 
return to the facility on 
day 4 for clinical 
assessment and would call 
if the caregiver did not 
return 
 
- Some providers reported 
not initiating follow-up, 
but relying on the 
caregivers to return to the 
facility or call if the 
baby’s condition did not 
improve 
- Some providers said they 
requested the caregivers to 
return to the facility on day 
4 for clinical assessment 
and would call if the 
caregiver did not return 
 
- Some caregivers reported 
providing enough oral 
amoxicillin to the caregiver 
until day 4 and then 
requesting they return for 
the complete regimen 




Supplemental Table 1. Adapted SEM to assess multiple levels of influence on caregiver 
acceptability of guidelines  
 
Levels of influence Description Constructs explored in the 
interviews 
Individual  Factors related to the 
caregivers’ knowledge and 
perception of care provided 
per the guidelines including 
antibiotics and referral 
Caregiver autonomy in 
decision-making to seek care 
and accept referral; caregiver 
perception of illness severity; 
previous experiences with 
care at public sector facilities 
Interpersonal  The role and influence 
household factors and other 
key actors in healthcare 
decision-making 
Influence of economic 
factors, household 
responsibilities, and family 
members in decision-making 
for the infant’s care (e.g., 
husband, mother or mother-
in-law, other family 
members) 
Organizational  Care received at public sector 
health facility and 
relationship with providers 
Availability and accessibility 
of public sector services and 
medicines; Caregiver 
relationship with the provider; 
Provider motivation to 
facilitate referral and follow-
up 
Community  Social and cultural values 
that motivate or impede 
acceptability of treatment per 
the guidelines 
Social and cultural values that 
influence care-seeking in this 
context; community 






4.9 Figures for Paper 2 
 
Figure 1. Adapted socioecological model for analysis of embedded mixed methods study to 












Chapter 5.  Paper 3: Patterns and determinants of 
caregiver non-adherence to oral amoxicillin for sick 
young infants receiving simplified antibiotic treatment 
5.1 Abstract 
 
Background: Infections remain a significant contributor to newborn morbidity and mortality. To 
increase access to treatment in resource-limited settings, WHO issued guidelines for managing 
possible serious bacterial infection (PSBI) in young infants (0-59 days) when hospital referral is 
not feasible for families. The simplified antibiotic regimen includes a critical home-based 
treatment component—oral amoxicillin twice daily for seven days. We report results from a 
mixed methods implementation research study that assessed patterns and determinants of 
caregiver non-adherence to oral amoxicillin in three rural sub-districts of Bangladesh during 
October 2015-August 2016. 
Methods: This study took place in 19 primary health centers and catchment area communities. 
We extracted data for all infection cases from facility registers and followed-up families at their 
homes to assess caregiver-reported adherence with treatment through administration of a 
questionnaire. Adherence was defined as a categorical variable: 1) Adherent (10-14 doses); 2) 
Underuse (<10 doses); 3) Overuse (>14 doses). Bivariate analysis was conducted to examine 
associations between independent variables and adherence based on an adapted conceptual 
framework. Multivariable multinomial logistic regression was performed to examine selected 
factors with adherence adjusting for covariates. In-depth interviews (N=16) with caregivers were 
analyzed to identify barriers and facilitators to adherence.  
Results: During the 10-month period, 229 caregivers of sick young infants reported they were 
responsible for giving oral amoxicillin to their sick infants. 62.4% of caregivers reported 
(N=143/299) administering 10-14 doses of oral amoxicillin to the infant during the illness 
episode, which we classified as adherent. 14.8% (N=34/229) of caregivers reported giving the 
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infant fewer than 10 doses at home, while 22.7% (N=52/229) of caregivers reported exceeding 14 
doses of oral amoxicillin. Mothers that reported receiving follow-up from the provider during the 
illness period were less likely to provide fewer than ten doses (RR: 0.19; 95% CI: 0.05 – 0.74). 
While mothers that reported any barriers to giving oral antibiotics were more likely to provide 
fewer than ten doses (RR: 0.42; 95% CI: 0.22 – 0.78). No factors were associated with exceeding 
the recommended dosage.  Qualitative data suggest caregivers had a better understanding of the 
regimen when the provider gave verbal and written instructions, marked the dropper to reflect the 
dosage amount and demonstrated giving the first dose. Caregivers reported skipping doses when 
the baby experienced side-effects to the medicine (e.g., vomiting), and would discontinue 
treatment if they believed the baby was no longer sick.  
Conclusion: Provider counseling on continuing medicine and follow-up with sick infants is 
important for caregiver adherence to the oral amoxicillin regimen. Improving the quality of 
counseling to include messages on handling side-effects and reinforcing the need to complete the 
full course may improve adherence. Strategies are needed to improve provider adherence to the 
guidelines—including demonstrating the first dose and day 4 follow-up—as the guidelines are 
scaled-up nationwide.  
5.2 Introduction 
 
Appropriate case management of serious infections in newborns, including early 
identification and appropriate treatment with antibiotics, may result in a 24% reduction in 
infection-related neonatal deaths (1-4). In 2015, the World Health Organization (WHO) released 
new guidelines for managing young infants (0-59 days) with possible serious bacterial infections 
(PSBI) when hospital care is not feasible for families. The guidelines are based on systematic 
review of the evidence, including trials in sub-Saharan Africa and South Asia, which showed that 
simplified antibiotic treatment regimens—including fewer injections combined with oral 
amoxicillin—was as effective as the standard seven day course of a combination of gentamicin 
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and penicillin (5-9). The revised guidelines also changed recommendations for infants (7-59 
days) with fast breathing as the only sign of illness based on findings that showed oral amoxicillin 
is equivalent in clinical effectiveness to parenteral therapy for these infants (8). These guidelines 
are intended for implementation in resource-limited settings where many infants with PSBI may 
not receive the recommended in-patient treatment (9-12). Bangladesh was one of the first 
countries to adopt the WHO recommendations (13). In 2015, the government of Bangladesh 
partnered with funding agencies, implementation groups, and research organizations to 
operationalize the guidelines in primary health facilities in a few selected districts (13). A mixed 
methods implementation research study was embedded in program rollout to document lessons 
around implementation and inform nationwide scale-up (9, 10, 14). 
Simpler antibiotic regimens have been found to be associated with improved patient 
adherence, reduced misuse of antibiotics, and higher treatment acceptance by patients (15, 16). 
For infants with PSBI, the simplified antibiotic treatment regimen aims to improve access to care 
and includes a critical home-based treatment component with oral amoxicillin. Randomized 
controlled trials that contributed to the evidence of simplified treatment reported high treatment 
adherence for combination therapy regimens (5, 7, 8). However, since these were efficacy trials, 
well-trained study personnel were responsible for visiting the homes of infants and ensuring 
correct administration of the antibiotics. As part of the implementation research study, we aimed 
to study caregiver adherence to outpatient oral amoxicillin in the absence of study intervention.  
Previous studies of ambulatory treatment of childhood illnesses, including pneumonia, 
with oral antibiotics report a wide range of caregiver adherence to antibiotic regimens—from 
40%-97%— and primarily focus on treatment of children under-five years of age (17-20). With 
growing concerns about antibiotic resistance, there is an increasing focus in the adherence 
literature on rational use of antibiotics—including both underuse and overuse—in community 
settings (15, 16, 21-23). To our knowledge, this is first study assessing predictors, barriers and 
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facilitators to caregiver adherence to oral amoxicillin regimens for young infants receiving 
outpatient treatment according to the revised infection management guidelines in Bangladesh.   
The caregivers’ experience with administering antibiotics is an important contributor to 
acceptability and clinical effectiveness of outpatient treatment. Adherence to medication is 
complex and multi-faceted, making predicting non-adherence to medication difficult (24). WHO 
defines adherence as “the extent to which the persons’ behavior, including medication-taking, 
corresponds with agreed recommendations from a healthcare provider” (25, 26).  We utilized 
WHO’s five dimensions of adherence  as well as findings from previous studies to inform our 
conceptual framework for this study (Figure 1) (15, 16, 21, 25-27). Here, we discuss mixed 
methods study findings on caregiver adherence to oral antibiotic regimens including determinants 
of adherence and barrier and facilitators to home treatment.  
5.2 Methods 
Context and Intervention 
 
Bangladesh is divided into eight administrative divisions, which are further divided into 
districts and sub-districts. In rural areas, sub-districts are divided into unions, then into wards 
(28). Our study area included union-level health centers in two sub-districts of Sylhet in Sylhet 
division and one sub-district in Lakshmipur in Chittagong division. Sylhet and Chittagong are 
historically low performing divisions of Bangladesh for maternal, newborn and child health 
indicators, including low rates of facility delivery and skilled attendants at birth (28).  
The MOHFW maintains a three-tier system for delivering public healthcare services at all 
administrative levels and follows the Integrated Management Childhood Illness (IMCI) protocol 
for management of sick children in primary health facilities (29, 30). Implementation of the 
infection management guidelines targeted union-level primary health facilities (i.e., UH&FWCs), 
which are generally staffed by 2-3 formally trained providers—the Sub-Assistant Community 
Medical Officer (SACMO) and the Family Welfare Visitor (FWV). Some of these facilities have 
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a position for a doctor available, but these posts are often vacant (31-33). The SACMO has 3 
years training on general healthcare, including child health, from a Government Medical 
Assistant Training School (31). The FWV has at least 18 months training from a private or 
government facility on midwifery and contraceptive management (29, 31, 33).   
The SACMO is the designated provider for assessing, classifying and treating young 
infants according to the guidelines. To aid these workers in identifying sick infants, the 
Bangladesh guidelines include a clinical algorithm for classifying signs of infection in young 
infants, guidance on antibiotic treatment, referral advice and follow-up (34). Infants with signs of 
PSBI (fever, hypothermia, convulsions, respiratory rate ≥60 breaths per minute if infant is <7 
days, severe chest in-drawing, no movement or movement only upon stimulation, feeding poorly 
or not feeding at all) are classified as Critical Illness (CI), Clinical Severe Infection (CSI), or 
Isolate Fast Breathing in infants aged 0-6 days (IFB <7). Accordingly, the SACMO provides the 
first dose of antibiotics based on the infant’s weight and refers the infants with signs of PSBI (i.e., 
CI, CSI, and IFB [<7D]) to the sub-district hospital (Upazila Health Complex [UHC]; catchment 
area ~250,000 persons) for inpatient care (29, 34). Young infants classified as CSI or IFB (<7D) 
whose families decline hospital referral are eligible for simplified antibiotic treatment with 
injectable gentamicin once daily for two days and oral amoxicillin twice daily for seven days. 
Hospital referral is the only option for critically ill infants.  Caregivers of infants with CSI that 
decline referral are instructed to return to the UH&FWC the next day for the 2nd gentamicin 
injection. The SACMO follows-up with caregivers over telephone on the fourth day, and if the 
infant’s condition has not improved, advises the caregivers to seek care at the sub-district 
hospital. On the eighth day of treatment, the family receives a home visit from the Family 
Planning Inspector (FPI), who are trained as supervisors of frontline workers, to assess treatment 
compliance and the condition of the infant (34). Caregiver compliance with return visits and 
provider adherence to day 4 follow-up are reported elsewhere (Applegate, Paper 2). In this paper, 
we assessed caregiver adherence to the oral amoxicillin regimen—twice per day for seven days—
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for infants receiving outpatient antibiotic treatment (e.g., CSI and IFB cases). As part of training 
on the updated PSBI guidelines, SACMOs received training on the importance of counseling 
caregivers on the oral antibiotic regimen and were instructed to ask about treatment compliance at 
the fourth day of treatment. Henceforth, we will refer to SACMOs as “providers” and the 
UH&FWCs as “health centers.”  
Design and Data Collection 
 
Project partners—Projahnmo and MaMoni Health Systems Strengthening (HSS)—
supported the MOHFW to implement the guidelines in 3 sub-districts of the selected districts, 
Sylhet and Lakshmipur respectively. Both implementation partners have extensive experience 
supporting maternal, newborn and child health (MNCH) interventions and health system 
strengthening in rural Bangladesh, which has been described previously (35, 36). The supportive 
inputs from these two partners primarily focused on improving the performance and capacity of 
health services, including collaborating with the MOHFW to ensure the availability of antibiotics 
at study area health centers and supporting training and supervision of providers. Project partners 
also worked with government frontline workers to promote awareness and community 
engagement with the public sector healthcare system. Beyond ensuring availability of oral 
amoxicillin at the health centers and training of providers in the guidelines, implementation 
support did not include activities with caregivers to promote adherence to the simplified antibiotic 
regimen.  
Our study employed a mixed methods approach to data collection following a convergent 
parallel design where quantitative and qualitative data are collect concurrently (37). Data 
collectors visited the 19 UH&FWCs weekly to abstract data from facility records of young infants 
that sought services from October 2015-August 2016. Our study team aimed to follow-up all 
young infants (0-59 days) classified as infection at study area health centers to assess compliance 
with referral, adherence to outpatient treatment, and treatment outcomes. Follow-up by the study 
team took place between days 9 and 15 of treatment to not interfere with government follow-up 
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visits on days 4 and 8. Caregivers of young infants that provided verbal consent were enrolled in 
the study. The study team administered a questionnaire to assess counseling and follow-up by the 
provider, frequency and total number of antibiotic doses provided, barriers to therapy, and 
examined caregivers’ decision-making and confidence to give medicine to their infant. The 
questions on adherence to medicines administered within the home were adapted from the 
Medical Adherence Questionnaire (MAQ), which is a scale validated in low-literacy populations 
to identify barriers to treatment adherence (38). 
In-depth interviews with caregivers were conducted in both study areas to explore 
barriers and facilitators to adherence. Caregivers were purposively selected based on their infant’s 
categorization of infection. We conducted in-depth interviews with caregivers of infants for each 
category of PSBI. However, we prioritized reaching a point of saturation for the clinical severe 
infection cases because these infants receive referral to the hospital and are eligible for simplified 
antibiotic treatment, including two gentamicin injections, when referral is not feasible for 
families. The goal of these interviews was to assess acceptability of the guidelines and the 
facilitators and barriers to providing oral amoxicillin from the perception of caregivers of young 
infants receiving treatment according to the guidelines. In-depth interviews were used to assess 
the caregivers’ understanding and experience with administering treatment (e.g., how often did 
you give the medicine?). We also asked questions to examine the caregivers’ self-efficacy as it 
relates to their ability to give medicine to their infant as this has been shown to be a contributor to 
adherence (26). 
All researchers following up the mothers in the community were Bangladeshi and 
conducted interviews in the local language (Sylheti in Sylhet, and Bangla in Chittagong). 
Interviews were recorded and transcribed into English by trained translators for analysis. 
Following the interviews, research assistants also participated in debriefing sessions led by the 
research officers utilizing a thematic framework. Notes from these debriefing sessions were also 




We defined adherence as caregivers’ self-report of providing 10-14 doses of oral 
amoxicillin during the illness episode. This range was chosen based on WHO criteria for 
adherence and is consistent with other studies that define adherence as 80% compliance with the 
recommended doses (10, 19, 25). Mothers that reported giving their infants doses outside of this 
range were classified as one of two non-adherent groups: 1) Mothers providing fewer than 10 
doses (i.e., underuse) or 2) Mothers that reported providing more than 14 doses (i.e., overuse).  
We adapted the WHO adherence framework to outline relevant factors that may influence 
adherence to the oral amoxicillin regimen (Figure 1). Social and economic factors included 
mother’s age, education, family size, religion, and mother’s employment. We adapted WHO’s 
dimension of patient-related factors to include factors related to both the mother and infant: 
caregiver-related factors (mother’s role in decision-making for their child health and confidence 
to administer medicine to the baby) and infant-related factors (age and sex of the baby). The 
mother was considered to be involved in decision-making about child health if they reported 
being the primary decision-maker or is they shared responsibility of decision-making with their 
husband or another family member. We included the infant’s infection classification as an illness-
related factor to represent illness severity. Provider-related factors were reported by the 
caregiver and included counseling on continuing oral amoxicillin at home and receiving follow-
up from the health center provider during the illness period. Medical counseling and reported 
follow-up from the provider were based on maternal responses in the follow-up questionnaire. 
Therapy-related factors included caregiver’s report of any barriers to treatment.  
Analysis 
We calculated the frequency, proportion and corresponding 95% Confidence Interval 
(CI) for oral amoxicillin doses given at the health center and home of the infant. We used the 
conceptual model (Figure 1) to identify the independent variables with a potential effect on 
adherence. We examined unadjusted associations for all independent variables with the dependent 
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variable—fewer than ten doses, adherent (10-14 doses), or exceeded recommended doses—using 
Pearson’s chi-squared test for independence.  A multivariable multinomial regression model was 
fitted to estimate Relative Risk Ratios (RRR) and 95% CI adjusting for variables associated at 
p<0.20 in bivariate analysis. The variables for infant age and provider follow-up were also 
included in the multivariate model because of its importance to our conceptual model. We 
assessed collinearity for all independent variables in the final model and excluded any variables 
associated at r >0.5. No variables were excluded due to collinearity. Barriers to treatment were 
examined as both a combined variable (i.e., any barrier reported) and the distribution by 
adherence group was calculated for specific barriers. Quantitative data were analyzed using Stata 
version 14 (StataCorp LP). 
For the qualitative analysis, we employed an integrated approach to development of the 
coding framework (39). The framework was developed using a priori codes derived from the 
interview guides and the research questions related to medication adherence. Emergent codes 
were added to the codebook as necessary to capture themes that were suggested in the data but 
not initially anticipated in the a priori codes. We coded transcripts using the computer software 
program Dedoose. This study employed analytical methods of continual analysis, coding, and 
memoing. Our team reviewed transcripts of respondents throughout the study period based on 
both inductive and deductive themes. We adapted the questionnaire to explore emergent themes 
(40). Ultimately, we developed a coding framework—including a priori and emergent codes—
based on iterative review of the qualitative data, which was used for the final analysis. Each 
transcript was coded using this scheme and charting of the coded passages was used to facilitate 
interpretation of the data between two researchers. 
5.3 Results 
 
Of the 583 young infants classified as infection at the study area health centers, our team 
followed-up and enrolled 78.6% (N=458) of their caregivers during home visits (Figure 2). We 
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excluded young infants with critical illness and local bacterial infection (N=143) because they 
were not eligible for simplified treatment per the updated guidelines. We excluded caregivers that 
reported accepting referral to the higher-level facility (N=23) or changing treatment during the 
illness episode at the advice of a doctor (N=26). Questionnaires missing the number of doses 
provided at home were also excluded from the analysis (N=10). Ultimately, 229 young infants 
received oral amoxicillin from 17 health centers in Sylhet (N=7) and Lakshmipur (N=10) and 
were included in this analysis.  
A total of 23 interviews were conducted with caregivers during the study period. For this 
analysis, we excluded caregivers that reported the baby was critically ill or the family accepted 
referral (N=4), and caregivers that reported the baby “had disease of the umbilicus” (e.g., local 
bacterial infection) (N=3) since these infants were not eligible for simplified antibiotic treatment 
according to the revised guidelines. A total of 16 caregivers were included in our analysis of 
barriers and facilitators to adherence. 
Quantitative  
  
Of these 229 infants, health center records indicated 99.1% (N=227/229) received the 
first dose of oral amoxicillin from the provider on the day of assessment. However, 93.3% 
(N=210/229) of caregivers reported their infant did not receive the first dose of oral amoxicillin at 
the facility (Table 1). 62.4% of caregivers reported (N=143/299) administering 10-14 doses of 
oral amoxicillin to the infant during the illness episode, which we classified as adhering to the 
regimen (Table 1). 14.8% (N=34/229) of caregivers reported giving the infant fewer than 10 
doses at home and 22.7% (N=52/229) of caregivers reported exceeding 14 doses of oral 
amoxicillin. In bivariate analysis, adherence to the amoxicillin regimen was significantly different 
by study district, maternal education and for mothers that reported any barriers to providing 
treatment compared to mothers that reported no challenges (p<0.05) (Table 2).  
In multivariate multinomial regression analyses, only provider-related and therapy-
related factors were associated with non-adherence (Table 3). Only 20.5% (N=47/229) of 
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caregivers reported receiving follow-up from the provider after the initial day of treatment. 
Mothers that reported receiving follow-up from the provider during the illness period (e.g., day 4 
follow-up) were less likely to provide fewer than ten doses than mothers who did not receive 
follow-up (RR: 0.19; 95% CI: 0.05 – 0.74). 30.6% (N=70/229) of caregivers reported 
experiencing challenges to providing treatment to the infant. Mothers that reported any barriers to 
giving oral antibiotics at home were more likely to give the baby fewer than ten doses (RR: 0.42; 
95% CI: 0.22 – 0.78). No factors were found to be significantly associate with the caregivers 
reporting exceeding the recommended dosage for oral amoxicillin. When we examined the 
distribution of specific barriers reported by caregivers, we found mothers reporting the baby had a 
negative side effect after taking the medication was the only barrier that differed by adherence 
classification (Table 4).  
Qualitative  
 
 During in-depth interviews, all mothers of sick infants reported feeling confident in their 
ability to administer oral amoxicillin to their infants at home. When asked if other family 
members were involved in helping to administer the medication, most caregivers reported relying 
on themselves to provide the medication according to the doctor’s instructions. Occasionally, 
mothers said the baby’s father or grandmother may help provide the medicine, especially if this 
family member accompanied the mom to the health center and heard the doctor’s instructions.  
Most mothers discussed receiving instructions from the provider on continuing medicine 
at home, but the extent and quality of counseling varied. Some mothers reported they received the 
oral amoxicillin already prepared by the provider, while others reported they were instructed to 
reconstitute the powder at home using water that had been boiled. When probed on the provider’s 
instructions for giving the medication, caregivers reported a better understanding of the regimen 
when the provider had shown them how to measure the medicine in the dropper and demonstrated 
administering the first dose to the baby. As one mother recalled, 
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Doctor apa [SACMO] showed how feeding is to be done by the dropper, if one feeding 
was at 7 pm, the next feeding will be at 7 am of the next day – Mother of sick infant  
 
We found that mothers had better recall of the dosage amount when the provider marked the 
correct dosage line on the medicine dropper,  
Drops was given. First mark to second mark of the drop were given 2 times daily. Doctor 
had written the ways of feeding and also told us verbally. – Mother of sick young infant 
 
Some mothers reported that they did not receive verbal counseling from the provider on 
administering the medicine, but rather instructions were only written on a prescription slip. 
Occasionally caregivers reported being instructed to give the full medicine bottle over a week’s 
time. In these cases, the caregiver was not able to recall the amount they administered with each 
dose.  
When probed on barriers to adhering to the treatment regimen, few mothers reported 
forgetting a dose, and most said that they did not have trouble remembering to give their infant 
the medications. When asked what she does to remember to administer the amoxicillin, one 
mother said with a smile, “We remember without any help. Our child’s face reminds us. We 
always stay close to our children.” When asked whether they had difficulty remembering the 
correct amount to give the child, the mothers indicated that they did not have an issue because 
they referred to the marked dropper, medicine bottle and/or prescription slip as a reminder. The 
most frequently reported reason for skipping a dose of treatment was if the infant vomited the 
medicine after ingesting it, which caused the mother to worry about the condition of the infant. 
Some mothers reported strategies for administering the dose to the baby; for example, feeding the 
medicine to the baby slowly from the dropper so that it was better tolerated. As one mother 
explained, “I need to feed slowly. She cannot eat when I feed quickly.” Several mothers also 
reported consulting the provider if the baby vomited after medication was administered,  
If the child vomits due to the medicine, then I stop giving it. Then I go to the doctor. The 
doctor tells me to give the medicine again after vomiting, about after 10 minutes.  




If my child starts vomiting after giving medicine, then I will consult with the doctor who 
gave the medicine. I will ask if I should continue it or not. I will decide depending on 
what the doctor says. –Mother sick young infant 
 
For mothers that reported stopping the medicine before completing the full regimen, the most 
commonly reported reason was seeing improvement in the baby’s condition. As one mother 
stated, “If the disease is gone, then I stop the medicine.” When probed on what they do with any 
remaining medicine, few mothers said they saved the amoxicillin for another illness episode or 
another child. More often, mothers reported disposing any unused medicine because they had 
been instructed by providers to not reuse medicine that is unsealed or more than one week old. 
5.5 Discussion 
This study aimed to explore caregiver adherence to oral amoxicillin treatment for sick 
young infants receiving the simplified antibiotic therapy from outpatient health centers in 
Bangladesh. Few caregivers reported that their infants received any doses of oral amoxicillin at 
the health center, which conflicted with health center records. Nearly two-thirds of caregivers 
reported adhering to the correct range of oral amoxicillin doses at home. We adopted dimensions 
of the WHO framework for medication adherence to examine the association of factors that 
contributed to or hindered optimal adherence to the regimen (26). Our quantitative analysis 
indicates that mothers reporting any barriers to treatment were more likely to give their babies 
fewer than ten doses. However, receiving follow-up from the provider had a protective effect for 
underdosing. Qualitative data indicate caregivers are confident in their ability to give oral 
antibiotics to their babies and relied on the provider’s instructions for determining the dosage 
amount and frequency. Caregivers reported better understanding of the home-based regimen 
when counseling included both verbal and written instructions—including marking the dosage 
line on the dropper—and the provider demonstrated administering the first dose to the infant. 
Caregivers identified the baby vomiting after ingesting the medicine as the primary reason for 
skipping doses, while their perception that the baby was no longer sick was often cited as the 
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reason for stopping treatment early. These findings suggest reinforcing the importance of follow-
up and improving the quality of provider counseling—including demonstrating giving medicine 
to the baby, incorporating guidance on managing side-effects, and the importance of completing 
the full course of antibiotics—may improve caregiver adherence to the oral amoxicillin regimen. 
According to the guidelines, providers should provide the first dose of oral amoxicillin on 
the day of assessment at the health center. When we compared data from health center records 
with the caregiver questionnaire, we found that 99.5% (N=209/210) of the infant records where 
caregivers reported receiving zero doses at the facility had the first oral amoxicillin dose recorded 
in the register. Discordance between these data sources suggest providers may be giving the 
caregivers the oral amoxicillin to administer at home without providing the first dose to the 
infant. Qualitative data supports this notion, as few caregivers reported that the provider 
demonstrated how to give medication to the infant. Furthermore, some caregivers stated they 
prepared the oral amoxicillin at home with boiling water. Previous analyses from this study 
identified few health centers had a source of clean water available (Applegate, Paper 1). In these 
facilities, providers may give the amoxicillin powder to be reconstituted by the caregiver at home. 
It is also possible that providers refrained from administering the first dose as a time-saving 
measure, or that caregivers in our study did not remember receiving the first dose of oral 
amoxicillin at the facility. Training and supervision sessions should reinforce to providers the 
importance of providing the first dose of oral amoxicillin to prevent delays in initiating treatment 
and demonstrate proper administration for caregivers. Future program efforts should explore this 
finding further to better understand potential barriers to preparing and administering the first dose 
in the health center.  
A previous evaluation of IMCI practices in rural outpatient facilities in Bangladesh found 
less than 10% of caregivers of sick children were counseled on how to administer medications at 
home. In exit interviews, none of the caregivers could correctly describe how to administer oral 
antibiotics to the child at home (32). We found 87% of caregivers reported receiving counseling 
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on oral antibiotics, which caregivers reported contributed to a better understanding of the 
regimen. We also found caregivers that reported receiving follow-up from the provider were less 
likely to give the baby fewer than ten doses. Our findings are consistent with previous studies, 
which have identified communication between the provider and caregiver as a key factor for 
adherence to outpatient oral antibiotic regimens (21, 41). However, the association of barriers 
with non-adherence and qualitative data suggest targeting supports to improve the quality of 
counseling may further bolster adherence. In interviews, mothers reported skipping doses most 
frequently due to the baby vomiting the medicine, and the most common reason for the mom 
stopping treatment early was when they believed the baby recovered. Both barriers should be 
addressed in counseling—at the facility and during follow-up—and indicated on the written 
instructions. Less than one-quarter of caregivers reported receiving follow-up from the provider 
after the day of assessment at the health center. Future program training and supervision sessions 
should reinforce that follow-up of infants receiving outpatient treatment is critical for the safety 
of the baby and promoting caregiver adherence to oral amoxicillin (9). Strategies to monitor for 
accountability and improve providers’ compliance with fourth day follow-up should be explored 
and tested as the guidelines are scaled-up nationwide.  
Successful implementation of the revised WHO guidelines will increase access to 
antibiotic treatment as well as antibiotic consumption. The WHO guidelines recognize that 
extensive use of antimicrobials increases the risk of antimicrobial resistance. Compared to current 
recommendations, the revised WHO guidelines are not expected to increase the risk of antibiotic 
resistance, but it is recommended that surveillance be increased to monitor resistance patterns (9, 
10). Like many adherence studies, the barriers included in our study questionnaire primarily 
focused on reasons caregivers skipped doses or stopped treatment early. Our model did not yield 
significant associations to help us explain why more than 20% of caregivers reported exceeding 
the recommended number of doses. Qualitative data suggest lack of counseling on continuing 
medication or poor specificity of instructions by providers may contribute to an excess use of 
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antibiotics. For example, some caregivers reported being instructed to give the full medicine 
bottle in a week but were not able to recall the amount per dose, which may have resulted in 
caregivers exceeding the optimal number of doses to finish the bottle. Future studies examining 
caregiver knowledge of rational antibiotic use are important for identifying drivers of overuse and 
ensuring access to antibiotics without excess usage (15, 16). 
Surprisingly, we did not identify associations between caregiver-related factors and 
adherence. We explored caregiver self-efficacy to provide medication to the infant in both the 
questionnaire and interview guides but found little variation in caregivers’ reported confidence to 
administer medication to the baby. Caregivers frequently reported confidence to administer 
antibiotics and relied on themselves to make decisions about continuing treatment or following-
up with the doctor with questions. In this setting, antibiotic use for young children is common due 
to both a high number of illness episodes and widespread availability of over-the-counter 
antibiotics (22, 42, 43). Therefore, it is likely caregivers in our study have previous experience 
with giving antibiotics to infants and children, which may bolster their confidence. We also did 
not identify associations between adherence and infant or illness-related factors—such as age and 
infection classification. Additional research on caregiver adherence to oral antibiotic regimens for 
simplified antibiotic treatment in newborns is needed to explore predictors of adherence and 
contribute to an appropriate conceptual model.  
One critical limitation of our study is that we were only able to follow-up 78.6% 
(N=458/583) of caregivers and infants in the community. Thus, we were not able to assess 
adherence for those caregivers and infants that were lost to follow-up, which may have differed 
significantly from our study population. Our outcome measure—caregiver’s self-report of 
number of doses given to the infant—is a subjective measure of adherence and vulnerable to 
reactive effects and recall bias (26, 27, 37). Reactive effects may be a threat due to respondents’ 
social desirability to respond favorably about adhering to treatment especially if they knowingly 
stopped administering treatment against recommendations. In attempt to control for this threat 
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and capture an objective measure of adherence, we asked to see the medication bottle and 
prescription slip prior to asking questions about dosage. However, many caregivers did not have 
the medicine bottle available at the time of the interview and the details of the prescription slip 
were not recorded by data collectors. As a result, caregivers’ self-reported adherence to the 
regimen may be over- or underestimated compared to an objective measure of adherence (44).  
Our study suggests healthcare providers are instrumental for promoting caregivers’ 
adherence to ambulatory oral amoxicillin treatment for sick young infants. Promoting provider 
adherence to the guidelines, including follow-up with the caregiver during the illness episode, 
may reduce undertreatment of sick infants. Caregivers indicated that they rely on the providers’ 
instructions for continuing medicine and will consult the provider when the baby experiences a 
side-effect to the medicine, such as vomiting. Efforts should be made to improve the quality of 
counseling and integrate messages on completing the full course and how to proceed when the 
baby has a negative reaction to the medicine. Future research is needed to explore drivers of 
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5.7 Tables for Paper 3 
Table 1. Distribution of oral amoxicillin doses provided to the infant for the illness episode 
 
Location 
Doses Administered n (%) 
N=229 
95% CI 
Doses given at the facility   
Zero 210 (91.7%) 87.3% – 94.9% 
One 11 (4.8%) 2.4% – 8.4% 
Two 1 (0.4%) 0.01% – 2.4% 
Don’t know/Can’t 
remember 
7 (3.0%) 1.2% – 6.2% 
Doses given at home   
<10 34 (14.8%) 10.5% – 20.1% 
10-14 143 (62.4%) 55.8% – 68.7% 



























Social and Economic Factors    
Study District      
      Sylhet  50 (21.8%) 33 (66.0%) 13 (26.0%) 4 (8.0%) 
0.003* 
      Lakshmipur 179 (78.17) 110 (61.5%) 21 (11.7%) 48 (26.8%) 
Maternal Age       
      <20 years 47 (20.5%) 29 (61.7%) 2 (4.3%) 16 (34.0%) 
0.067       20-29 years 126 (55.0%) 76 (60.3%) 23 (18.3%) 27 (21.4%) 
      =>30 years  56 (24.5%) 38 (67.9%) 9 (16.1%) 9 (16.1%) 
Maternal Education      
     No education 14 (6.1%) 9 (64.3%) 4 (28.6%) 1 (7.1%) 
0.006*      1-5 years (Primary) 41 (17.9%) 30 (73.2%) 9 (22.0%) 2 (9.8%) 
     =>6 years 
(Secondary & above) 
174 (76.0%) 104 (59.8%) 21 (12.1%) 49 (28.2%) 
Religion       
      Islam 225 (98.3%) 142 (99.3%) 32 (14.2%) 51 (22.7%) 
0.116 
      Others 4 (1.8%) 1 (25.0%) 2 (50.0%) 1 (25.0%) 
Family size       
      1-4 36 (15.7%) 17 (47.2%) 7 (19.4%) 12 (33.3%) 
0.361 
      5-6 85 (37.1%) 51 (60.0%) 13 (15.3%) 21 (24.7%) 
      7-8 69 (30.1%) 47 (68.1%) 10 (14.5%) 12 (17.4%) 
      ≥ 9 39 (17.0%) 28 (71.8%) 4 (10.3%) 7 (18.0%) 
Mother works      
    Yes 39 (17.0%) 24 (61.5%) 6 (15.4%) 9 (23.1%) 
0.991 
    No 190 (80.9%) 119 (62.6%) 28 (14.7%) 43 (22.6%) 
Caregiver-related factors   
Mother included in decision-making about child health    
      Yes 177 (77.3%) 115 (65.0%) 28 (15.8%) 34 (19.2%) 
0.064 
      No 52 (22.7%) 28 (53.9%) 6 (11.5%) 18 (34.6%) 
Mother can take child to health center alone    
      Yes 110 (48.0%) 71 (64.6%) 21 (17.7%) 26 (23.6%) 
0.463 
       No 119 (52.0%) 72 (60.5%) 13 (11.8%) 26 (21.9%) 























      Not confident 2 (0.9%) 1 (33.3%) 2 (66.7%) 0 (0%) 
0.116       Somewhat confident 37 (16.2%) 22 (59.5%) 7 (18.9%) 8 (21.6%) 
      Very confident 189 (82.9%) 120 (63.5%) 25 (13.2%) 44 (23.3%) 
Infant-related factors 
Age of infant      
     <7 days 16 (7.0%) 9 (56.3%) 4 (25.0%) 3 (18.8%) 
0.407        7-28 days 75 (32.8%) 49 (65.3%) 13 (17.3%) 13 (17.3%) 
       29-59 days 138 (60.3%) 85 (61.6%) 17 (12.3%) 36 (26.1%) 
Sex      
       Male 133 (58.1%) 83 (58.0%) 21 (15.8%) 29 (58.1%) 
0.859 
       Female 96 (41.9%) 60 (42.0%) 13 (13.5%) 23 (41.9%) 
Illness-related factors 
Illness classification      
       CSI 60 (26.2%) 33 (55.0%) 14 (23.3%) 13 (21.7%) 
0.095 
       IFB  169 (73.8%) 110 (65.1%) 20 (11.8%) 39 (23.1%) 
Healthcare provider-related factors 
Counseling on continuing medication at 
home 
    
       Yes 201 (87.8%) 130 (64.7%) 28 (13.4%) 43 (21.4%) 
0.174 
       No  28 (12.2%) 13 (46.4%) 6 (21.4%) 9 (32.1%) 
Received follow-up from provider     
       Yes 47 (20.5%) 34 (72.3%) 4 (8.5%) 9 (19.2%) 
0.240 
       No 182 (79.5%) 109 (59.9%) 30 (16.5%) 43 (23.6%) 
Therapy-related factors 
Caregiver reported any barriers to treatment    
       Yes 70 (30.6%) 34 (48.6%) 18 (25.7%) 18 (25.7%) 
0.003* 
       No 159 (69.4%) 109 (68.6%) 16 (10.1%) 34 (21.4%) 








Table 3. Multinomial logistic regression of factors associated with caregiver-reported dosage not 
meeting or exceeding the recommended oral amoxicillin regimen for young infants receiving 




Relative Risk Ratios (RRR) (95% CI)  
Underuse (<10 doses) vs. 
Adherent (10-14 doses) 
Overuse (>14 doses) vs. 
Adherent (10-14 doses) 
Social and economic factors   
Study District   
      Sylhet  ref ref 
      Lakshmipur 0.49 (0.15 – 1.52) 2.86 (0.74-11.05) 
Maternal Age    
      <20 years ref  
      20-29 years 3.39 (0.70-16.50) 0.72 (0.32-1.62) 
      =>30 years  2.32 (0.41-13.12) 0.80 (0.28-2.27) 
Religion    
      Islam 0.35 (0.02 – 7.00) 0.49 (0.03-9.01) 
      Others ref ref 
Maternal Education   
     No education ref ref 
     1-5 years (Primary) 0.91 (0.19 – 4.39) 0.52 (0.04-7.16) 
     =>6 years (Secondary & above) 0.44 (0.08 – 2.23.40) 2.83 (0.29-27.35) 
Caregiver-related factors   
Mother involved in decision-making about child health  
      Yes 1.14 (0.38 – 3.41) 0.47 (0.22-1.03) 
       No ref ref 
Caregiver confidence in ability to administer medicine 
      Not confident ref ref 
      Somewhat confident 0.22 (0.02 – 3.14) 232993.9 (0) 
      Very confident 0.16 (0.01 – 2.00) 221220.3 (0) 
Infant-related factors  
Age of infant   
     <7 days ref ref 
       7-28 days 0.57 (0.11 – 3.08) 1.26 (0.23-6.75) 





Relative Risk Ratios (RRR) (95% CI)  
Underuse (<10 doses) vs. 
Adherent (10-14 doses) 
Overuse (>14 doses) vs. 
Adherent (10-14 doses) 
Illness-related factors   
Illness classification   
       Clinical severe infection 2.22 (0.79 – 6.17) 2.11 (0.83-5.39) 
       Isolated fast breathing  ref ref 
Healthcare provider-related factors   
Counseling on continuing medication at home  
       Yes 0.44 (0.12 – 1.59) 0.37 (0.13-1.03) 
       No  ref ref 
Received follow-up from provider   
       Yes 0.19 (0.05 – 0.74)* 1.29 (0.48-3.49) 
       No ref ref 
Therapy-related characteristics  
Caregiver reported barriers to treatment  
       Yes 4.14 (1.69 – 10.18)* 1.62 (0.77-3.42) 
       No ref ref 

























Reported Barriers      
No barriers 159 (69.4%) 16 (10.1%) 109 (68.6%) 34 (21.4%) 0.003 
Forgot to administer a dose 22 (9.6%) 4 (18.2%) 13 (59.1%) 5 (22.7%) 0.402 
Inconvenience 4 (1.8%) 1 (25.0%) 1 (25.0%) 2 (50.0%) 0.324 
Baby had a negative side 
effect 
12 (5.24%) 9 (75.0%) 3 (25.0%) 0 < 0.001 
Baby’s condition improved 14 (6.1%) 4 (28.6%) 7 (50.0%) 3 (21.4%) 0.302 
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Chapter 6. Discussion 
6.1 Summary of study findings  
 
Increasing families’ access to appropriate care and timely antibiotic treatment for 
newborn infections is critical to reduce neonatal mortality. WHO’s guidelines for managing PSBI 
in young infants with simplified antibiotic treatment is an evidence-based intervention that will 
make it possible for families to access treatment for their sick infants when hospital referral is not 
feasible. Implementation of public health programs and policies, however, is known to be 
challenging—especially in resource-constrained settings where the need is often greatest. Mixed 
methods assessment of implementation research outcomes allowed for exploration of 
implementation fidelity and acceptability of the guidelines (Table 1). Findings described in this 
thesis will enable more effective problem-solving by policymakers and programs to strengthen 
implementation of Bangladesh’s national guidelines and inform strategies for scale-up of the 
intervention nationwide. 
Paper 1: Health facility readiness and provider performance 
 
The aim of this paper was to assess facility readiness and provider performance on key 
components of the guidelines—classification and antibiotic treatment—over the study period. In 
the implementation research literature, the extent to which an intervention was implemented as 
intended in the original protocol is known as fidelity (1). Vacancies in the SACMO position 
limited the number of facilities included in this study and receiving implementation support for 
program rollout. At baseline, none of the included facilities had adequate supply of antibiotics of 
all functioning equipment required for guideline implementation, which were supplied by 
implementation partners during the study period.  
Provider performance on the guidelines varied by facility and infection severity. Errors in 
classification and antibiotic dosage were highest at the beginning of the study period and 
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decreased over time. Interviews with providers suggest errors in early implementation may be due 
to providers learning new methods for assessment, classification, and treatment; and some 
providers’ concerns about the efficacy of simplified antibiotic regimens. Strategies to monitor 
early performance and targeted supports are important for enhancing implementation fidelity.  
Paper 2: Caregiver acceptability of guidelines  
 
This study aimed to explore acceptability of the infection management guidelines from 
the perception of caregivers and providers. Few caregivers accepted referral to the sub-district 
hospital, suggesting low acceptability of this option for continued care and reinforcing the value 
of the simplified antibiotic treatment option. Barriers to referral feasibility included economic and 
household factors, and previous experiences with poor quality of care at the sub-district hospital. 
When referral was not accepted, providers and caregivers indicated high acceptability of 
simplified antibiotic treatment for infants receiving outpatient treatment, which they attributed to 
caregiver preference for providing oral antibiotics at home versus continued parenteral treatment 
at the hospital, reduced medical and travel costs, and less time away from their household and 
other children. Some providers reported developing local solutions—including engaging informal 
providers to provide the second gentamicin injection—to address organizational barriers and 
promote compliance with the simplified antibiotic regimen.  Follow-up of young infants receiving 
simplified treatment is critical, but only about two-thirds of infants received fourth day follow-up. 
Some providers’ reported deviations from the guidelines that shifted responsibility of follow-up 
to the caregiver, which may have contributed to lapses.  
Caregivers’ perception of trust and communication with providers were influential in 
caregiver acceptability of care. These findings suggest strengthening providers’ interpersonal 
skills—including training on counseling that is culturally sensitive—and reinforcing the 
responsibility of the provider to initiate and continue follow-up could improve compliance and 
acceptability of the guidelines.  
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Paper 3: Caregiver adherence to oral amoxicillin regimen 
 
The simplified antibiotic regimen includes a critical home-based treatment component—
oral amoxicillin twice daily for seven days. The aim of this paper was to assess patterns and 
determinants of caregivers’ adherence to outpatient oral amoxicillin treatment to contribute to our 
measure of implementation fidelity. Nearly two-thirds of mothers reported providing an 
acceptable dosage range to their infants. Caregivers had a better understanding of the regimen 
when the provider utilized multiple strategies for communicating the instructions—including 
verbal and written instructions, marking the dropper to reflect the dosage amount and 
demonstrating how to give the first dose.  
Mothers that reported receiving follow-up from the provider during the illness period 
were less likely to provide too few doses; while mothers that reported any barriers to giving oral 
antibiotics were more likely to provide below the recommended dosage. Caregivers discussed 
skipping doses when the baby experienced side-effects to the medicine (e.g., vomiting), and 
indicated they would discontinue treatment if they believed the baby was no longer sick. 
Improving the quality of counseling to include messages on handling side-effects and reinforcing 
the need to complete the full course of antibiotics may improve caregiver adherence. Strategies 
are needed to improve provider adherence to the guidelines—including provision of the first dose 
and day 4 follow-up.  
6.2 Implications for policy and practice 
 
This study was designed to capture the implementation experience of the updated PSBI 
guidelines through systematic data collection in a real-world setting. The findings from this study 
will contribute to the global efforts of WHO to increase treatment access for families of young 
infants in low-resource settings that cannot accept hospital care, which has the potential to reduce 
infant deaths globally. Our primary objective, however, was to provide the Bangladesh MOHFW 
and implementing partners with findings to strengthen implementation and inform nationwide 
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scale-up of the guidelines within Bangladesh. Therefore, this section focuses on the study 
implications within this context, including recommendations for the MOHFW and our 
implementing partners in Bangladesh (Box 1).  
Project inputs were required for ensuring health centers had functioning equipment and 
adequate supply of gentamicin and oral amoxicillin. Since the conclusion of our study, 
Bangladesh has incorporated the infection management guidelines into their current National 
Newborn Health Program as part of the 4th Health, Population and Nutrition Sector Program and 
secured the necessary budget for procurement of the essential drugs and equipment under this 
plan (2). While this policy provides the mechanism for procuring and supplying antibiotics to the 
targeted health centers, our findings suggest potential challenges to the structure of healthcare 
provision—including shortages of health workers and poor facility infrastructure—may adversely 
affect fidelity of implementation. For example, clean water is important for reconstituting the oral 
amoxicillin powder, but few health centers in our study area facilities had provision for clean 
water, which may serve as a barrier for providers giving babies the first dose of oral amoxicillin. 
Development partners should continue to monitor and advocate for facility strengthening as 
bottlenecks in supply chains and health worker vacancies threaten scale-up and sustainability of 
the program.  
As providers gained practice with using new equipment, classifying infants according to 
the algorithm and calculating dosage, their adherence to the guidelines improved. Strategies to 
monitor early performance and targeted supports to underperforming facilities may accelerate this 
learning curve. Improving the quality of mentoring—including engaging providers in developing 
local solutions—may improve providers’ ownership of the guidelines and help identify early 
barriers to implementation. For example, stakeholder meetings were important for identifying 
early challenges and informed subsequent supervision and refresher trainings. 
Our findings also suggest strengthening providers’ counseling skills, incorporating 
culturally sensitive messages, may improve both caregiver acceptability of the guidelines and 
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adherence to the oral amoxicillin regimen. For example, caregivers demonstrated a better 
understanding of the oral amoxicillin regimen when providers employed multiple strategies for 
continuing treatment at home—including verbal and written instructions, marking the amount on 
the dropper, and demonstrating the first dose. Additionally, incorporating messages on potential 
side-effects of oral amoxicillin (e.g., vomiting)—including directions on re-administering the 
dose—and the importance of completing the full course of antibiotics may improve adherence. 
Furthermore, strategies to monitor for accountability and improve providers’ compliance with 
fourth day follow-up should be prioritized. In addition to ensuring the safety of the infant, 
caregivers reported greater acceptability of the guidelines and improved adherence to oral 
amoxicillin when they received follow-up from the provider.  
Uncertainty around treatment outcomes, especially for referred cases, is a major barrier to 
monitoring the long-term effectiveness of the program. The guidelines recommend that providers 
follow-up with the caregiver, or hospital providers, to ensure families reach the referral facility; 
however, this follow-up is not recorded in the registers, so the health outcomes of these infants 
are not routinely tracked. Families that accept referral are more likely to have infants with serious 
illness and—in the current system—are more likely to be lost to follow-up. Systems for tracking 
referral cases need to be established and tested during rollout of the guidelines, and indicators for 
monitoring the care and outcomes of these cases should be integrated into routine systems. For 
PSBI cases receiving outpatient treatment, the day 8 follow-up visit is critical for assessing 
treatment outcomes. However, we found this visit was not regularly happening. Further 
investigation into improving functionality of these visits is needed as this strategy is scaled-up in 
Bangladesh. 
6.3 Strengths and limitations 
 
The major strength of this study is the use of both quantitative and qualitative approaches 
to provide a deeper understanding of the research questions than either method separately (3, 4). 
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The mixed methods design is well-suited to implementation research because it provides a way to 
understand multiple perspectives, different types of causal pathways, and multiple outcomes (1, 
5). However, our study had several limitations including a short study period and lack of a 
comparison group. Our study period was limited to one-year, which was necessary based on the 
government’s plans for scale-up. The lack of a comparison group and lack of randomization make 
the study more vulnerable to internal and external threats to validity. We aimed to improve 
internal validity by collecting data at multiple points in time. We extracted data on case 
management at all facilities implementing the guidelines in our study area on a weekly basis, 
administered the facility checklist prior to rollout and at two additional time points, and 
conducted interviews with all providers in our study area. Collecting both quantitative and 
qualitative data at multiple time points allowed us to assess trends in provider performance and 
identify changes in barriers and facilitators to implementation over the study period. However, we 
were unable to causally link implementation strategies to changes in practice outcomes due to 
lack of a comparison group (6). 
Another limitation is that we do not have specific measures of quality of care at the study 
area health centers. We aimed to explore caregiver acceptability of the guidelines and their 
perceptions of the quality of public sector care based on a follow-up questionnaire and interviews. 
However, this study would have been strengthened by the direct observations of care. The 
estimated incidence of PSBI in young infants (95.4/1000) (7) in this setting, coupled with low 
care-seeking rates from the primary health facilities, led us to expect few infants would seek care 
at the study area health centers during the initial implementation period. Thus, direct observations 
of care were not feasible, and we were limited to analysis of facility records and qualitative 
interviews to assess compliance with the guidelines. There is variation among providers in how 
they record and report data, which was not controlled for in our data collection. Therefore, our 
data is subject to reporting bias and performance on care indicators should be interpreted 
judiciously. For example, we found discrepancies between the providers’ registers and 
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caregivers’ report for oral amoxicillin treatment, which suggests potential reporting bias among 
providers. However, it is also possible that some of these discrepancies are due to errors in 
caregiver recall.  Future program efforts should review register completeness during supervision, 
or periodic program review, to monitor for accountability and address challenges associated with 
incomplete registers in a timely manner.  
We were unable to follow-up more that 20% of the caregivers to assess patterns and 
determinants of antibiotic adherence. This is a major limitation of our study because adherence 
for those caregivers may have differed significantly from the caregivers that participated in the 
study questionnaire. Additionally, this limited our ability to explore agreement between provider 
and caregiver reports of care received for sick infants in our study area. Our analysis of adherence 
was based on a caregiver report of the number of doses provided, which is a subjective measure 
of adherence. Reactive effects may be a threat due to respondents’ social desirability to respond 
favorably about adhering to treatment especially if they knowingly stopped administering 
treatment against recommendations. In attempt to control for this threat and capture an objective 
measure of adherence, we asked to see the medication bottle and prescription slip prior to asking 
questions dosage. However, many caregivers did not have the medicine bottle available at the 
time of the interview and the details of the prescription slip were not recorded by data collectors. 
As a result, caregiver self-reported adherence to the regimen may be over- or underestimated 
compared to an objective measure of adherence (8).  
Finally, the potential lack of generalizability of these study findings to other developing 
country settings is a limitation of this study. Although generalizability was not a primary goal for 
this study, it will be important to consider this when formulating conclusions for dissemination 
globally. Additionally, it will be important to compare our findings with those from the other 
WHO-coordinated implementation research sites to learn about other countries’ experience 
implementing the guidelines and improve external validity.  
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6.4 Future research 
 
Based on expected PSBI incidence for young infants in this context, we estimated that 
only 16.3% of the expected cases sought care from the study area health centers. Our findings 
indicate informal providers were the preferred first choice in care due to their ability to meet the 
caregivers’ emotional and social needs, reliability in providing drugs, and accessibility. Low rates 
of utilization are a major threat to the sustainability of this intervention. Our findings suggest 
potential strategies for improving caregivers’ trust in public sector providers, but further 
investigation is needed to assess care-seeking patterns and determinants in this population. 
Additionally, strategies for changing care-seeking behavior should be tested and tailored to fit the 
local context. 
Referral to the hospital remains the first-line recommendation for PSBI cases (9). 
However, few caregivers accepted referral to the sub-district hospitals, suggesting low 
acceptability of this option. Caregivers indicated distrust in hospital doctors, inconsistent 
availability of medicines, and financial constraints as the primary barriers to referral feasibility. 
Our study did not include implementation support activities or data collection at the sub-district 
hospital (i.e., UHC)—the recommended referral facility. Thus, we do not have data from the 
referral facilities to assess referral compliance, quality of care provided, or treatment outcomes 
for families accepting referral. Given referral complexities identified in this study, we anticipate 
referral compliance to be lower than acceptance rates recorded in the union-level health center 
records. Future studies should include data collection at public sector referral facilities to better 
understand barriers to referral compliance, quality of care, and identify opportunities for 
strengthening management of newborn infections. 
Providers and caregivers indicated high acceptability of simplified antibiotic treatment 
for infants receiving outpatient treatment. For infants with clinical severe infection receiving 
simplified antibiotic treatment, the second gentamicin injection is critical. Local solutions for 
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promoting compliance when the visit falls on a weekend or a day when the UH&FWC 
provider(s) are unavailable—including potential engagement with the private sector—need to be 
explored further in this context. Future studies are needed to examine the potential for engaging 
informal and formal private providers, including the potential for fostering public-private 
partnerships (PPP) in this context (10-12). Additionally, public sector providers’ opinions around 
engaging with private providers as allies should be explored as this has previously been identified 
as a barrier to implementation of PPP (13). 
Some providers indicated their preference to begin treatment of PSBI in young infants 
with more expensive, broader spectrum antibiotics, despite WHO recommendations to reserve 
these drugs for after first-line antibiotic treatment (e.g., gentamicin & amoxicillin) fails. 
Additionally, nearly one quarter of caregivers reported exceeding the recommended dosage of 
oral amoxicillin when providing treatment to their infants at home. These findings suggest 
potential misuse of antibiotics, by both providers and caregivers, which may contribute to 
increasing rates of antibiotic resistance in this setting. Promoting rational antibiotic use in 
Bangladesh is complicated by both the lack of access to quality care and an abundance of access 
to antibiotics from unregulated providers and pharmacies (14). Strategic planning to curb 
antibiotic resistance is necessary for preserving the effectiveness of existing first-line antibiotics, 
preventing rises in childhood morbidity and mortality due to bacterial resistance, and controlling 
the economic burden that antibiotic resistance poses to the health system (15, 16). Future research 
should examine drivers of antibiotic misuse in this setting, including providers’ assessment of 
effectiveness of simplified antibiotic regimens, the influence of pharmaceutical companies and 
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6.6 Tables for Chapter 6 
Table 1. Framework of implementation research outcomes and mixed methods findings by dissertation study objective 
 
Implementation Research Study Objectives 









intended in the 











• Project inputs were required for ensuring health centers had functioning 
equipment and adequate supply of oral amoxicillin. As providers 
gained practice with using new equipment and calculating dosage, their 
adherence to the guidelines improved. 
 
• Provider adherence to the guidelines improved over the study period, 
largely due to improvements in correctly classifying signs of clinical 
severe infection and calculating dosage of oral amoxicillin. 
 
• Clinical supervision, mentoring and training sessions were valued by 
providers and may have accelerated improvements in implementation 
fidelity. Stakeholder meetings were important for identifying early 
challenges and informed subsequent supervision and refresher 
trainings. 
 
To what extent 
did providers 
adhere to the 
guidelines?  
 
To what extent 
did caregivers 




• Patterns of non-adherence included caregivers giving too few and too 
many doses of oral amoxicillin. Caregivers demonstrated a better 
understanding of the oral amoxicillin regimen when providers 
employed multiple strategies for explaining the regimen—including 
verbal and written instructions, marking the amount on the dropper and 
demonstrating the first dose 
 
 





• Provider adherence to the guidelines—including demonstrating the first 
dose of oral amoxicillin and engaging in follow-up—were associated 
with improvements in caregiver adherence practices 
 
• Caregivers that reported barriers to treatment (e.g., baby vomiting the 
medicine) were more likely to provide too few doses of amoxicillin, 
which may be due to both skipping doses or stopping treatment early if 









there gaps in 
service delivery 
and care of PSBI 
cases? 
 
• Few caregivers accepted referral to the sub-district hospitals, 
suggesting low acceptability of this option. Caregivers indicated 
distrust in hospital doctors, inconsistent availability of medicines, and 
financial constraints as the primary barriers to referral feasibility. 
 
• Referral cases are not currently tracked, so providers rarely knew the 
treatment outcome for these sick infants. Some providers reported 
facilitating referral by calling the UHC and following-up with the 
caregiver, which increased caregivers’ satisfaction with care. 
 
• Providers and caregivers indicated high acceptability of simplified 
antibiotic treatment for infants receiving outpatient treatment, which 
they attributed to caregiver preference for providing oral antibiotics at 
home, reduced medical and travel costs, and less time away from their 
household and other children. 
 
• Few infants sought care from the study area health centers during early 
implementation, which may be due to caregiver preference for care 
from the private sector, including informal providers in their 
community.  
 
What was the 
uptake of the 
intervention by 






Box 1. Recommendations for strengthening implementation of Bangladesh’s infection management 
guidelines for young infants in rural primary health centers 
 
• Practical training on recognizing and interpreting the signs of PSBI and calculating antibiotic 
dosage according to the baby’s weight and dosage chart may improve provider performance on 
the guidelines. Training should also incorporate provider education on appropriate antibiotic use 
and the effectiveness of gentamicin and amoxicillin for treating newborns with community-
acquired infections in this setting.  
 
• Strategies to monitor early performance and targeted supports to underperforming facilities may 
accelerate provider adherence to the guidelines.   
 
• Improving the quality of mentoring—including engaging providers in developing local 
solutions—may improve providers’ ownership of the guidelines and aid in identifying early 
barriers to implementation. 
 
• Training and supervision should emphasize the clinical and teaching value of providing the full 
course of antibiotics and administering the first dose of oral amoxicillin at the facility. Potential 
barriers to providers preparing and demonstrating the first dose—including availability of clean 
water in the facility—should be explored as the guidelines are rolled out to new areas.  
 
• Counseling was considered important by providers and caregivers. Training and supervision 
should aim to strengthen provider counseling skills through: 
 
o Practicing case scenarios for different types of infection classification to cover 
counseling on pre-referral antibiotic treatment, hospital referral, the simplified regimen, 
and plans for follow-up 
o Emphasizing the need for providing verbal and written instructions for cases accepting 
referral and cases receiving the oral amoxicillin regimen 
o Encourage continued communication with the caregiver and ensure the caregiver has the 
provider’s phone number 
o Encourage the provider to include other family members (e.g., the baby’s father and 
grandmother) whenever possible 
 
• Counseling modules should also incorporate culturally sensitive messages on: 
 
o Clinical importance of the gentamicin injections and address caregiver fears about 
medicines weakening the baby 
o Potential side-effects to oral amoxicillin (e.g., vomiting) and directions on re-
administering the dose 
o Importance of completing the full course of oral amoxicillin even if the baby is no longer 
symptomatic  
 
• Referral to the hospital remains the first-line recommendation for PSBI cases. Referral linkages 
between the UH&FWC and UHC should be strengthened and indicators for tracking referral 
cases are needed in HMIS. In the interim, UH&FWC providers should initiate contact with UHC 




Box 1. Recommendations for strengthening implementation of Bangladesh’s infection management 
guidelines for young infants in rural primary health centers 
 
• For infants with clinical severe infection receiving simplified antibiotic treatment, the second 
gentamicin injection is critical. Local solutions for promoting compliance when the visit falls on 
a weekend or the UH&FWC provider(s) are unavailable—including potential engagement with 
the private sector—need to be explored further. 
 
• Strategies to monitor for accountability and improve providers’ compliance with fourth day 
follow-up should be prioritized. In addition to ensuring the safety of the infant, caregivers 
reported greater acceptability of the guidelines and improved adherence to oral amoxicillin when 
they received follow-up from the provider. 
 
• Day 8 follow-up did not happen regularly in early implementation. Barriers to this visit by the 
Family Planning Inspectors (FPI) need to be explored further to develop strategies for improving 













Appendix 2. Dosage chart 
 
Antibiotic dosage for sepsis management of infant aged 0-59 days at Union health and 
family welfare center 
Child 
Weight (kg) 
Gentamycin dosage: 40 mg/ml 
(Intramuscular injection) 














1.50 < 1.75 0.15 6 15 80 0.8 
1.75 < 2.0 0.17 6.8 17 90 0.9 
2.0 < 2.5 0.2 8 20 110 1.1 
2.5 < 3.0 0.35 14 35 140 1.4 
3.0 < 3.5 0.45 18 45 160 1.6 
3.5 < 4.0 0.5 20 50 190 1.9 
4.0 < 4.5 0.55 22 55 210 2.1 
4.5 < 5.0 0.6 24 60 240 2.4 
5.0 < 5.5 0.7 28 70 260 2.6 
5.5 < 6.0 0.75 30 75 290 2.9 
6.0 < 6.5 0.8 32 80 310 3.1 
Gentamycin Injection: This injection should be administered intramuscularly. Dosage: 
5.0-7.5 mg/kg body weight once daily for total 2 days. Each 2 ml injection contains 80 
mg gentamycin; i.e. each ml contains 40 mg gentamycin. Use insulin syringe to 
administer injection gentamycin for children. 
Amoxicillin Drop: Oral administration in children. Dosage: 50 mg /kg body weight in 
every 12 hours (twice daily) for 7 days. Each 1.25 ml contains 125 mg of amoxicillin. 
Method of preparing drop: First, shake the bottle properly to loosen all powder. Mix 
10 ml (2 measuring spoon full) boiled cold water with powder into the bottle and shake 




Appendix 3. Caregiver interview guide 
 
In Depth Interview (IDI) Guide:   
Caregivers of Cases 
IRB No.:  6607 
PI: Abdullah Baqui 
PI Version: 2; Date:  28 March 2016 
 
General instructions:  Interviewers, please read the following opening script (Part B) to the respondent 
and then proceed with asking him/her the questions listed in Part C. Some questions have specific 
probes, but please feel free to probe on additional points of interest to guide the discussion as needed. 
 
 
Part B:  Opening script 
 
Opening script—Individual interview with Caregivers of Young Infant Infection Cases: Thank you 
for agreeing to participate in our study. As previously mentioned, we are going to ask you some 
questions about your experience as a caregiver of a young infant that was recently treated for infection. 
Please respond to these questions as honestly and descriptively as possible. Your identity will be kept 
confidential so please feel comfortable sharing your stories. We will now begin! 
 
Part C:  Guiding Questions 
 
Illness Episode:  
1. What are the symptoms that you first observed in your child during the illness you 
reported?  
2. When did you decide to seek care out of the home? 
o What was the reason for seeking care? 
o Who made the decision to seek care? 
o How long after you recognized the first symptoms was this decision made?   
 
Care Seeking:  
3. Where did you first seek care? (Probe: self-medication, relatives/neighbors, medicine 
salesman, village doctor, traditional healer, religious leader, other?) 
4. How did you come to the decision to bring your infant to this particular provider 
(FWC or other type of providers)?  
5. How distant is your home from this center? What are the implications, if any, 
of this distance on your care seeking of your young infant? 
 
Care experience:  
1. IDI Code:  
2. Interviewer 
Code:  
3. Date:   
4. Start 
Time:  5. End time:  
6. Location:  
7. Relationship of 
participant to 
infant:(ex: Mother, 
Aunt, Grandmother)  
8. Description of Setting 
(Surroundings, general atmosphere, 





6. Describe your visit with the provider (Probe: Ask the following questions about each 
source of care, and repeat the series of questions until there is no other source of care) 
• How long did you have to wait to see the provider?  
• Who treated your infant while you were there?  
• What did this provider tell you about the baby’s illness?  
• What was treatment was given to the baby?  
• Was any injection or medication given?  
• What was the cost to you, if any, for the visit and services provided? 
 
7. Do you visit the private chamber of SACMOS from FWCs? If yes, why? If 
you have experience of getting your young infant treated in both public and 
private sector, did you notice any difference? (Probe: What were the 
differences? Why do you think they did it differently?) 
 
 
Referral experience  
 
8. Did they make a referral for you to see another provider or hospital? 
9. *If no referral was made: Please describe the advice that the provider gave to you  
a. Probe: Please describe what happened next 
10. *If a referral was made:  Did you accept the referral?  
a. If yes: Describe the process of how you got to the next facility 
i. Transport?  
ii. Cost?  
iii. How long after visit did you go to facility?  
iv. What treatment was given?  
b. If no:  
i. Why was referral refused?  
ii. Describe what happened next (Visiting any other provider) 
 
 
Day 2 Follow Up Visit 
11. After your baby was diagnosed, were you asked to return to the facility on the 
following day?  
• If no, what follow-up advice were you given? 
• If yes, did you return for this follow-up visit?  
o If you did not return on the next day, then why did you not return for the 
follow-up visit? 
o If you did return on the next day, can you tell me what happened?  
▪ What time of day did you arrive? How long did you wait to be 
seen?   
▪ Who cared for your infant?   
▪ What care was provided? What was discussed?  




      Treatment Adherence 
12. What did you do to treat the sick infant at home?  
• How many days did you treat the infant for?  
• How much medicine did you give each day? 
• How did you decide on that course of treatment? 
o [if treatment was for less than the recommended number of days]:  did you 




number of days that are generally recommended, and ask if they were aware 
that this was the recommendation] 
• Did you discuss treatment with any other family or community members? If so, 
whom? 
• Is there any medicine remaining? Why? 
• Would you show me the medicine bottles? (if available) 
o *Interviewer note: Please make a note of how much medicine if leftover. If 
possible take a picture of the bottle 
 
Caregiver’s self-efficacy about administering medication  
 
13. Who fed the medication to the infant? 
 
14. How did you feel about your ability to administer the medications to your infant 
properly?  
• If any, what were your reservations about administering the medications to your 
infant? 
 
15. If any, can you describe the challenges you faced related to administering the 
medications?  
• Probe: Timing of administering medication? 
• Probe: Cooperation of infant in receiving medication? 
 
16. How did you know that administration of the medication was successful?  
• What helpful strategies were used to administer the medication to your infant?  
• How did you feel after the medication was successfully administered to your 
infant?  
 
17. What mode of treatment do you prefer- giving medicine to baby at home or taking the 
medicine at hospital? (Probe: Explore if there is any preference of one mode over the 
other) 
• Which method of treatment do you prefer? Why?  
• What would make administering the medication to your baby a more positive 
experience?  
 
At-home Follow Up Visit 
18. Did you receive any follow-up visits at home from a health provider?  
• If yes, please describe these visits 
o Where did they occur?  
o Who was the provider that made the visit? 
o How many days after your first visit to the UH&FWC did the visit 
happen? How many visits did you receive?  
o What happened during the visit?  
• What did you like about these visits?  
• If anything what would you change about the visit if you had the option? 
• What other follow-up services did you receive? When did you receive these 
services? 
o Probe: Did you receive a phone call? Text message? 
o Please tell me who called you and what was discussed. 
19. Can you hold the SACMO accountable if there is any issue regarding the 
treatment and follow up of your young infant? How? 
 
 




20. What was the treatment outcome for your baby?  
• Why do you think this was the outcome? 
• Are you satisfied with the care you received from FWCs? Explain.  
 
Other issues  
1. Do you want to add anything else which we might have missed? (Probe: any 





Appendix 4. Caregiver group discussion guide 
Focus Group Discussion Guide:   
FGD with Caregivers of Young Infants 
 
IRB No.:  6607 
PI: Abdullah Baqui 
PI Version: 2; Date:  18 November 2015 
 
General instructions:  This guide provides the questions and topics that will be addressed in 
the FGD. The guiding questions are listed by subheadings related to program processes. 
Please adhere to the following instructions when facilitating this FGD: 
1. Please begin by welcoming individuals as they arrive to the FGD and obtaining 
consent 
2. Fill out Part A: Background Information after obtaining consent and before starting 
the FGD.  
3. When it is time to begin, start the recorder, welcome participants as a group and read 
Part B: Opening Script 
4. Proceed with Part C: Guiding Questions and facilitate the discussion 
5. After the discussion concludes, thank the caregivers for their participation, stop the 
recorder, and dismiss the participants. Record the end time on the Part A: 
Background Information table 
Part A: Background Information 
 
Part B:  Opening Scripts 
 
Opening script—Group interview:  Good morning/afternoon, I would like to thank you for 
giving the time to speak with us in this interview in which we would like to learn more from 
you about your recent experience seeking care for your sick infant.  Firstly, let me introduce 
myself.  I am [name] and my colleagues are [name] and [name].  We are a team of 
researchers engaged by Johns Hopkins University to conduct a study in collaboration with 
the Ministry of Health in order to help strengthen this program. As such there are no right or 
wrong answers because you are only expected to share your experiences.  In addition to that, 
let me say that the information that we share in this group should be considered confidential.  
1. FGD Code:  2. Facilitator Code:  
3. Date:   4. Start Time:  5. End time:  
6. Location:  
7. # Of 
participants:   
8. Description of Setting    
(Surroundings, general atmosphere, 







8. Caregiver Information 
Name (Code) Gender Religion Relationship to child (Mother, 
grandmother, etc)  
 
    
    
    
    




Each of you has been given a number that will be used to record your comments, so you will 
not be identified by name.  Please do not share the opinions of others outside of this group.  
We should respect each others’ opinions and give each other turns when speaking. 
 
Please let’s begin with everyone introducing themselves using their number.  
 
Part C:  Guiding Questions 
Care seeking: 
1. How do caregivers of infants in the community know when their baby is sick? What 
symptoms would they notice?  
o Probe:  Anything else? 
2. When do caregivers in the community generally decide to seek care out of the home? 
o Probe: Who usually makes the decision to seek care? 
3. Where do people usually first seek care when their babies are sick? 
o Why is this the first choice provider? 
o Describe what happens when people go to this provider?  ? 
▪ Probe: What kind of care is administered?  
4. Do people ever seek care from more than one provider?  
o    If yes, where?  Describe the experience.  
o If yes, why do they see more than one provider?  
 
Care at the union facility 
5. What do caregivers in the community think about the FWCs/Union Level Health 
Facilities?  
o What do people like about the FWC?  
o What do people dislike about going to the FWC?  
o What generally happens when someone visits an FWC with their sick baby?  
▪ Probe: Who cares for them (nurse, doctor, SACMO)?  
▪ Probe: How long is the wait to be seen? 
▪ Probe: What care is usually given?  
o What level of satisfaction or dissatisfaction do people have in regard to the 
care they receive at the FWC?  
6. What kinds of referrals, if any, does the FWC usually make? 
o Do people generally follow referrals made by the FWC to other providers?  
o Why? Why not?  
7. What other services do the FWCs provide?  
o What follow-up services are made by the FWC, if any?  
 
Treatment Adherence  
8. Describe how caregivers in the community generally feel about administering 
medication to their infants 
o What, if any, are the concerns they might have about administering 
medication themselves?  
 
9. How do they learn the directions for administering medication to their infants?  
o When would they stop administering medication to the infant?  






Appendix 5. Provider interview guide 
 
In Depth Interview (IDI) Guide:   
Health Providers (SACMO) 
IRB No.:  6607 
PI: Abdullah Baqui 
PI Version: 1; Date:  29 September 2015 
 
General instructions:  Interviewers, please read the following opening script (Part B) to the 
respondent and then proceed with asking him/her the questions listed in Part C. Some 
questions have specific probes, but please feel free to probe on additional points of interest to 
guide the discussion as needed. 
 
Part A: Background Information 
 
Part B:  Opening Scripts 
 
Opening script—Individual interview with SACMO:Thank you for agreeing to participate in 
our study. As previously mentioned, we are going to ask you some questions about your 
experience as a SACMO implementing the new guidelines for infection management in 
young infants. Please respond to these questions as honestly and descriptively as possible. 
Your identity will be kept confidential so please feel comfortable sharing your stories. We 
will now begin! 
 
Part C:  Guiding Questions 
Training 
2. Tell me about the training that you participated in on the new guidelines (Probe:  
content, timing, who implemented) 
3. What do you think worked well in the training?  What didn’t work well? 
4. What changes are needed in the training approach, if you think anything should be 
changed 
Case management 
5. Please describe the last young infant that you saw, and how you used the new 
guidelines when treating this infant. 
6. What challenges do you encounter in implementing the new guidelines? 
• Assessing cases? 
• Referring cases? 
• Treating cases? 
7. What are the families’ reactions to the treatment guidelines (referral and/or home 
treatment)? 
• Can you tell me about a specific example of how they reacted that way?  
8. If there are any, what challenges to implementing the new guidelines exist?  
• How should they be addressed? 
Technical Materials 
1. IDI Code:  
2. Interviewer 
Code:  
3. Date:   4. Start Time:  5. End time:  
6. Location:  
7. FWC where 
SACMO works:  
8. Description of Setting    (Surroundings, 
general atmosphere, weather, observations 





9. Please tell me about the technical materials that support you in the implementation of 
the new guidelines (probe:  job aid, register, etc) 
• What do you think is useful about these materials? 
10. What improvements or changes would you make to these materials to make them 
more helpful, if any? address 
 
Supervision 
11. Please tell me about the last time you received a supervision visit and what happened 
during the visit? 
12. How would you describe the effectiveness of the supervision visit?  
• Probe: Did you find the supervision visit to be helpful?  Please explain.  
13. What were your expectations of the supervision visit?  
• How did the supervision visit meet your expectations?  




14. What is the process for completing reports on the implementation of the new 
guidelines? 
• What is your opinion about the reporting format?  (Probe: What are the good 
things? Things that need improvement?) 
• What changes would you like to see to the report, if any?  (Probe:  Format, 
frequency, content) 





16. How are the UH&FWCs supplied with drugs for the new guidelines? (Probe:  How 
does this compare to other drugs supplied to UH&FWC?) 
17. What has been the status of the drug supply? Have there been any issues? (Probe:  
any stock outs?)  What are the reasons? 




19. How are community mobilization events organized and implemented.  Who attends? 
20. What concerns came up in community mobilization events?  How were these 
addressed? 
21. What successes and challenges have you witnessed in this community mobilization 




Appendix 6. Provider group discussion guide 
Focus Group Discussion Guide: 
SACMO 
IRB No.:  6607 
PI: Abdullah Baqui 
PI Version: 1; Date:  11 November 2015 
 
General instructions:  This guide provides the questions and topics that will be addressed in 
the FGD. The guiding questions are listed by subheadings ‡‡related to program processes. 
Please adhere to the following instructions when facilitating this FGD: 
1. Please begin by welcoming individuals as they arrive to the FGD and obtaining 
consent 
2. Fill out Part A: Background Information after obtaining consent and before 
starting the FGD.  
3. When it is time to begin, start the recorder, welcome participants as a group and 
read Part B: Opening Script 
4. Proceed with Part C: Guiding Questions and facilitate the discussion 
5. After the discussion concludes, thank the SACMOs for their participation, stop 
the recorder, and dismiss the participants. Record the end time on the Part A: 
Background Information table 
 
Part A: Background Information 
 
Part B:   
 
Opening Script 
Good morning/afternoon, Thank you for taking the time to join this FGD in which we hope to 
learn more about the new guidelines for managing infections in young infants. I am [name] 
and my colleagues are [name] and [name].  We are a team of researchers engaged by Johns 
Hopkins University to conduct a study in collaboration with the MOH in order to help 
strengthen this program.  Our main focus is to hear SACMO opinions about how the 
guidelines are working and how the program is supported. 
In the discussion we will be interested to hear your experiences with the 
implementing the new guidelines for management of infections in young infants. As such there 
are no right or wrong answers because you are only expected to share your experiences. This 
1. FGD Code:  2. Facilitator Code:  
3. Date:   4. Start Time:  5. End time:  
6. Location:  7. # Of participants:   
8. Description of Setting    (Surroundings, 
general atmosphere, weather, observations 






8. SACMO Information 






Do they belong to 
this area 
(union/upazila?) 
      
      
      




should not be viewed as a job evaluation exercise but rather a contribution to help strengthen 
the program. The information that you share with us will be combined with the opinions we 
receive from other participants, and your name will not be reported.  The information that we 
share in this group should be considered confidential. Each of you has been given a number 
that will be used to record your comments, so you will not be identified by name. Please do 
not share the opinions of others outside of this group. We should respect each others’ 
opinions and give each other turns when speaking. Please let’s begin with everyone 
introducing themselves using their number, and telling the group how long you have been 
working in your position, and what you did prior to that. 
 
Part C:  Guiding Questions 
Training 
1. How do you and your SACMO colleagues generally feel about the training they received 
on the new guidelines?  
 
Case management 
2. What are the benefits that you and your colleagues see to using these new treatment 
guidelines?  
3. What are the challenges when using these new guidelines when managing cases? How can 
these be addressed?  




5. Please share your opinion of the technical materials that support you in the 
implementation of the new guidelines (probe:  job aid, register, etc.) 
 
Managing infants with infection in private practice vs. public practice 
6. Do you manage young infants with signs of infection differently in your private practice 
than what is described in these guidelines?  (Probe: What are the differences? Why do 
you do it differently?) 
7. Have you changed how you manage infant infections in your private practice as a result 
of this new training? (Probe:  If yes, what ‡are the changes? Why or why not?)  
 
Supply chain 
8. Describe the availability and supply of drugs for implementing the new guidelines  
- (Probe:  How does this compare to other drugs supplied to UH&FWC?) 
9. Have there been any issues with supply? (Probe:  any stock outs?)  What are the reasons? 
10. What changes do you think should be made to the drug supply systems, if any? 
 
Community mobilization 
11. What opinions do you have about the community mobilization activities?  
12. What concerns came up in community mobilization events?  How were these addressed? 
13. What successes and challenges have you witnessed in this community mobilization 
approach? How would you improve the challenges faced? 
14. What do you think should be done for community mobilization if they are not aware of 







Appendix 7. Case follow-up & treatment adherence 
questionnaire 
This form is to be completed for tracking the child (<60 days) who received treatment/services 
from union level health facility during last 15 daysfrom thesurveillance period in the site. The name 
and contact address of the child (cases) will be collected from service register of the union health 
facility. 
1. Address and identification information 
1.01 Country/Site        
1.02 Upazila        
1.03 Union        
1.04 Village        
1.05 Bari        
1.06 Household         
 
1.11 
Child’s hospital ID (from service register of 
H&FWCs) 
              
1.12 Woman's Current ID     -    -   -   
1.13 Woman's Permanent ID     -    -   -   
1.14 Woman's Name   
1.15 Husband's Name   
1.16 Household Head’s Name   
1.17 Contact phone number   
 
Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 
A0
0 
Did you visit the 
UH&FWC (name of 
the facility) for your 








Interviewer’s Home Visit 
2.01 Date of visit |_____|_____|-|_____|_____|-|_____|_____|  
2.02 
Day of follow 
up/tracking 
|________|th 














___ ___:___ ___ 
  





Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 




When did you visit 
the UH&FWC (name 









Where were you seen 
by the provider?  
In the FWC exam room 1 
  
In the SACMO private chamber 2 
In the FWV exam room 3 




Don’t Know 8 
A0
3 
Did you pay money 
for this visit? 
Yes  1  
No 2  
Don’t Know 8  
A0
4 
What treatment was 
prescribed by the 
provider for your 
infant? 
Do  not prompt at 
first ;   
Record all 
unpromped answers 












Injection  1 2  
Antibiotic 1 2  
Referral 1 2  
Other (specify) 
______________ 
1 2  
No treatment prescribed 1 2 →A08 
Don’t Know 1 2   →A08 
A0
5 
If treatment was 
prescribed by the 
provider for your 
infant, what was the 
name the medicine? 
Ask the caretaker to 
show the prescription 
bottle if available and 
identifiy from the list. 
If bottle is not 
available then 
indicate caregiver’s 
self-report and circle 
all that are 
mentioned. 
Gentamicin 1  




No treatment prescribed 4 →A08 
Don’t Know 8 →A07 
A0
6 
Data collector: Please 
indicate if the 
medicine bottle was 
available and if any 
medicine remained in 
the bottle 
Yes, bottle was available and 
medicine remained in the 
bottle 
1   
Yes, bottle was available and 
no medicine remained in the 
bottle 
2    
No, bottle was not available 3  




Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 
A0
7 
Did you pay money 
for the drug given to 
your infant by the 
provider? 
No 2  
A0
8 
Did the service 
provider refer your 
infant to a higher 
facility? 
Yes  1   
No 2 →A19 
A0
9 
Did the provider give 
you a referral slip?  
Yes  1   
No 2  
A1
0 
Where did he/she 
refer your infant? 
·(Upazila Health Complex) 1   
 (District Hospital) 2  





 (Does not know) 5  
A1
1 
Did you agree to go 
there?  
Yes  1   
No 2 →A14 
A1
2 
Did you reach to the 
referral facility centre 
according to advice?  
Yes  1 
 
No 2 →A14 
A1
3 
Place and time of 












(24 hour)  __ __ : __ __ 
A1
4 
What were the 
reasons of rejection 
of referral or you 
being unable to go to 
referral facility?  
Do not prompt 
Ask what else, 
multiple answer 
possible 




Too costly/ Lack of money B 
Too far from house C 
 Transport problem D 
 No one accompanied E 
 Not enough time to go F 
Family didn’t allow me to go G 
Service hour inconvenient H 
HF found closed/nobody there  I 
Poor quality of services at 
facility 
J 
Poor quality & staffs at HF K 
Lack of privacy L 
Unpleasant behavior at center M 
Long queue at HF N 






Section A: Sepsis Case Tracking 







What happened after 
arrival at hospital?        
Hospital admission  1 
Section 
B 
         How many days?  
|______|______|      
Referred to higher faciliy 2 →A16 
Admission advised  but did not 
admit the child  
3 →A18 





Did not find doctor at health 






Did you go to the 
second referral 
facility according to 
advice?  





Place and time of the 











(24 hour)  __ __ : __ __ 
A1
8 
Why did not you take 
the baby at higher 
facility for better 
treatment or admit to 
hospital per advice? 




















Too costly/ Lack of money B 
Too far from house C 
 Transport problem D 
 No one accompanied E 
 Not enough time to go F 
Family didn’t allow me to go G 
Service hr inconvenient H 
HF found closed/nobody there  I 
Poor quality of services at 
facility 
J 
Poor quality & staffs at HF K 
Lack of privacy L 
Unpleasant behavior at center M 
Long queue at HF N 









Did the service 
provider give advice 
on taking further 
medication?  
Yes 1   
No 2  
Don’t know/can't remember 8 
 




Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 
A2
0 
Did the service 
provider ask you to 
visit the facility to 
take medication/ 
drug on the next day?   
No 2 →A23 




Did you visit the 
UH&FWC on the next 
day accordingly?  
Yes 1  
No 2 →A23 
A2
2 
Was any injection 
given to your child 
when you returned to 
the UH&FWC on that 
day?  
Yes 1   
No 2   




Did the service 
provider ask you to 
continute medication 
at home?  
Yes 1  
No 2 →A27 




Can you tell me the 
name of the medicine 




Amoxicillin  1  




Don’t know/can't remember 8  
A2
5 
Can you tell me how 
many days you were 
instructed to 
administer the 
medicine at home? 




Don’t know/can't remember 8  
A2
6 
Can you tell me how 
many times a day you 
were instructed to 
give the medicine to 
your infant at home? 
Once 1  




Don’t know/can't remember 8  
A2
7 
Did he/she give 
advice about the 
signs of illness that 
required your return 
to the facility?   





Do you remember 
any of the danger 
signs that he/she 
mentioned?   





What symptoms did 
your baby have?  
Do  not prompt at 
first ;  
Ask what else,  
Record all 
unpromped answers 







Severe chest in-drawing 1  2   
Lower temperature/ 
Hypothermia 
1  2   
Fever or Raised temperature 1  2   
Poor or no sucking reflex 1  2   




Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 
Less movement than normal/ 
movement only when stimulate 
1  2   
Central cyanosis 1  2   
Convulsion /history of 
convulsions 
1  2   
Persistent vomiting/unable to 
feed 
1  2   
Bulging fontanelle 1  2 
 
Others 1.  1  2   
Others 2. 1  2   
A3
0 
Did the service 
provider tell you they 
would provide follow-
up phone calls or 
home visits?  
Yes 1  
No 2  








ask about your infant 
after the initial visit?   
Yes 1  
No 2  




What did he/she 
talk/ask about?  
Current status of the child 1 
 
Importance of completing the 
full course of 
antibiotic/medication 
2  
Danger sign/when to return to  
hospital 
3  
Other (specify) ___________ 4  
Don’t know/can't remember 8  
A3
3 
Did the provider 
advise you to take the 
baby back to the 
facility during this 
follow-up contact? 
Yes  1  





Did anyone visit your 
household and ask 
about current 
condition of the yor 
child after the initial 
visit?  









Please tell me the 
particulars of the 
visiting service 
provider. 
Who? Name: _____________ Don’t know=8  
  




(24 hour)  __ __ : __ __ 
A3
6 
What did he/she 
talk/ask about?  
Current status of the child 1 
 
Importance of completing the 






Section A: Sepsis Case Tracking 
Q# Question Coding categories Code Skip 
Danger sign/when to return to  
hospital 
3  
Other (specify) ___________ 4  
Don’t know/can't remember 8  
A3
7 
Did he/she physically 
examine your child? 
Yes 1  
No 2  
Don’t know/can't remember 8  
A3
8 
Did the provider 
advise you to take the 
baby back to the 
facility during this 
follow-up visit? 
Yes 1   
No 2  









Yes  1  












For this episode of your 
infant’s illness, did you 
or another family 
member administer 
medicine to the infant 
at home?  
Yes 1  
No 2 →B14 
Don’t know/can’t 




Were you the person 
primarily responsible 
for giving medicine to 
the infant?  
Yes 1 →B04 
No 2 →B03 
Don’t know/can’t 




If the respondent was 
not the person primarily 
responsible for giving 
medicine to the infant, 
who was?  
Infant’s mother 1  
Infant’s father 2  
Infant’s 
grandmother/grand
father 3  
Sister /brother 4  
Other (specify) 
________________ 5  
Don’t know/can’t 




Did you ever forget to 
administer medication 
to your baby? 
Yes 1  
No 2  
Don’t know/can’t 
remember 8  
How often did you have 
difficulty remembering 
Very often  1  







to give the baby his/her 
medicine? 
Prompt each response 
first as options and the 
record     
Did not have 
trouble 
remembering 3  
Don’t know/can’t 




Sometimes parents do 
not administer 
medication as directed 
for reasons other than 
forgetting. Were there 
any days that you did 
not administer 
medication for other 
reasons? 
Yes 1  
No 2  
Don’t know/can’t 




Did you ever feel it was 
an inconvenience to 
adhere to the 
medication schedule? 
Yes 1  
No 2  
Don’t know/can’t 




Did you ever stop 
administering 
medication to your 
baby because they had 
a negative side effect 
when they took the 
medication? 
Yes 1  
No 2  
Don’t know/can’t 




Did you ever stop 
administering 
medication to your 
baby because they 
seemed to not be sick 
anymore? 
Yes 1  
No 2  
Don’t know/can’t 




When administering the 
medication, how 
confident were you in 
your ability to properly 
give the medication to 
the infant? 
Very confident  1  
Somewhat 
confident 2  
Not confident 3  
Don’t know/can’t 




How confident were 
you in your ability to 
administer the 
medication every day as 
instructed by the 
provider? 
Very confident  1  
Somewhat 
confident 2  
Not confident 3  
Don’t know/can’t 




How confident were 
you in your ability to 
administer the 
medication more than 
one time each day as 
instructed by the 
provider? 
Very confident  1  
Somewhat 
confident 2  
Not confident 3  
Don’t know/can’t 




How confident were 
you in your 
understanding of the 
Very confident  1  
Somewhat 





for administering the 
medication at home? 
Not confident 3  
Don’t know/can’t 




How confident were 
you in your ability to 
identify the following 
signs of illness in your 
infant?  
Prompt for each 
symptom and circle the 
corresponding number 









nt     
Severe chest in-
drawing 




1 2  3 
Fever or Raised 
temperature 
1 2  3 
Poor or no sucking 
reflex 
1 2  3 
Unconscious  or 
drowsy 





1 2  3 
Central cyanosis 1 2 3 
Convulsion /history 
of convulsions 




1 2 3 
Bulging fontanelle 1 2  3 




umbilicus/ Red and 
swollen    




What is the current 
status of your child?  
Alive and recovered 
at home 
1 →C01 
Sick and at home 2 →C01 
Sick and admitted 
at hospital 
3 →B16 




If B1(2), date and time 





|____|____|   
Visiting time (24 





If B15(4), date, time and 
causes of death 












*   
 
 
End the interview with thanks. Before leaving the interview place, carefully check whether all the 




______________________________    
 _________________________ 
Signature of data collector      Signature of reviewer 






Ending time of 
interview 
 




Visit Outcome  
 
Interview Completed……….. 01 
Interview incomplete………. 02 
Respondant absent…………. 03 
Refused to give interview …04 
Migrated out………………… 05 




If the outcome code between 03-06 then 
plan for one return visit and indicate 
below (C03) 
C03 
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